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ABSTRACT 
Probiotics have been used as a prophylactic antibiotic alternative to improve health and 
growth performance in animals. However, the selection of probiotic strains is limited due to the 
lack of stability during storage, processing and passage through the upper gastrointestinal tract. 
In the current study, pea protein isolate-alginate based capsules (PPC) were made by extrusion 
and their efficacy to improve probiotic viability during storage, feed processing and delivery to 
the distal intestine were investigated. Encapsulation protected against loss of Bifidobacterium 
adolescentis viability during freeze-drying compared to non-encapsulated bacteria. Capsules also 
improved the viability of freeze-dried B. adolescentis during long-term (335 d) storage at -80 °C. 
In contrast, encapsulation did not improve viability of B. adolescentis or Lactobacillus reuteri 
when stored above 0 ºC. Loss of viability during short duration (up to 180 s) heat challenge (up 
to 90 °C) was reduced by encapsulation. Encapsulation also protected against loss of viability 
during heat challenge up to 90 °C with a pressure of 95 MPa for 30 s, however, encapsulation did 
not protect bacteria added to feed and subject to commercial pelleting. A naturally selected 
antibiotic resistant L. reuteri, was selected to facilitate strain-specific tracking of viable bacteria 
in the gastrointestinal tract. Supplementation of pigs with encapsulated antibiotic resistant L. 
reuteri in feed did not increase bacterial counts in upper tract compared with non-encapsulated 
bacteria, however, the counts of viable antibiotic resistant L. reuteri in the distal gastrointestinal 
tract and feces of pigs was increased. In conclusion, pea protein isolate-alginate based 
encapsulation improved bacteria viability during freeze-drying and provided limited benefit 
during cold storage of sensitive bacteria. Improved resistance to environmental challenge (heat 
and pressure) was observed, but was insufficient to protect against conditions found during 
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commercial feed pelleting. Encapsulation may improve the shelf life of probiotic bacteria during 
cold storage and this work is the first work to show improved delivery of bacteria to the distal 
digestive tract of the pig. However, post-pellet application technologies and improved methods 
of viability protection during storage above 0 ºC are required to broaden the commercial 
application of probiotics in the feed industry. 
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1 GENERAL INTRODUCTION 
Probiotic organisms, as defined originally in 1907 by Elie Metchnikoff, are 
microorganisms that hold the promise to promote host health upon ingestion (Metchnikoff and 
Mitchell, 1907). The addition of probiotic organisms to animal feeds has been reported to 
support a number of benefits in livestock species including improvement in animal growth 
performance (Cao et al., 2013), decline of pathogenic organisms in infected animals (Casey et al., 
2007), and decreased incidence of diarrhea (Jood et al., 2012). Probiotic organisms have thus 
been commercially applied in the feed industry as growth promoters and alternatives to 
antibiotics across species (Khosravi et al., 2012; Suo et al., 2012; Giri et al., 2013).  
One crucial requirement for applying probiotics in the feed industry is to maintain a 
sufficiently high viability of the probiotic organism under various processing, storage and feed 
delivery conditions such that sufficient numbers of live organisms reach the colon to be able to 
mediate beneficial effects (Bouhnik, 1993). Challenges to probiotic viability include changes in 
moisture concentration, heat stress, physical compression, oxygen exposure and exposure to 
other feed ingredients with selective antimicrobial action presented during drying, manufacturing, 
storage, delivery and handling (Kurtmann et al., 2009; Weinbreck et al., 2010; Borges et al., 
2012). Furthermore, following ingestion, probiotic organisms may be sensitive to digestive 
enzymes, gastric acid, bile salts and secreted antimicrobial compounds present in the 
gastrointestinal tract (Brinques and Ayub, 2011; Zhang et al., 2013).  
To date, the primary solution to these challenges has been the selection of thermostable, 
acid and oxygen tolerant strains. However, very few strains meet this requirement, which limits 
the application of other probiotic species that could provide added health benefits. In the current 
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feed market, only a few probiotic organisms (Enterococcus feacium, spore generating Bacillus 
spp, and Saccharomyces cerevisiae) have been incorporated into commercial pelleted feeds. The 
development and application of technologies that provide a more static environment for microbes 
during feed processing and delivery could broaden the selection of probiotic strains suitable for 
commercial application.  
Recently, encapsulation methods have been employed to entrap probiotics into a coating 
matrix to provide additional protection against environmental changes and mediate controlled 
release in the distal gut. Alginate is an inexpensive, non-toxic, gel-forming material. It has been 
broadly used in encapsulation (Su et al., 2011; Sathyabama et al., 2014). However, alginate alone 
has not shown a sufficient protection of probiotics (Lee and Heo, 2000). The addition of a 
concentrated protein source, such as pea or whey protein has provided additional protection in 
combination with alginate (Klemmer et al., 2011a). Other cryoprotectants like skim milk, 
glycerol and cysteine-HCl may also provide significant protection during storage and freeze-
drying (Pan et al., 2013).   
An efficient and low-cost coating for probiotic application in animal feed is needed. Thus, 
the overall objective of this project was to investigate the efficacy of pea protein isolate and 
alginate based capsules in maintaining probiotic viability during storage, feed processing and 
delivery to the intestine in food animals. 
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2 LITERATURE REVIEW 
2.1 Challenges to maintaining viability and efficacy of probiotics in feed applications  
Probiotic organisms have been incorporated into the diets of animals for decades and are 
reported to provide several significant benefits to animal health and production (Vanbelle et al., 
1990). Recent restrictions on antibiotic use in animal agriculture have increased interest in the 
use of probiotics as alternatives for antibiotic growth promotion and prophylaxis (Cheng et al., 
2014). Antibiotic use for growth promotion in livestock was banned by the European Union (EU) 
in 2006 due to the risk associated with an increase in the prevalence of antibiotic-resistant genes 
in pathogens that can adversely affect humans (Dibner and Richards, 2005). Increased regulatory 
restriction on antibiotic use, combined with consumer demand for products raised without the 
use of antibiotics, has expanded the market for probiotics in the animal feed industry such that 
the probiotic industry is expected to grow annually by 7.7 % between 2016 and 2021 to an 
anticipated market value of $4.71 billion US (Anonymous, 2017a).  
In the feed market, there are many commercial products that contain single or multiple 
probiotic strains. A summary of probiotics currently used in animal feed market are listed in 
Table 2.1. The summary is based on a review of products registered by the European Food 
Safety Authority (Additives and Products or Substances used in Animal) and is supplemented by 
a review of company websites known to offer probiotic products. The United States, the EU and 
Canada each have unique regulatory systems for identifying and regulating probiotic products. 
The United States uses the phrase Direct-Fed Microbial products (DFM) for probiotics in animal 
feed. A list of the approved DFMs that can be incorporated into animal feed can be found in the 
Association of American Feed Control Officials (AAFCO) (Pendleton, 1998). 
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Table 2.1. List of commercial direct feed microbial products used in the animal feed industry. Products are summarized by probiotic strain, 
product and company name, target animal(s), heat tolerance, storage conditions and shelf-life*. 
Category  Strain(s) Name Company Animal Heat Tolerance  Storage Conditions & Shelf-life Ref. 
Bacillus spp. B. subtilis  
(C-3102) 
Calsporin® Asahi Calpis 
Wellness 
Broilers, Hens, 
Swine, Horses, 
Dogs 
Can be pelleted up 
to 90 °C 
Stored 37 months (mo) at 25 °C 
under 60 % relative humidity 
(RH) or 6 mo at 40 °C under 
75 % RH. 
1 
        
 B. subtilis  
(DSM 17299) 
 
GalliPro® 
 
Chr. Hansen Poultry Can be pelleted up 
to 84 °C (86.7 % 
survival) 
 
Stored up to 35 mo at ambient 
temperature or for 24 mo when 
stored at 37 °C (82 % survival 
rate). 
2 
 
 
        
 B. subtilis 
(CBS 117162)  
Animavit® Kemin Pig Can be pelleted at  
80 °C (80 % 
recovery) 
Stored at 25 °C or 30 °C for 18 
mo (results in 24 % reduction in 
viability). 
3 
 
        
 B. subtilis (ATCC 
PTA-6737) 
Clostat® 
 
Lactosan Poultry  Can be pelleted up 
to 90 °C 
Stored for 3 years (yr) at room 
temperature. 
4 
        
 B. licheniformis 
(DSM 5749) and 
B.subtilis (DSM 
5750)  
BioPlus® 
 
Chr. Hansen Swine, Poultry Can be pelleted up 
to 95 °C 
 
Stored for 24 mo in a cool, dry 
place at temperatures not 
exceeding 25 °C. 
5 
        
 B. cereus var. toyoi 
(NCIMB 
40112/CNCM I-
1012) 
Toyocerin® Rubinum 
S.A 
Poultry, Pig Can be pelleted to 
90 °C 
Stable when stored for 21 mo at 
15-25 °C or 6 mo for 30 °C. 
6 
        
 B. amyloliquefaciens 
(CECT 5940) 
Ecobiol® Norel S.A. 
(Evonik)  
Poultry  Can be pelleted up 
to 80 °C 
Stable when stored for one year at 
ambient temperature in original 
packaging. 
7 
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Table 2.1. List of commercial direct feed microbial products used in the animal feed industry. Products are summarized by probiotic strain, 
product and company name, target animal(s), heat tolerance, storage conditions and shelf-life. Continued. 
 
Category  Strain(s) Name Company Animal Heat Tolerance  Storage Conditions & Shelf-life Ref. 
Lactic acid 
bacteria  
Pediococcus 
acidilactici 
(MA18/5M) 
Bactocell® Lallemand Laying hens 
/Fish/Pig 
Apply through 
drinking system (no 
information on 
pelleting) 
Stored for 24 mo at room 
temperature.  
8 
        
 L. farciminis (CNCM 
MA 67/4R) 
Biacton® Chemvet  Pig/Poultry  Can be pelleted, 
heat resistant at 80 
˚C for 20 min and 
at 95 ˚C for 2 min   
Coated bacteria stored for 12 mo 
in dry and original packaging. 
9 
        
 L. acidophilus and  P. 
freudenreichii 
Bovamine®
Dairy  
  
Chr. Hansen Rumen  Do not exceed   
48.9 °C when 
mixing (no 
information on 
pelleting) 
  
Stored in freezer until mixture 
with feed (no information on the 
length of storage). 
10 
        
 L. reuteri  Finelact®  Asahi Calpis 
Wellness 
Poultry Add to the drinking 
water (no 
information on 
pelleting)  
Stored for two mo when 
refrigerated at 39 °F (4 °C) or 
lower and two years when 
refrigerated at -15 °C. 
11 
        
 L. acidophilus 
 
  
PoultriMax
® 
Chr. Hansen Poultry Post pelleting 
application   
Stored in a cool, dry location. 12 
        
 E. faecium (NCIMB 
11181)  
 
Lactiferm® Chr. Hansen Pig, Calves and 
Poultry  
Post pelleting 
application   
Stored refrigerated (4-5 ºC) in 
original, closed packaging. 
13 
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Table 2.1. List of commercial direct feed microbial products used in the animal feed industry. Products are summarized by probiotic strain, 
product and company name, target animal(s), heat tolerance, storage conditions and shelf-life. Continued. 
Category  Strain(s) Name Company Animal Heat Tolerance  Storage Conditions & Shelf-life Ref. 
 E. faecium NCIMB 
10415 
Cernivet® 
LBC ME20 
PLUS 
Cerbios-
Pharma SA 
Calves, 
Chickens and 
Swine 
Microencapsulated  
can be pelleted (no 
pelleting 
temperature 
information) 
Stored for 18 mo at 2-8 °C, 
enclosed in the original container. 
14 
        
 E. faecium  
(DSM 7134) 
Bonvital® Lactosan Calve, Piglet 
and Broiler  
Can be pelleted at 
70-72 °C. After 
pelleting, 85 % of 
the initial activity 
was recovered 
Stored for 12 mo at 4 °C or 20 °C 
or stable when stored for 6 mo at 
37 °C. 
15 
        
 E. faecium  
(NCIMB 10415)  
Cylactin® DSM  Multispecies   Can be pelleted up 
to  95 °C 
Stored for up to one year when 
refrigerated, or six mo at 2-8 °C, 
or for two mo at 25 °C or for 4 
weeks (wk) at 37 °C. 
 
16 
        
 E. faecium  
(CECT 4515) 
Fecinor® Norel S.A. 
(Evonik) 
Poultry, Swine   Good resistance up 
to 60°C. At 70 °C 
there was 0.4 log 
loss (no information 
on pelleting) 
Stored for 12 mo at 25 °C and 
40 °C (0.7 log loss). 
17 
        
 E. faecium  
(DSM 10663/NCIMB 
10415) 
Oralin®  Chevita 
GmBH 
Calves, Piglets, 
Broilers, 
Turkeys, Dogs 
and Cats 
Not able to pellet  Stored for 12 mo at room 
temperature. 
18 
        
Yeast S. cerevisiae  
(CNCM I-1077 and I-
1079) 
Levucell® 
series 
Proternative
® series 
Lallemand Multiple species  
 
Can be pelleted in 
Titan model 
(encapsulated) up to 
80 °C 
Stored for 24 mo in closed 
packaging in cool dry place. 
19 
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Table 2.1. List of commercial direct feed microbial products used in the animal feed industry. Products are summarized by probiotic strain, 
product and company name, target animal(s), heat tolerance, storage conditions and shelf-life. Continued. 
Category  Strain(s) Name Company Animal Heat Tolerance  Storage Conditions & Shelf-life Ref. 
 S. cerevisiae 
 (NCYC Sc 47) 
ActiSaf® Lesaffre Ruminants Can be pelleted up 
to 80 °C 
Stored for 12 mo at 30 °C (less 
than 0.1 log value loss). 
20 
        
 S. cerevisiae  
(MUCL 39885) 
Biosprint® Prosol SpA Multiple species Can be pelleted up 
to 80 °C 
Stored for 24 mo in an aluminium 
foil package under vacuum at 
25 °C. 
21 
        
 S. cerevisiae  
(NCYC R-625) 
InteSwine®  Integro Gida 
SAN. Ve 
TIC A.S 
Pig Can be pelleted at 
85 °C 
Stored for 12 mo at 30 °C (less 
than 0.1 log value loss). 
22 
        
Others  Cellulomonas sp. Spiromac-c Geomarine 
Biotechnolo
gies 
Beef cattle  Not indicated  Stored for two years in a dark, 
cool place away from direct 
sunlight. 
23 
        
 Live intestinal 
microflora derived 
from Specific 
Pathogen Free 
chickens   
Aviguard® MSD 
Animal 
Heath/ 
Lallemand  
Poultry Spray application. 
no pelleting 
information  
Stored for 18 mo in original 
packaging. 
24 
        
 E.  faecium, 
P. acidilactici, B. 
animalis, L. reuteri  
PoultryStar
®
 Biomin Poultry  Can be pelleted in 
the 
microencapsulated 
form (no 
temperature 
information) 
Stored for 12 mo in the original 
package and stored in cool and 
dry place. 
25 
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*References are listed in Appendix A.   
 
 
 
  
 
  
        
Table 2.1. List of commercial direct feed microbial products used in the animal feed industry. Products are summarized by probiotic strain, 
product and company name, target animal(s), heat tolerance, storage conditions and shelf-life. Continued. 
Category  Strain(s) Name Company Animal Heat Tolerance  Storage Conditions & Shelf-life Ref. 
 L. acidophilus, L. 
helveticus, L. 
bulgaricus,  
L. lactis, S. 
thermophilus and E. 
faecium  
Lactina® Chevita Pig and Poultry  No information. Stored for a year under nitrogen at 
5 °C (while under oxygen lead to 
2 log reduction). 
With storage at 37 °C, there was a 
loss of 2 log/g under nitrogen and 
4 log/g in the presence of oxygen. 
26 
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The US Food and Drug Administration (FDA) also has a program called “Generally Recognized 
as Safe” (GRAS), whereby ingredients on this list are exempt from regulation as additives 
(Bajagai et al., 2016). In contrast, EU regulations require that each probiotic product registration 
must provide documentation detailing product identity, safety and efficacy to be assessed by a 
scientific commission (Bajagai et al., 2016). In Canada, probiotics in animal feed are regulated 
by the Canadian Food Inspection Agency (CFIA). Four microorganisms are listed in Feed 
Ingredient Schedule IV part II, including three bacterial genera (Bacillus, Enterococcus, 
Lactobacillus) and yeast. Part II of Schedule IV lists feed ingredients and additive categories that 
have been registered based on a proprietary manufacturing process. Unfortunately, CFIA does 
not provide detailed information regarding registered products. Similarly, there is no list of 
registered commercial probiotic products provided by the FDA in the United States. Thus, the 
probiotic list provided in the table may not include all probiotic products on the global market. 
However, the table provides a comprehensive list of commonly used probiotics strains currently 
used in animal nutrition identified through an extensive literature search.  
Information summarized in Table 2.1 includes product category, the specific 
microorganism, product name, name of the manufacturer, target animal(s), heat tolerance, 
storage condition and shelf-life. Commercial probiotic products can be placed into three main 
categories based on the taxonomy of the organisms including Bacillus spp. (B. subtilus, B. 
licheniformis, B. cereu, B. amyloliquefaciens), lactic acid bacteria (L. farciminis, L. acidophilus, 
L. reuteri, Enterococcus faecium, Pediococcus acidilactici) and yeast (Saccharomyces 
cerevisiae). The taxonomic distribution of probiotic organisms is extremely narrow compared to 
the diversity of organisms colonizing the digestive tract of animals with a potential probiotic role. 
A major factor affecting taxonomic diversity in successfully commercialized probiotic strains is  
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the requirement to provide the animal with viable organisms and the susceptibility of most 
microorganism species to losses during processing, storage and passage through the digestive 
tract. 
Among the three categories listed in Table 2.1, only spore-forming Bacillus spp. and 
yeast strains show consistent survival after pelleting (a common process used in feed milling) 
and can survive storage at ambient temperature for a reasonable period of time. Lactic acid 
bacteria products are typically applied just prior to feeding by mixing with feed, or with water, 
due to limited resistance to conditions associated with feed processing and storage (Kalavathy et 
al., 2003; Jung et al., 2008). The only exception is a microencapsulated lactic acid bacteria (L. 
farciminis (Chemvet, 2017) and E. faecium (Simon et al., 2005).   
Ideally, bacterial strains suitable for animal feed production should be able to maintain 
high viability during several challenges experienced during probiotic manufacturing, feed 
processing and gastrointestinal delivery, as illustrated in Figure 2.1. Probiotic manufacturing 
exposes organisms to thermal, oxidative and chemical stressors during culture, drying, packaging 
and storage. Probiotics are also exposed to mechanical, oxidative and thermal stressors during 
feed processing and storage. Finally, on the delivery of formulated feed to the farm, probiotic 
strains are exposed to chemical and thermal stressors during storage in outside feed bins and 
transport to the feed bunk, as well as during passage through the upper gastrointestinal tract. 
Several studies have also highlighted the potential challenges probiotics face during food 
industry processing (Sissons, 1989; Tripathi and Giri, 2014). However, very few studies have 
investigated the effects of feed processing on probiotics (Kosin and Rakshit, 2006). Here, we 
reviewed the challenges in the feed industry associated with the commercial delivery of viable 
probiotic products.   
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Figure 2.1. Possible challenges to probiotics used in animal feed 
 
2.1.1 Probiotic manufacture and storage   
Probiotic products are manufactured prior to being incorporated into feed. The primary 
process of probiotic manufacturing includes selection of strains, fermentation, dehydration and 
packaging. After probiotic production, the product needs to be stored properly to maintain 
viability for future application. Probiotic manufacturing and storage can affect probiotic 
properties in several ways (e.g. viability, adhesion, thermophilic, immunologic functions) 
(Grześkowiak et al., 2011). Strain selection (Godward et al., 2000), cultural media and methods 
(Elo et al., 1991), drying methods and duration (Chávez and Ledeboer, 2007), protective 
additives (Corcoran et al., 2004), packaging material and method (Talwalkar et al., 2004), storage 
condition and solution (Mortazavian et al., 2007) can all affect probiotic properties, which could 
alter their future performance. A detailed review of each aspect is discussed below. 
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2.1.1.1 Probiotic selection and fermentation 
Probiotic strains developed for commercial application undergo a selection process based 
on their non-pathogenic and health-promoting effects, as well as their ability to survive stress 
experienced during probiotic processing and gastrointestinal digestion (Kosin and Rakshit, 
2006). Common selection processes include: 1) isolation, taxonomic identification and biosafety 
check; 2) acid tolerance (e.g. mimic stomach conditions); 3) bile tolerance; 4) adherence to 
epithelial tissue; 5) antimicrobial ability/antagonisms to pathogens; 6) stimulation of immune 
system; 7) resistance to processing conditions (e.g. heat, oxygen and storage); and 8) animal 
growth/health performance (Rodriguez et al., 2003; De Angelis et al., 2006; Torshizi et al., 
2008). Another major challenge in selecting suitable probiotic strains in the feed industry is the 
retention of bacterial viability during processing, and especially during pelleting. Identification 
of thermophilic probiotic bacterial strains, development of protective additives, and development 
of a coating capable of increasing resistance to stressors encountered during probiotic 
manufacturing and feed processing have been areas of significant research interest. 
Probiotic strains selected for commercial application must be produced in large quantities 
typically by large-scale fermentation. Differences in fermentation time, growth medium 
composition and other culture conditions (e.g. temperature and pH) affect probiotic viability and 
function and must be controlled (Bajagai et al., 2016). The detailed information regarding the 
effect of fermentation conditions on probiotic viability and function has been reviewed by others 
(Champagne et al., 1996; Lacroix and Yildirim, 2007; Meng et al., 2008).  
2.1.1.2 Dehydration  
Following fermentation, spent culture medium is commonly removed by centrifugation 
and replaced with a dehydration medium prior to further dehydration, packaging, storage and 
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distribution. Dehydration is commonly used for long-term stabilization of probiotic organisms. 
However, survival of probiotic organisms during the dehydration process is critical and varies by 
dehydration method, bacterial species, bacteria cell harvest conditions, components of the 
dehydration medium and drying time (Golowczyc et al., 2011). Loss of probiotic viability during 
dehydration may be caused by leakage of intracellular components from cells into the 
surrounding environment due to cell membrane damage and increased cell permeability (Teixeira 
et al., 1995). In addition, approximately 80 % of bacterial cell reactions are related to water 
bound to macromolecules and organelles (i.e. bound water), instead of free water (Webb, 1960). 
The loss of bound water decreases the survival rate in probiotics by weakening cellular 
molecular bonds resulting in the loss of cell surface proteins and causing physical damage to the 
cell wall and membrane (Brennan et al., 1986). Interestingly, such damage may not result in 
immediate cell death but can cause bacteria to become sensitive to challenge compounds like 
oxgall (bile salts) and lysozyme encountered in the digestive tract (Brennan et al., 1986).  
Residual water percentage is a parameter typically used to confirm adequate drying 
because the viability of probiotics is very sensitive to percent residual water (Laulund, 1994). 
The percent of residual water can be affected by the drying medium, storage conditions, and 
species of probiotic (Scott, 1958; Webb, 1960; Fry, 1966). The presence of water in the final 
product provides a solution for chemical reactions, leads to sharp crystal formation during 
subsequent freezing and accelerates the oxidation of lipids (Karel, 1980). Generally, residual 
water of less than 4 % is considered desirable for long-term storage of dry products (Gardiner et 
al., 2000), whereas residual water higher than 10 % is not suitable for storage (Desmond et al., 
2002). Zayed and Roos (2004) compared 4 levels of residual water content (0 %, 2.8 %, 5.6 % 
and 8.8 %) and found 2.8 % or 5.6 % as optimal for freeze-dried  L. salivarius viability during 
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storage. Some reports have noted that a residual water of less than 4 % contributes to 
dehydration damage and a lower survival rate (Fry, 1966; Heidebach et al., 2010).  
Spray drying and freeze-drying are the most commonly used drying methods for 
probiotic products. During spray drying, a bacterial solution is forced under pressure through a 
nozzle to form small droplets in a heated chamber allowing for rapid evaporation of water 
(Gardiner et al., 2000). In freeze-drying, after initial water removal by centrifugation or filtering, 
water is removed after rapidly freezing bacteria by sublimation under a high vacuum (Meng et 
al., 2008). Thus, the stresses associated with spray drying are dehydration and thermal 
inactivation, whereas freeze-drying stresses include dehydration and freezing.   
Of the two common drying methods, spray drying is considered more cost-effective for 
large-scale probiotic production (Simpson et al., 2005; Santivarangkna et al., 2007). There are 
many studies examining the performance of different bacteria strains during spray drying (Lian 
et al., 2002; Simpson et al., 2005; Gardiner et al., 2000). Bacteria strain, outlet temperature and 
the inclusion of protective additives are critical factors affecting bacterial viability during spray 
drying. For example, the survival rate of B. infantis and B. longum differ by 0.08 to 82.59 % after 
spray drying, respectively (Lian et al., 2002). Similarly, after spray drying, Ranadheera et al., 
(2015) observed species differences among the survival rate of L. acidophilus, B. animalis and 
Propionibacterium jensenii (1 to 2 log reduction colony formatting unit [cfu]/g), maintained 
under the same conditions (Ranadheera et al., 2015). Furthermore, several studies have noted 
decreased survival rate with increased outlet temperature (Outlet temperature can exceed 100 °C; 
Golowczyc et al., 2011; Lian et al., 2002). Although convenient and economical, spray drying is 
not suitable for sensitive bacteria because of the high temperatures and harsh processes that 
probiotics are exposed to during this drying method. However, outlet temperature reduction 
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(Ananta et al., 2005), environmental adaption (Desmond et al., 2001), adding protective 
materials (Avila-Reyes et al., 2014) and encapsulation (Desmond et al., 2002) have been 
successfully applied during spray drying to improve bacteria survival. 
Freeze-drying is an alternative method to spray drying with comparatively higher 
survival rates, particularly for thermo-sensitive bacteria such as some Lactobacillus and 
Bifidobacterium species (Zayed and Roos, 2004; Saarela et al., 2006; Santivarangkna et al., 
2007; Bolla et al., 2011). An improved survival rate (>70 %) was observed with freeze-drying 
compared to spray drying (< 1 %) at 75 and 85 °C for Bifidobacterium pseudocatenulatum, with 
skim milk as a carrier. A number of factors affect viability during freeze-drying including 
freezing speed, cold stress and cell surface area. The speed of freezing is important and can 
affect survival rate. Slow freezing increases the solute concentration in the unfrozen portions 
leading to intracellular ice crystal formation (Zhao and Zhang, 2005). Therefore, a fast freezing 
process is more desirable. Cold stress (i.e. freezing) can also lead to stabilization of the 
secondary structure of RNA resulting in a reduced efficiency of gene expression that may 
contribute to bacterial inactivation (van de Guchte et al., 2002). 
Furthermore, cell surface area has been associated with crystal formation during freezing 
and affects the survival of probiotics. For example, during freeze-drying, studies have noted that 
enterococci with smaller spherical cells have a higher survival rate than lactobacilli with larger 
rod-shaped cells (Fonseca et al., 2000). However, it is noteworthy, that Chandralekha et al. 
(2016) reported that although freeze-drying improved survival rates compared with spray drying 
the loss of viability during storage was more rapid for freeze-dried products possibly negating 
some of the benefits of this method. Survival rate was higher in L. helveticus after freeze-drying 
compared to spray drying at a high (120 °C) or low (82 °C) temperature. However, bacteria dried 
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with low temperature spray drying had higher functionality, as demonstrated by lactic acid 
production and enzyme activity (Johnson and Etzel, 1995). Therefore, the selection of freeze-
drying or spray drying should be based on bacteria strain properties and the downstream 
production purposes.   
2.1.1.3 Storage 
There are many factors that may affect the viability of dry powdered probiotics during 
storage including temperature, rehydration and oxygen exposure. The degree of impact varies by 
probiotic strain. Optimizing storage conditions, packaging method and protective additives are 
all important considerations in maintaining viability and extending the shelf-life of dehydrated 
probiotic products prior to incorporation into feed.  
A long shelf-life and resistance to fluctuating storage temperatures are desired for 
probiotic products for user convenience and cost reduction. It is recommended that probiotic 
organisms be stored at 4 to 5 °C (Mortazavian et al., 2007). Increasing storage temperatures 
above 4 °C accelerates the loss of probiotic viability even though an ambient storage temperature 
is preferred in the industry to reduce storage costs. For example, a comparison of the viability of 
spray dried L. paracasei and L. salivarius, after 2 mo storage, drying with skim powder and 
stored at 4, 15 and 30 °C, indicated that the best survival rate of both strains was 4 °C with a 
survival rate of 92 % and 13 %, respectively. Storage at 15 °C decreased survival rate to 11 and 
2 %, respectively (Gardiner et al., 2000). Therefore, a storage temperature below 4 °C was 
recommended for sensitive strains. Furthermore, Bruno and Shah (2003) found that -18 °C was 
the best temperature for storing encapsulated B. longum, which had a minimal 1.6 log cfu/mL 
loss after 20 mo of storage. In the same study, storage at 4 and 20 °C resulted in greater than 5 
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log cfu/mL reduction and a bacteria count below detection for encapsulated bacteria after 5 mo 
storage, respectively (Bruno and Shah, 2003). 
Relative humidity (RH) and water activity should also be considered during storage. High 
RH leads to water reabsorption in dried products and a loss of viable cells during long-term 
storage. Under a RH of 45 % compared to 12 %, the loss of whey protein encapsulated L. 
acidophilus was approximately 2 log cfu/mL higher after 180 d at 22 °C (Rodrigues et al., 2011). 
A high water residual also leads to the loss of probiotic viability during storage. Controlling 
water residual to less than 4 % for dry products has been observed to reduce viability loss during 
long-term storage (Vesterlund et al., 2012). 
Besides temperature and moisture, oxygen is another critical challenge probiotics face 
during storage. Molecular oxygen is toxic to probiotics and is especially lethal for strict 
anaerobic strains. In order to survive under aerobic conditions, anaerobic strains have to convert 
reactive oxygen to nontoxic molecules to lower the risk of death from oxidative damage 
(Talwalkar and Kailasapathy, 2004). In anaerobes, the oxidative and reductive reactions are 
regulated by pyridine nucleotides, such as Nicotinamide Adenine Dinucleotide (NADH). 
Generally, the activation of NADH oxidase (NADH-H2O2 and NADH-H2O), which are 
commonly found in lactic acid bacteria, can reduce molecular oxygen (Condon, 1987). The 
incomplete reduction of O2 from NADH oxidase is followed by its removal through superoxide 
dismutase (SOD) (Sanders et al., 1995) and NADH peroxidase (Thomas and Pera, 1983). 
Bacterial oxygen tolerance is related to its ability to scavenge molecular oxygen. Oxygen 
tolerance in anaerobic bacteria generally increases with higher levels of NADH oxidase and 
NADH-peroxidase (Talwalkar and Kailasapathy, 2003).  
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Oxygen tolerance in probiotics is species specific. For example, L. acidophilus is 
generally more tolerant than Bifidobacterium spp. during oxidative stress (Talwalkar and 
Kailasapathy, 2003; Vasiljevic and Shah, 2008). At the same oxygen challenge level (21 %), the 
NADH oxidase and NADH peroxidase were consistently lower in Bifidobacterium spp. when 
compared to L. acidophilus strains. Oxygen tolerance of bacteria can also differ among the same 
genus; in Bifidobacterium spp., levels of NADH oxidase (ranging from 4.66 to 18.91 per mg of 
total protein of the cell free extract) and NADH peroxidase (ranging from 7.56 to 16.86 per mg 
of total protein of the cell free extract) have been observed to vary widely (Talwalkar and 
Kailasapathy, 2003). Differences in NADH oxidase and peroxidase in Bifidobacterium spp. may 
have also explained differences in among-species survival during incubation in ambient air; after 
48 h incubation in ambient air, B. adolescentis did not survive, whereas the survival percentage 
of B. bifidum, B. breve and B. longum species was above 78 % (Andriantsoanirina et al., 2013). 
Probiotic viability during storage may also differ by strain due to variation in their 
resistance level for exposure to oxygen, heat and cold stressors. For example, the viability of L. 
acidophilus was highest when stored at 2 °C, whereas the viability of B. lactis was highest when 
stored at 8 °C in yoghurt after 20 d (Mortazavian et al., 2007). In contrast to sensitive lactic acid 
bacteria strains, spore-forming strains and yeast are more stable during storage. The difference in 
storage stability among different probiotic strains is evident in the list of commercial products 
provided in Table 2.1. Whereas, Bacillus spp. and yeast products have a minimum one-year 
shelf-life when stored at ambient temperature, non-coated Lactobacillus spp. require storage at a 
lower temperature (- 4 °C or below 0 °C) to maintain their shelf-life.  
Packaging is one of the solutions to reduce environmental-induced stress in probiotic 
organisms during storage. The type of packaging material, the permeability of packaging (e.g. 
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oxygen and light), packaging technique (e.g. vacuum vs. non-vacuum) all affect probiotic 
viability (Dianawati et al., 2016). Product packages provide a barrier between the probiotic 
organism and external atmosphere (e.g. oxygen and humidity). During storage of probiotic 
products, viability is generally higher with a lower percent oxygen in the package. For example, 
glass packaging is more protective than plastic barriers because less oxygen can permeate into 
the packaging (Dave and Shah, 1997; Jayamanne and Adams, 2004). However, due to the high 
cost and difficulties in handling glass packaging, plastic film packaging is more commonly used 
(da Cruz et al., 2007). Applying the proper packaging method can also improve bacteria viability 
during storage. Vacuum packaging is commonly utilized in the food industry to reduce oxygen 
levels in the final product and improve the shelf-life of meat and dairy products (Schillinger and 
Lücke, 1987; Kasımoğlu et al., 2004; Talwalkar et al., 2004). It is recommended that freeze-dried 
bacteria cultures are stored under vacuum or under nitrogen gas at low temperatures (El-Sadek, 
1975; Champagne et al., 1991). For example, Yang and Sandine (1979) observed that vacuum 
packaging was the most suitable storage package for freeze-dried lactic acid bacteria stored at  
25 °C, when compared to storage under gas (e.g. nitrogen, carbon dioxide and argon). Similarly, 
vacuum packaged Pantoea agglomerans maintained its viability of 10
9 
cfu/mL during storage for 
90 d at 4 °C, whereas a 2.5 log cfu/g reduction was observed when it was stored under nitrogen 
gas (Costa et al., 2002). 
During probiotic manufacturing, protective materials are commonly applied to probiotics 
to limit damage from freezing, drying, and oxidation. Cryoprotectants are chemical compounds 
used during the freezing process to protect against cell damage by increasing solute 
concentration. Cryoprotectants can act intracellularly or extracellularly depending on their 
chemical properties. Penetrating cryoprotectants bind to water inside the cell to prevent 
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hyperosmotic injury and promote the formation of fine ice crystals over large, damaging ice 
crystals. Non-penetrating cryoprotectants form a viscous layer on the cell surface causing water 
to partially efflux from the cell and decreasing the generation of ice crystals inside the cell 
(Hubálek, 2003). The most commonly used cryoprotectants for bacteria are glycerol, saccharides 
and skim milk. Glycerol decreases the freezing point of the cellular fluid. Carbohydrate hydroxyl 
groups stabilize cell membrane by inhibiting oxidative cell damage (Smirnoff and Cumbes, 
1989). Saccharides protect proteins against denaturation, limit intracellular dehydration and 
stabilize membrane function and structure during freezing (Storey et al., 1981; Rudolph and 
Crowe, 1985; Hino et al., 2007). Skim milk stabilizes cell membranes and milk proteins form a 
protective coating on cells (Abadias et al., 2001). Several investigators have observed that 
glycerol (2-55 %), saccharides (1-68 %) and skim milk (1-10 %) provide significant protection to 
bacteria viability during freeze-drying and/or with further storage (Hubálek, 2003; Capela et al., 
2006; Kanmani et al., 2011a).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
Oxygen reducing agents are used to extend probiotic shelf-life. L-cysteine-HCl, a 
sulphur-containing amino acid, is commonly employed in anaerobic bacteria media to reduce the 
oxygen concentration (Kataoka et al., 1997; Rymovicz et al., 2011) and as a donor of amino 
nitrogen that favours the growth of Bifidobacterium spp. (Güler-Akın and Akın, 2007). However, 
the effects of cysteine-HCl differ by bacterial strains and storage temperature. The addition of 
cysteine-HCl in encapsulated B. animalis improved protection during storage at -80 °C, but not 
under exposure to other temperatures (21, 4, or -20 °C) and not for the bacteria strains L. caesi, L. 
paracasi, or L. acidophilus (Sousa et al., 2012). 
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2.1.2 Feed processing and delivery  
Compound animal feed is formulated using selected ingredients to meet nutritional 
requirements for growth and health with minimal cost. The most commonly used operations to 
produce compound animal feeds are grinding, mixing, pelleting or extruding. These methods are 
designed to improve feed nutritional value, adjust moisture content and modify nutrient density. 
However, these processes must be tightly controlled as the heat, pressure and moisture from each 
operation can be applied in excess, negatively affecting nutritional value and/or lowering the 
bioactive and thermally-sensitive feed additives (e.g. vitamins, enzymes and probiotic organisms; 
Pickford, 1992; Herrero-Vanrell et al., 2000; Simon et al., 2005). In the case of probiotic 
organisms, viability must be maintained in the range of 10
6 
cfu/g of feed in order to achieve 
health and/or performance benefits (Herrero-Vanrell et al., 2000). Maintaining viability during 
feed processing is a major challenge for the probiotic industry; feed processing can markedly 
affect the ease of commercial application of probiotic supplements in food producing animals. 
This section provides a review of the conventional feed processing operations and the potential 
stressors associated with each. 
2.1.2.1 Grinding and mixing   
Grinding reduces the feed partial size thus increasing the surface area for wetting, as well 
as chemical and enzymatic digestion. The most commonly used methods for grinding are 
hammer and roller mills. A hammer mill consists of a set of hammers and a defined screen size 
in a grinding chamber. Feed ingredients enter the grinding chamber and are impacted by rapidly 
moving hammers until the feed can pass through a screen selected to achieve the desired particle 
size (Amerah et al., 2007). A roller mill has several sets of rollers that feed ingredients pass 
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through compressing the feed components to achieve the desired particle size. The distance 
between the rollers controls the particle size (Amerah et al., 2007).  
Mixing of ingredients may occur before or after grinding of ingredients, to generate a 
complete diet. There are several different types of mixing machines. Mixing occurs in a chamber 
with single or multiple rotating paddles or screws (in a horizontal or vertical orientation) that act 
to blend feed ingredients to achieve uniformity. Limited information is available regarding the 
interaction of feed ingredients and probiotic additives. However, probiotic additives approved in 
the EU have included a viability test to establish the stability of the probiotic with feed premixes 
(FEEDAP Panel, 2006 and 2010).  
The addition of probiotic additives before grinding is not common but rather, feed 
additives are more commonly added during mixing. Currently, there is no direct assessment of 
the effect of feed grinding on probiotic viability in the scientific literature. However, grinding 
may pose a potential hazard because the direct pressure and compression used to break down 
feed ingredients may be harmful to bacteria.  
The pressure during grinding varies between machines and by feed ingredient, and there 
is little information on the exact pressure applied during this process. The pressure can be as high 
as 486 MPa, when a hammer mill is used to crush stones (Isnugroho et al., 2016), compared to a 
maximum 50 MPa in roller mills (Martens and Pingel, 2016). A pressure of more than 20 MPa 
was reported to have adverse effects on bacterial cell integrity, enzymatic reactions and gene 
expression, all of which could impact viability (Follonier et al., 2012). For example, in the case 
of dried L. acidophilus, only one-third of bacteria survived after exposure to 180 MPa (Chan and 
Zhang, 2002). Generally, most vegetative cells will inactivate at a range between 200 to 400 
MPa, while spores inactivate around 800 MPa with exposure to a temperature of up to 120 °C 
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(Cheftel, 1995; Hogan et al., 2005). Similarly, Sheehan (2007) noted a reduction in bacterial 
viability ranging from 5.9 to 7.9 log cfu/g for L. salivarius, B. lactis, L. casei and L. rhamnosus, 
after a pressure challenge at 400 MPa for 5 min. However, viability was not reduced with cocci 
and bacilli strains hand ground in a mortar and pestle with sand (Gould et al., 1975). The effect 
of pressure on bacteria is dose dependent, whereas additional research on the effect of grinding 
on bacteria is needed to better inform feed processing; particularly with respect to potential 
interactions with other feed ingredients.  
2.1.2.2 Pelleting and extruding 
Pelleting is a commonly used feed processing operation defined which combines 
moisture, heat and pressure to form small particles into pellets (Falk, 1985).  Pelleting of feeds 
improves animal performance and feed conversion rate that in turn improves feed palatability, 
reduces foodborne pathogens, decreases feed wastage and thermal modification of starch, binder 
activation, and also reduces selective feeding (Behnke, 2001; Medel et al., 2004). However, the 
heat and pressure used (or generated) during the pelleting process is perhaps the greatest 
challenge to probiotic viability during feed processing, reflected in part by the recognition that 
this process can aid in foodborne pathogen control (Considine et al., 2008).   
In a pelleting machine, mashed feed first passes through the conditioner apparatus where 
the feed is exposed to dry or steam heat prior to entering the pelleting chamber (Abdollahi et al., 
2013a). The conditioner process is used to gelatinize starch and improve pellet quality but can 
also reduce microbe and pathogen viability (Skoch et al., 1981). Conditioned feed enters the 
pelleting chamber and passes through a metal die by mechanical force. Pellet size is determined 
by the size of perforations in the die. The conditioner temperature, retention time and die hole 
size significantly affect feed pellet quality and nutrition value (Briggs et al., 1999; Abdollahi et 
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al., 2010, 2013b). Generally, steam pressure used during conditioning ranges from 102 to 442 
kPa, with a feed residency time of fewer than 2 min (Thomas et al., 1997). For monogastric 
animal feed, the conditioner temperature ranges from 70 to 90 °C (Doyle and Erickson, 2006). A 
higher temperature can be used to control feed-borne pathogens, and a lower temperature can be 
used to aid the incorporation of sensitive enzymes or select probiotics (Spring et al., 1996; Jones 
and Richardson, 2004; Doyle and Erickson, 2006). The metal die size ranges from 0.5 to 10 mm 
in diameter across animal species, depending on feed application (Bertipaglia et al., 2010; Gopal 
et al., 2010; Abdollahi et al., 2013c).   
The challenges for adding dried probiotic additives before pelleting are: 1) high 
temperature (up to 90 °C for 2 min) and rehydration (by steam addition) in the conditioner and 2) 
pressure and secondary heating generated by mechanical friction in the die chamber. There is 
limited research on probiotic survival because of the harsh conditions created during pelleting. 
Current research is mainly limited to heat tolerant species such as Bacillus spores and yeast. Less 
research has been focused on lactic acid bacteria due to their susceptibility to heat exposure. For 
example, in the case of Bacillus spp., Amerah et al. (2013) found that the survival rate of B. 
subtilis was more than 90 % after pelleting at 75, 85 and 90 °C using steam. Moreover, the 
recovery of B. cereus after pelleting at 75 °C was 90 % (Jadamus et al., 2001). In the case of 
yeast, there was a 10-fold (1 log cfu/g) loss of viable S. cerevisiae after pelleting with steam for 
12 s at 82 °C (Aguirre-Guzmán et al., 2002). Unlike Bacillus spp., spores and yeast, the survival 
of lactic acid bacteria were low even at reduced pelleting temperatures. Among lactic acid 
bacteria, E. faecium showed an improved resistance to pelleting. The survival rate of E. faecium 
was 100, 92, 50 and 35 % after pelleting in feed at 50, 60, 70, 80 °C, respectively (Simon et al., 
2005). In contrast, survival was minimal with L. reuteri, L. mucosae, L. plantarum and L. rossiae 
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(only about 10 % survival) after pelleting at a very low temperature of 60 °C for 40 s (De 
Angelis et al., 2006). A number of studies have reported survival of probiotic organisms 
following pelleting, although the rate of survival and pelleting conditions were not provided. 
Examples include studies examining B. subtilis, B. licheniformis and Pediococcus spp. (Ng et al., 
2014); L. acidophilus and L. casei and Scytalidium acidophilum (Huang et al., 2004) and B. 
licheniformis (El-Haroun et al., 2006).  
Extrusion is a feed process often used for aquaculture and pet feed manufacturing. Like 
pelleting, mash feed materials may also be conditioned (e.g. steamed or dried) prior to extrusion. 
The conditioned feed is then pushed through a die by screws. Compared to pelleting, the level of 
heat (up to 200 °C), moisture and pressure applied in extrusion are usually higher (Hilton et al., 
1981). There are even fewer studies on the effect of extrusion on probiotic survival rate 
compared to pelleting, which could be due to the harsh and highly lethal conditions created 
during extrusion. Aguirre-Guzmán et al. (2002) applied low temperature, cold extrusion to 
shrimp feed containing S. cerevisiae at 72 °C using a lab meat grinder and reported a 105-fold 
decrease in viability. Studies have reported the inclusion of Bacillus spp. in extruded fish diets 
(Ye et al., 2011; Cha et al., 2013) but details on extrusion conditions or bacterial survival rate 
were not disclosed.  
During hydrothermal processes in pelleting and extrusion, the biggest challenges for 
probiotic incorporation are the synergetic effects of heat, moisture and pressure. Processing 
temperatures are much higher than the temperatures reached during storage (reviewed in section 
2.1.1.3). It has been reported that any temperature higher than 45 to 50 °C during processing can 
be harmful to probiotic viability (Kang et al., 2012; Tripathi and Giri, 2014). The pressure during 
pelleting and extrusion is material and method dependent. Pressure and temperature can reach up 
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to 123 MPa and 200 °C during feed processing, respectively (Hilton et al., 1981; Thomas et al., 
1997). As mentioned above, any pressure above 20 MPa is harmful to bacteria. High pressure 
and heat can be lethal to bacteria when applied alone, and a dramatic reduction also occurs when 
heat and pressure are applied in combination (Considine et al., 2008). The combination of heat 
and pressure are commonly used in the food industry for sterilizing food products (Patterson and 
Kilpatrick, 1998). Similar synergistic effects were observed with a combination of heat and 
moisture (Marshall et al., 1963). Therefore, the combination of all three challenges (e.g. heat, 
moisture and pressure) during feed production poses a significant stress on the incorporation of 
probiotic additives during processing.   
2.1.2.3 Storage after feed processing   
Storage conditions of feed following processing are highly variable and are an additional 
challenge to probiotic organism survival. Feeds, once prepared, are stored and transported using 
auger and/or pneumatic systems to move feeds. Feed is typically stored at ambient outdoor 
temperatures that vary by season, and storage duration can range from days to months. Once feed 
is delivered into animal husbandry facilities and prepared for animal consumption, probiotics in 
feed are also subject to the conditions in the barn, such as temperature and moisture changes. 
Similar to storage prior to feed incorporation and processing, once probiotics are mixed with 
feed, storage under 4 °C appears optimal for viability. For example, L. brevis, L. plantarum and 
Pediococcus pentosaceus were sprayed on feed and their viability examined after storage at -22, 
0, 4 and 8 °C for 25 d. The best storage temperature was 4 °C in contrast to significant viability 
loss after 15 d of storage at room temperature (Owunmi et al., 2016).  Similarly, Aly et al. (2008) 
observed improved viability of B. subtilis and L. acidophilus mixed in feed over 4 weeks and 
stored at 4 °C, compared with storage at 25 °C. Guerra (2007) observed reduced viability of 
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Pediococcus acidilactici, Lactococcus lactis subsp. lactis, L. casei subsp. casei and E. faecium 
(in the range of 2.35 to 2.57 log cfu/g) mixed in pig diets and stored at room temperature for 8 d. 
In another study, the recovery of B. cereus toyoi after 8 weeks in feed was 92 % compared to E. 
faecium with a recovery of only approximately 50 % (no storage temperature indicated) (Simon 
et al., 2005). Feed storage remains a significant challenge to the commercial application of 
probiotic organisms given the range of environmental temperatures (e.g. - 40 to + 40 °C) under 
which feed is stored, dependant on the geographic region. 
In summary, feed processing combines numerous stressors including heat, moisture and 
pressure that act synergistically to produce a lethal environment for probiotic organisms. Indeed, 
the use of specific feed processing techniques (such as pelleting and extrusion) to control the 
dissemination of pathogens is in contradiction to the survival of probiotic organisms. Solutions 
such as the selection of more resistant microbes (Gardiner et al., 2000), reducing processing 
temperatures (De Angelis et al., 2006), developing post-processing probiotic application methods 
such as spraying and vacuum coating (Cavadini et al., 1999; Kirejevas, 2007; Pascher et al., 
2008), and developing protective materials or encapsulation (Chávez et al., 2007; Rokka and 
Rantamäki, 2010) will be important in expanding the commercial application of probiotics in the 
food animal industry. 
2.1.3 Transit during digestive tract delivery 
Viable probiotic organisms that have survived manufacturing, processing and/or storage, 
must also survive the proximal gastrointestinal tract following consumption in order to be 
metabolically active in the distal gut to provide a health benefit. The gastrointestinal tract is a 
complex environment where conditions are established to affect nutrient digestion by physical, 
chemical, and enzymatic processes mediated through both host secretions and microbial activity 
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(Salminen et al., 1998). Maintaining probiotic viability at a sufficient level during passage 
through digestive processes of the upper gastrointestinal tract, as well as avoiding immune 
secretions designed to protect against pathogens, is challenging. Specific stressors encountered in 
the upper digestive tract include: mechanical force, low pH, bile acids, pancreatic enzymes, 
antimicrobial peptides, secreted IgA and other antimicrobial compounds of host origin and 
microbial origin arising from communities already colonized in these spaces. Mechanisms of 
competition with indigenous bacteria for probiotic colonization has been well reviewed (Walker 
and Duffy, 1998; Lee and Salminen, 2009) and will not be examined here. In this section, the 
environmental challenges present in the upper gastrointestinal tract of monogastric animals 
associated with mechanical, chemical and enzymatic processes during feed digestion will be 
examined. Focus will be on swine and poultry as major food producing monogastric species. 
2.1.3.1 Overview of monogastric animal digestive tract physiology   
Although the upper gastrointestinal tract of swine and poultry species includes 
anatomical structures unique to each species, the fundamental physiological processes of 
digestion are similar. In swine, the mouth serves in feed mastication and lubrication, the stomach 
localizes acidification, and the upper small intestine neutralizes stomach contents followed by 
enzymatic digestion and emulsification. In the mouth, feed is ground using teeth to reduce 
particle size and lubricated with serous and mucoid saliva (enriched in either bicarbonate or 
mucopolysaccharides, respectively), to facilitate swallowing and transit of the food bolus to the 
stomach, buffer against pH change and initiate wetting. Saliva also contains antimicrobial factors 
such as lysozyme and antimicrobial peptides.   
In the stomach, gastric acid and pepsinogen are the primary secretions that reduce pH 
from 6 to 2 and initiate protein hydrolysis, respectively (Ange et al., 2000). The lower pH, 
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resulting from gastric acid, is a major challenge to many acid-sensitive bacteria and the 
antimicrobial properties associated with low gastric pH is considered a major line of defence 
against enteric pathogens (Giannella et al., 1972). Feed resides in the stomach from 1.4 to 6 h 
(Davis et al., 2001) prior to entry into the upper small intestine where liver and pancreatic 
secretions neutralize stomach acids, and deliver a variety of digestive enzymes and bile salts to 
facilitate enzymatic digestion and lipid emulsification.  
Digestion and absorption of nutrients occur as feed passes through the rest of the small 
intestine with a transit time of 3 to 12 h (Latymer et al., 1990). On exit of the small intestine the 
remaining feed material enters the large intestine and caecum, where the primary function is 
water and electrolyte absorption. The transit time is much slower in the large intestine reaching 
up to 50 h in transit to the colon (Latymer et al., 1990). The undigested feed components, slow 
transit time and limited host secretions contribute to a high density of microbial colonization in 
this location, reaching 10
11
 cfu/g contents. 
Poultry demonstrates some unique digestive tract physiology compared to swine. First, 
the crop is a non-glandular outpouching of the esophagus used to store and wet feed. In birds, the 
proventriculus is the site of acid secretion, which differs from the stomach of the pig in that 
residence time is much shorter because the crop serves as the primary postprandial storage site in 
the case of meal feeding. Furthermore, poultry possesses a unique organ known as the gizzard, 
which replaces in part the mastication function of the teeth in mammals such as swine. The 
gizzard is extremely efficient at feed particle size reduction, with an average particle size leaving 
the gizzard reported to range from 115 to 211 µm (Hetland et al., 2002). Feed passes directly 
from the proventriculus to the gizzard such that the pH in both locations is similar, ranging from 
2.7 to 4.1 (Jiménez-Moreno et al., 2009). The small intestine of poultry functions in the same 
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way as the pig, although it is markedly shorter on body weight basis. The colon in birds is 
extremely short such that the major site of microbial fermentation is the paired ceca. The passage 
time in chickens is very short; in the chicken transit time is consistent between the short small 
intestine and colon and can be as little as 2 to 3 h (Lentle et al., 2006)． 
The amount of indigenous bacteria and variety of species are a reflection of the 
characteristics of each location of the pig digestive tract. In the stomach and upper GI tract, the 
number of indigenous bacteria is 10
3
 to 10
5
 cfu/g and consists predominantly of acid-resistant 
lactobacillus and streptococci due to the low pH and rapid transit time. This number increases to 
10
8
 cfu/g in the distal small intestine due to the slower passive time and neutralized pH, when 
compared to the stomach. The hindgut (cecum and colon) has a relatively slow transit time, and 
significant undigested substrate for fermentation, supporting a large number of bacteria (e.g. 10
10 
to 10
12
 cfu/g), diverse species, low redox potential and high short chain fatty acid content (Fooks 
et al., 1999). Commonly, probiotic additives are targeted for delivery to the distal small intestine 
and hind gut as locations where the densest populations of microorganisms and highest 
fermentative activity occurs.  
2.1.3.2 Challenges of probiotic application in mouth and stomach  
The main challenges facing probiotic additives during transit in mouth and stomach 
include mechanical force, enzymatic action (e.g. lysozyme, pepsin) and gastric acid. Pressures 
higher than 20 MPa may result in negative effects on bacterial viability (see Section 2.1.2.1; 
Follonier et al., 2012). The pressure in the jaw when feeding is between 0.56 to 3.39 kPa in 
Hanford and Sinclair minipigs (Dutra et al., 2010) and up to 0.7 MPa in humans (Kohyama et al., 
2004). Therefore, although the exact effect of mechanical force by mastication on probiotic 
additives is unknown it is unlikely to be a primary factor affecting viability.  
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Lysozyme is an antimicrobial enzyme secreted by host mammals and birds and is 
commonly found in tears, saliva, mucus, and egg white (Jollès and Jollès, 1984). Lysozyme 
hydrolyzes bonds in peptidoglycans (specifically, a glycoside hydrolase that targets the 1, 4-beta-
linkages between N-acetylmuramic acid and N-acetyl-D-glucosamine residues), the major 
component of the Gram-positive bacterial cell wall, causing loss of cell integrity and cell death 
(Rada et al., 2010). Lysozyme can also affect Gram-negative bacteria when the inner 
peptidoglycan region is exposed after the outer cell wall is disrupted (Saurabh and Sahoo, 2008). 
Lysozyme can be used in the food industry as a preservative due to its antimicrobial activity 
(Cardarelli et al., 2007), and has been considered as an antibiotic alternative feed additive in the 
animal feed industry (May et al., 2012; Oliver and Wells, 2015).  
Lysozyme sensitivity is both species- and strain-dependent. For example, sensitivity 
differed by species and strain for bacteria in the Bifidobacterium genus with exposure to 400 
µg/mL lysozyme (Rada et al., 2010). Also, the growth percentage of different L. delbrueckii 
strains ranged from 6 to 100 % after challenge in 1 µg/mL lysozyme (Guglielmotti et al., 2007). 
Since the lysozyme level in the saliva of humans can reach up to 76.7 µg/mL (Tenovuo et al., 
1986; Perera et al., 1997), resistance to lysozyme has become one of the primary criteria for 
probiotic selection in many studies in the food industry, especially for Lactobacillus and 
Bifidobacterium spp. (Neviani et al., 1992; Guglielmotti et al., 2007; Rada et al., 2010). There is 
little information on the activity of lysozyme in the intestine of domestic animals, although it has 
been reported that a much higher lysozyme level is found in the stomach of ruminant animals 
relative to other mammals (Dobson et al., 1984). Further work on the implications of lysozyme 
mediated effects on probiotic viability relative to food and/or companion animals may be 
required.  
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One of the biggest challenges for maintaining probiotic viability in the gastrointestinal 
tract is the low pH in the stomach due to gastric acid. Indeed, the gastric environment is 
considered a significant barrier to entry of pathogens to the small intestine (Giannella et al., 1972; 
Herrero-Vanrell et al., 2000). Acid conditions increase diffusion of H
+
 into bacterial cells leading 
to increased energy expenditure (e.g. H
+
 efflux) to maintain cytosolic pH and reduce the 
inactivation of sensitive enzymes and damage to proteins and DNA (Presser et al., 1997). For 
instance, the survival of B. adolescentis declined quickly from 9 to 6 log cfu/mL in the first 5 
min of challenge and another 3 log cfu/mL for the following 10 min at pH 2 (Klemmer et al., 
2011b). The viability of several species of lactic acid bacteria, including L. rhamnosus, B. 
longum, L. salivarius, L. plantarum, L. acidophilus, L. paracasei, and B. lactis, was also 
decreased by 6.01 to 7.05 log cfu/mL after challenge at pH 2 for 2 h (Ding and Shah, 2007).   
Similar to other stressors, different strains showed varied resistance to low pH. Spore-
forming Bacillus subtilis were fully resistant after challenge at pH 2 for 3 h (Guo et al., 2006). 
However, no bacteria survived with challenge of pH 2 for 2 h for several other spore-forming 
bacteria (e.g. B. coagulans, B. laevolacticus, B. racemilacticus, Sporolactobacillus inulinus). 
Only one strain of Bifidobacterium (B. laevolacticus DSM6475) showed 86 % survival after 
challenge in pH 2.5 for 2 h (Hyronimus et al., 2000). The differences in acid tolerance between 
strains may be due to the activity of H
+
 - ATPase, which serves to pump out H
+
 from the cell to 
maintain homeostasis such that species with higher enzyme activity are more tolerant 
(Matsumoto et al., 2004).  
2.1.3.3 Challenges of probiotic application in small intestine   
Another significant challenge for probiotic delivery in the intestinal tract is bile. Bile is 
secreted into the duodenum after feed ingestion to aid in the digestion of lipids and to neutralize 
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gastric acids. Bile acids are a main component of bile that are conjugated with the amino acids 
glycine or taurine to form bile salts. Bile salts are potent detergents important in the 
emulsification of lipids, thereby facilitating lipid enzymatic digestion (Hofmann and Mysels, 
1992). Bile not only aids the digestion of lipids but also has antimicrobial functions (Begley et al., 
2006). As a strong detergent for lipids, bile can alter cell membrane integrity and permeability by 
dissolving membrane lipids leading to cell leakage and death (Begley et al., 2005). Moreover, 
bile acids can cause cell damage on the molecular level, such as RNA and DNA damage, 
oxidative stress and protein misfolding (Bernstein et al., 1999; Powell et al., 2001). Interestingly, 
bile can also act indirectly via its antimicrobial effects by altering host gene expression through 
the small intestine bile acid receptor (Inagaki et al., 2006). 
Survival during challenge in bile is an important selection criteria for probiotic bacteria. 
Despite the different concentrations, forms of bile, and culture medium used to investigate the 
effects of bile on bacterial viability, studies have consistently observed that bile reduces probiotic 
viability. However, the degree of negative effect of bile varies by species and strains. For 
example, after incubation in 3 % oxgall (a commercial purified animal bile), there was a 
reduction of about 4 log cfu/mL in viability of all strains including L. rhamnosus, B. longum, L. 
salivarius, L. plantarum, L. acidophilus, L. paracasei and B. lactis, after 4 h incubation and a 
further 2 log cfu/mL after 8 h incubation (Ding and Shah, 2007). B. lactis was the most 
susceptible strain with a reduction of 7.41 log cfu/mL. When B. lactis was exposed to 0.25 % of 
bile salt, there was no recovery of the bacteria after 10 min challenge, whereas B. adolescentis 
was inactivated with exposure to 0.1 % bile salt (Amor et al., 2002). In another study, tolerance 
was highest in spore-forming bacteria B. subtilis exposed to 1.2 % conjugated bile salt (minimum 
inhibitory concentration of 195 mM) relative to B. cereus (98 mM) and B. clausii (24 mM; 
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Spinosa et al., 2000). Bile not only affects spore-forming bacteria viability but spore germination 
rate. There was an approximately 20 % reduction in germination of B. subtilis after challenge for 
20-25 min to 1.2 % conjugated bile salts and 1 % non-conjugated bile salts (Spinosa et al., 2000).    
A combination of bile and pancreatic enzymes are commonly used in selection methods 
for probiotics to mimic upper intestinal conditions (Pitino et al., 2010). Pancreatic enzymes 
secreted by the pancreas include lipase, a variety of proteases, amylase and nucleases and have 
been shown to have negative effects on the viability of some sensitive bacteria strains. After 
challenges in intestinal juice (Pancreatin UPS, pH = 8.0) for 4 h, the viable number for B. 
adolescenstis and B. breve strains were below detection limit (Charteris et al., 1998). However, 
pancreatic enzymes did not reduce cell numbers for other resistant strains, including L. 
acidophilus, L. rhamnosus, L. reuteri and L. plantarum (Champagne and Gardner, 2008) and L. 
casei, B. bifidum and B. animalis (Charteris et al., 1998). Those enzymes can not only directly 
affect the viability of probiotics but can also reduce mucosal adhesion ability, a trait considered 
important for many probiotic strains. All of the bacterial strains (e.g. L. rhamnosus, L. casei, L. 
johnsonii, L. rhamnosus and B. lactis) tested by Ouwehand (2001) showed reduced adhesion to 
intestinal mucus after pre-treatment with pepsin, amylase, lipase, chymotrypsin, trypsin and 
pancreatin (Ouwehand et al., 2001).  
In the small intestine, several other antimicrobial products produced and secreted into the 
lumen by host animals can affect probiotic efficacy. These include products of innate and 
acquired immunity such as antimicrobial peptides and secretory IgA (Immunoglobulin A) 
(Hofmann and Eckmann, 2006). These factors have proved effective in defending against 
pathogenic microbes (Fubara and Freter, 1973; Honorio-França et al., 1997; Ayabe et al., 2000) 
and may also be important in mediating the composition of commensal bacteria, including 
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probiotic bacteria. Indeed, secretory IgA bind commensal bacteria and are known to stimulate 
secretion of antimicrobial peptides (Fukushima et al., 1998; Möndel et al., 2009). However, the 
direct effect of intestinal IgA and antimicrobial peptides on the viability of probiotic additives is 
not clear.  
In summary, maintaining probiotic viability from probiotic ingestion to delivery to the 
distal digestive tract is a complex process that involves mechanical, chemical and enzymatic 
processes associated with digestion. Monogastric animals (pig and poultry) possess unique 
digestive physiologies that may impart unique challenges in each probiotic species. Sensitivity to 
challenge conditions is species and strain dependent and may not only reflect viability but also 
probiotic function (e.g. mucus adherence). The challenges found in the stomach (associated with 
acid secretions) and in the small intestines (associated with bile salts and pancreatic enzymes) are 
the most significant. The application of additional protection materials to sensitive probiotics in 
animal feed may be beneficial in the delivery of viable and active probiotics to the distal 
digestive tract.  
2.2 Encapsulation                
Probiotic manufacturing, feed processing and gastrointestinal tract delivery can all 
contribute to added stress on probiotic bacteria. Applying additional protection against these 
stressors using encapsulation might help to maintain probiotic viability and/or may provide direct 
benefit to the target animal. Encapsulation is the process of covering or entrapping core materials 
in a wall-material matrix to offer additional protection to various “payloads” contained within 
(Risch, 1995). Encapsulation has been shown to provide protection against environmental 
changes including: dehydration stress during drying (Abd-Talib et al., 2013), heat challenge 
(Teoh et al., 2011), storage (Sousa et al., 2012), acidic challenge in simulated gastric juice 
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(Sultana et al., 2000; Annan et al., 2008) and passage through the digestive tract (Wang et al., 
2016). In addition to improving viability after each challenge, encapsulation can provide 
controlled release of core materials at a targeted location in the gastrointestinal tract (Anal and 
Singh, 2007). Encapsulation has broad applications not only in the protection of probiotic 
bacteria but also in the protection of vitamins, antioxidants, cells and other small molecules 
(Schrooyen et al., 2001). Identifying effective encapsulation methods and wall materials for 
application in probiotic delivery could broaden the range of available probiotic species used in 
the feed industry and potentially enhance the efficacy of existing probiotics. 
2.2.1 Encapsulation methods  
The two primary methods of encapsulation for probiotic organisms are extrusion and 
emulsion. These two approaches are relatively gentle, can be adapted to a variety of wall 
materials and have been broadly researched (Krasaekoopt et al., 2003). Other methods such as 
spray drying, fluidized bed coating and spray chilling have also been used for probiotic 
encapsulation (Anal and Singh, 2007) but will be reviewed here in limited detail. The various 
encapsulation methods can be manipulated to produce capsules of different sizes. Generally, a 
capsule size between 1 and 1000 µm is considered a microcapsule whereas a size range between 
10 and 1000 nm is considered a nanocapsule (Konan et al., 2002; Umer et al., 2011).  
2.2.1.1 Extrusion 
Extrusion is a relatively easy, gentle and inexpensive way to produce capsules that 
provide adequate protection of core material (Krasaekoopt et al., 2003). This method has two 
major steps (Figure 2.2). In the first step, a hydrocolloid solution and payload material solution 
are prepared. In the second step, the solution is extruded through a small outlet nozzle (e.g. 
syringe needle) to form droplets that are solidified in a cross-linking solution. The size of capsule 
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generated can be influenced by the protein concentration in the payload-hydrocolloid solution, 
the cation concentration in the cross-linking solution, the size of the outlet nozzle and the 
distance between the opening and the surface of the cross-linking solution (Krasaekoopt et al., 
2003). Typical capsule size using the extrusion method is in the large range of 2 to 5 mm.   
Capsules with larger diameters are expected to provide better protection for probiotic payloads 
compared to smaller sized capsules. However, larger capsules can ruin food texture and may 
have limited application in feed for smaller animals (Krasaekoopt et al., 2003).  
Extrusion has been described as “hard to scale up and slow” (Krasaekoopt et al., 2003). 
However, recent efforts have improved the potential commercial application of extrusion by 
increasing the production speed and improving the scalability of the manufacturing process. In 
theory, the fluid flow rate can be improved through the application of added pressure on the 
solution at the outlet nozzle. Different approaches for improving extrusion include the jet cutting 
method and electrostatic droplet generation as described elsewhere (Petrovic et al., 2007; 
Burgain et al., 2011). Capsules made by extrusion have been successfully used for probiotic 
encapsulations. For instance, Yeung (2016) observed improved viability (by 2 log cfu/ml) in L. 
lactis encapsulated with 1 % alginate and stored at room temperature after 7 d, when compared 
to free cells (not dried). Similarly, Chávarri (2010) prepared chitosan-coated alginate capsules 
containing L. gasseri and B. bifidum. These capsules protected the coated bacteria placed in 
gastric acid (pH = 2) or bile salts. 
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Figure 2.2. Extrusion method for encapsulating (adapted from Krasaekoopt et al., 2003) 
 
2.2.1.2 Emulsion  
Emulsion is another common method used to encapsulate probiotics. It is also a two-
phase process consisting of a discontinuous phase and a continuous phase. The discontinuous 
phase consists of the core material and supporting material. Core materials may include 
probiotics, flavours, proteins and enzymes (Krasaekoopt et al., 2003; Given, 2009; Li et al., 
2010), whereas supporting materials may include gum, alginate, chitosan, gelatine and plant 
proteins (Sultana et al., 2000; Krasaekoopt et al., 2003; Nag et al., 2011; Wang et al., 2014). The 
continuous phase consists of a vegetable oil (eg. canola oil, sunflower oil, soybean oil). The 
homogenized discontinuous phase (water) is mixed with the continuous phase (oil) to form a 
water-in-oil emulsion. A cross-linking solution is then added that hardens the wall material, 
trapping the core material inside, to form hydrocolloid capsules (Krasaekoopt et al., 2003). 
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Emulsion has broad applications and produces capsules with a small size (25 µm to 2 mm) 
compared to extrusion (Krasaekoopt et al., 2003). However, there are some disadvantages to 
emulsion including the high cost of vegetable oil (Krasaekoopt et al., 2003), difficulties in 
sterilizing the vegetable oil for aseptic applications (Gbassi and Vandamme, 2012) and the added 
stress on probiotics caused by rigorous stirring during capsule production. Several studies have 
noted increased probiotic protection for bacteria encapsulated using the emulsion methodology. 
For example, increased protection in simulated gastric juice was noted with several lactic acid 
bacteria including B. adolescentis protected with chickpea protein and genipin coating (Wang et 
al., 2014), B. bifidum entrapped with alginate and chitosan (Zhang et al., 2013) and L. 
acidophilus and Bifidobacterium spp. coated with alginate and starch (Sultana et al., 2000),  
compared to non-encapsulated bacteria.  
2.2.1.3 Other methods  
Spray drying is also commonly applied in probiotic encapsulations. As described above, 
spray drying is a rapid process whereby a liquid solution containing wall and core material is 
sprayed into a hot gas resulting in the formation of small (e.g. 10 µm to 500 µm), dry particles 
(Re, 1998). However, the fast and hot air used during spray drying can cause agglomeration and 
the stress resulting from exposure to heat and dehydration (during evaporation) can affect 
sensitive probiotic viability. The application of adapted methods during spray drying can 
improve probiotic viability. Modified methods include adding protectants and lowering 
temperature during spray drying or applying vacuum spray drying (Dolly et al., 2011; Jantzen et 
al., 2013; Lavari et al., 2014). Successfully encapsulated probiotics include L. reuteri coated with 
alginate and chitosan (Malmo et al., 2013), and Bifidobacterium  BB-12® (Chr. Hansen, 
Hónsholm, Denmark) with skim milk (Fritzen-Freire et al., 2012). 
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Fluidized bed coating is an encapsulation method whereby core material is suspended in 
a temperature and humidity controlled chamber and atomized in the air (Dezarn, 1995). The 
method uses hot-melt (e.g. fatty acid, waxes) or solvent-based (e.g. starches, gums) wall material 
for coating, yielding a capsule size of 50 to 500 µm. Core materials may include probiotics, 
vitamins, organic acid or lactic acid (Gibbs et al., 1999). Several studies applying fluidized bed 
coating for probiotic encapsulation have demonstrated increased protection of probiotics during 
in vitro simulated gastric juice challenge. For example, L. reuteri coated with whey powder and 
shellac (Schell and Beermann, 2014) and L. paracasei coated by trehalose, maltodextrin were 
successfully encapsulated by fluidized bed coating (Semyonov et al., 2012). The technology has 
also been successfully commercialized; the company Lallemand Inc. (Saint Simon, Canada) has 
successfully delivered their L. acidophilus, P. acidilactici, and S. cerevisiae probiotic product 
using Probiocap® technology which is based on fluidized bed coating. A mixture of fatty acids, 
vegetable wax and milk powder were used as wall material (Durand and Panes, 2007; 
Anandharamakrishnan, 2015).  
Spray chilling and cooling is another inexpensive method for encapsulation. Unlike in 
spray drying, where hot air is used to encapsulate core materials, spray chilling uses chilled or 
cooled air. Spray chilling and cooling is usually used to encapsulate solid materials such as 
minerals and vitamins (Okuro et al., 2013a) and has recently been applied to probiotic coating 
(Pedroso et al., 2012). Low melt point wall materials (e.g. lipids) are commonly used in this 
process. Briefly, melted material containing wall and core material, is injected into a chamber of 
cold air where the material solidifies to form capsules (Kuang et al., 2010). Spray chilling and 
cooling has several advantages over spray drying. Compared to spray drying, the cold 
temperatures used during spray chilling and cooling are better suited for probiotic encapsulation. 
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Further, the lipid coating material is predicted to delay capsule release until it reaches the 
intestine, rather than the stomach, based on the site of delivery of pancreatic lipases (Okuro et al., 
2013a). The first study to apply spray chilling in probiotic encapsulation was Pedroso (2012). In 
this study, B. lactis and L. acidophilus were entrapped in a lipid (palm and palm kernel fat) by 
spray chilling at 10 °C. Increased protection from encapsulation was observed with exposure to 
simulated gastric juice, intestinal fluid and storage at low temperatures (-18 °C) for 90 d 
compared to non-encapsulated bacteria (Pedroso et al., 2012). Cocoa butter was also employed in 
spray chilling (in place of lipids) and it provided a similar protection for B. animalis and L. 
acidophilus (Pedroso et al., 2013). Another study demonstrated increased protection with inulin 
or polydextrose-coated L. acidophilus via spray chilling (Okuro et al., 2013b). 
2.2.2 Encapsulation wall material  
The wall materials of encapsulation form the structure of the capsules and also provide 
protection for core bacteria during processing, storage and gastric acid challenge. A variety of 
chemicals can be used as the wall material for encapsulation including carbohydrates, proteins, 
and lipids as listed in Table 2.6. Each encapsulation method requires wall material suited to the  
Table 2.2. Categories and examples of wall materials used in encapsulation (adapted from 
Zuidam and Nedović, 2010) 
Category Wall materials 
Carbohydrate Starch, κ-Carrageenan gum, pectins, alginate, gellan, chitosan 
Proteins whey, caseins, plant protein isolates (pea, chickpea), gelatin 
Lipids Coconut fat, paraffin wax and beeswax 
 
encapsulation methodology employed such as the ability to form an emulsion or gelling 
properties (Desai and Park, 2005). More importantly, the unique properties of the wall material 
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will affect the mechanism of controlled release in the intestine which depends on pH, enzymatic 
degradation or osmotic pressure (de Vos et al., 2010). 
Polysaccharides are complex carbohydrates made up of chains of monosaccharides. 
Under certain conditions, three-dimensional structured gels are formed by polysaccharides in a 
process known as gelation (Rinaudo, 1993). Gelation is an important property of polysaccharides 
and is commonly employed in encapsulation applications to provide core material with added 
protection. Several polysaccharides have been applied in probiotic encapsulation due to the low 
cost and non-toxic properties associated with this methodology. Examples are alginate, gellan, 
chitosan (Chen et al., 2007; Klemmer, 2011a; Caetano et al., 2016). 
Protein isolates are also commonly used as an encapsulation wall material, either alone or 
in combination with polysaccharides. Plant based proteins including pea, lentil and soy protein 
isolates have been applied in probiotic encapsulation (Klemmer et al., 2012; Khan et al., 2013; 
Wang et al., 2014). Animal sourced proteins like casein, gelatin and whey protein are also 
commonly used (Picot and Lacroix, 2004; Annan et al., 2008; Heidebach et al., 2010). Use of 
plant-based proteins in capsule manufacturing could reduce the possibility of allergy and also 
broaden the market based on religious, dietary and ethical reasons (Klemmer, 2011a).   
More than one wall material can be used to produce capsules if necessary. These 
combinations usually consist of oppositely charged proteins and polysaccharides. Examples of 
protein-polysaccharide combinations include alginate and whey protein (Hébrard et al., 2010), 
chitosan and whey protein (Bastos et al., 2009), and alginate and pea protein (Klemmer, 2011b). 
Lipids may also be used in combination with alginate or other polysaccharides and are 
considered a good oxygen and moisture barrier (Weinbreck et al., 2010). This review will mainly 
focus on alginate and pea protein as example wall materials.   
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2.2.2.1 Alginate  
Alginates are a family of linear unbranched polysaccharides that contain different 
amounts of 1, 4’-linked β-D-mannuronic acid and α-L-guluronic acid residues (Gombotz and 
Wee, 1998). Alginate capsule beads can be “hardened” through the addition of divalent cations 
(including Ca
2+
, Sr
2+
, Ba
2+
, Cu
2+
, Ni
2+
) via exchange with sodium ions from guluronic acids. The 
assembly of these charged guluronic groups form the egg box structures shown in Figure 2.3 and 
Figure 2.4. Each alginate chain can join together to form a 3-D network. (Gombotz and Wee, 
1998). 
 
 
 
Figure 2.3. Alginate cross-linked by calcium ions to form an egg-box structure (adapted from 
Gombotz and Wee, 1998). 
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Figure 2.4. Scanning electron microscope picture provided by Dr. Michael T. Nickerson 
showing the internal structure of pea isolate-alginate capsules.  
 
Various probiotic species have been successfully protected in vitro through alginate 
encapsulation including, L. acidophilus, L. rhamnosus, L. plantarum, L. casei, B. adolescentis, B. 
animalis, B. bifidum, B. infantis , B. lactis and B. longum (Rokka and Rantamaki, 2010). Bacteria 
B. adolenscentis 15703T trapped in the alginate-gelatin matrix were challenged with simulated 
gastric juice (pH = 2.0) and simulated intestinal juice (pH = 7.4). The results of the study showed 
significant improvement of the viability of B. adolenscentis 15703T encapsulated with alginate-
gelatin and exposed to gastric conditions. The in vitro study also successfully demonstrated 
controlled-release of the encapsulated bacteria under intestinal conditions (Annan et al., 2008). 
The addition of a protein source, such as pea or whey protein, has also been found to provide 
added protection in combination with alginate (Klemmer et al., 2011a). 
The percentage of alginate used in encapsulation can affect the capsule size and 
protection significantly. The percentage of alginate used for encapsulation ranges from 0.5 - 4 % 
(Lee and Heo, 2000; Gul and Dervisoglu, 2017). Generally, increased alginate concentration 
results in greater capsule size and improved survival of core bacteria. Mandal (2006) 
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encapsulated L. casei in different alginate concentrations (2, 3, and 4 %) by emulsion in soybean 
oil. The survival of L. casei increased according to alginate concentration during challenge in 
gastric acid (pH 1.5) for 3 h. Encapsulation reduced the loss of viability of L. casei compared to 
free cells by 1-2 log cfu/mL increasing in a dose-dependent manner with the concentration of 
alginate used. After heat challenge at 55, 60 and 65 °C for 20 min, a similar trend was found 
with high alginate concentrations associated with improved survival of L. casei at 60 and 65 °C. 
Furthermore, the increased alginate concentration did not affect the release in simulated colonic 
conditions (Mandal et al., 2006).  
Similarly, Lee and Heo (2000) trapped B. longum with different alginate concentrations 
(2, 3, and 4 %) by extrusion. The survival of B. longum was improved in gastric juice challenge 
(pH = 1.55) with the increased alginate concentration. Loss of viability in simulated gastric juice 
when capsules were prepared with 4 % alginate was only 0.5 log cfu/bead, whereas there was no 
protection against loss of viability for free bacteria or bacteria encapsulated with 2 % alginate. 
Interestingly, the capsule size more than doubled from 1.03 mm to 2.62 mm as alginate 
concentration increased from 2 to 4 %. The authors indicated that very large capsules would 
cause coarseness of texture whereas small capsules did not provide sufficient protection 
suggesting that control of capsule size would be important particularly in human applications 
(Lee and Heo, 2000). Osman Gul (2017) tested the effect of different alginate concentrations on 
capsule size, survival of core bacteria during heat challenge, simulated gastric juice and intestinal 
juice on encapsulated L. casei. The best alginate concentration was 2 % and 2.5 % for extrusion 
and emulsification (Gul and Dervisoglu, 2017). 
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2.2.2.2 Pea protein isolates  
Pea (Pisum Sativum) proteins are important components in the human food and animal 
feed industries due to their physicochemical properties in food preparation as well as their 
nutritional value (Spielmann et al., 2008; Jezierny et al., 2010). Peas have a high protein 
concentration (246 g/kg DM) and are also rich in starch (478 – 534 g/kg DM) with crude fat 
ranging from (15 – 20 g/kg DM) (Jezierny et al., 2010). Pea protein isolate is the protein fraction 
concentration, which demonstrates good solubility in water, stability in heat, emulsification and 
foaming capacity (Donsì et al., 2010). Pea protein is an abundant material in Canada and 
especially in Saskatchewan, which represented 64 % of Canadian pea production in 2014 
(Anonymous, 2017b). Development of higher value products using pea proteins is likely to 
benefit product demand and provide opportunity for further processing. There are already 
published non-food/feed applications including film formation (Han and Zhang, 2008; 
Kowalczyk and Baraniak, 2011), stabilization of oil-in-water emulsions (Bogracheva et al., 1994; 
Franco et al., 2000; Gharsallaoui et al., 2010), and use in producing microspheres. Furthermore, 
pea proteins have been used for encapsulation of β-carotene (De Graaf et al., 2001) ascorbic acid 
and α-tocopherol (Pierucci et al., 2006; Pierucci et al., 2007; Pereira et al., 2009).   
Recently, pea protein isolate with alginate capsules (PPC) has shown promising abilities 
in protecting probiotic bacteria by encapsulation. Kotikalapudi (2009) encapsulated L. 
acidophilus (capsule size 3 mm) in a pea protein isolate (4 %) and alginate (0.5 %) system by 
extrusion and noted only 1 log cfu/mL loss in simulated gastric juice (pH = 2) when compared to 
free cells (loss 6 log cfu/mL). Similarly, Wood (2010) entrapped B. adolescentis in a 4.0 % pea 
protein isolate and 1.0 % alginate system (capsule size 2.2 mm) and observed improved survival 
during gastric juice challenge, whereas alginate alone did not provide any protection. The author 
suggested that pea protein strengthened the capsule and reduced porosity based on scanning 
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electron microscopy. Furthermore, Klemmer (2011) encapsulated B. adolescentis in pea protein 
isolate (2 %, 4 %, 6 %) and alginate (0.5 %) with a prebiotic (fructooligosaccharide) and 
compared various extrusion conditions. Encapsulated B. adolescentis survived in a simulated 
gastric juice (pH = 2) challenge (1 log cfu/mL reduction) compared to a more than 6 log cfu/mL 
reduction in free cells. Increasing needle (nozzle) size increased the capsule size. However, 
increase protein and prebiotic concentrations showed similar protection. Finally, capsules have 
been shown to break down and release probiotic payloads in simulated intestinal juice containing 
proteases,
 
proposed to hydrolyze capsule protein and high levels of Na
+
 proposed to displace 
Ca
++
 crosslinks between alginate
 
(Klemmer, 2011a). The efficacy of pea protein and alginate-
based capsules have also been examined during in vivo passage through the digestive tract as 
described in detail in the section below.   
2.2.3 Application of probiotic encapsulation  
2.2.3.1 Effects of encapsulation on probiotic viability following dehydration  
Probiotic organisms are commonly dehydrated to minimize environmental conditions 
required for storage and to extend the shelf-life. Drying without any protection is lethal to many 
sensitive probiotic strains and protective additives are often used to maintain probiotic viability. 
Protective additives include skim milk, sugars, glycerol and proteins (Meng et al., 2008). There 
is limited work investigating the effect encapsulation on microbial viability during dehydration. 
However, some positive impacts have been demonstrated. Heidebach et al. (2010) encapsulated 
two strains of probiotic bacteria (Lactobacillus F19 and Bifidobacterium Bb12) in casein based 
capsules and examined viability after freeze-drying (at -20 °C). Significant protection against 
loss of viability was observed in the case of the Lactobacillus strain (40 % survive compared to 
less than 10 %) but not the Bifidobacterium strain when compared with non-encapsulated 
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bacteria (Heidebach et al., 2010).  Several studies have investigated on the viability of probiotic 
organisms after drying. However, comparisons with non-encapsulated controls were not included. 
Abd-Talib et al. (2013) examined the viability of two strains of L. plantarum (B13 and B18) and 
two species of yeast (Kluyveromyces lactis and Saccharomyces blouradii) after encapsulation 
using a combination of gum arabic, gelatin, lecithin and coconut oil prior to spray drying (outlet 
temperature 70 to 75 °C). Loss of viability differed dramatically between the two bacterial 
strains; viability of L. plantarum B13 was reduced from 1.28 x 10
8 
cfu/mL to 2.1 x 10
6 
cfu/mL; 
whereas, L. plantarum B18 viability was reduced from 3.25 x10
7
 to 2.15 x 10
7
 cfu/mL. Loss of 
viability for the two encapsulated yeast species was similar at approximately 2 log cfu/mL 
reduction (Abd-Talib et al., 2013). In another study, whey-encapsulated L. reuteri was spray 
dried at 55 and 65 °C, and viability decreased from 1.6 x 10
9
 to 1.7 x 10
7
 cfu/g (Jantzen et al., 
2013) whereas for Bifidobacterium PL encapsulated with starch the reduction of viability was 
only 1 log cfu/mL after spray drying with an outlet temperature at 45 °C (O'riordan et al., 2001). 
The effects of encapsulation and cryoprotectant during freeze-drying for probiotic 
bacteria are similar. A survival rate of 11-15 % after freeze-drying was reported for P. 
acidilactici encapsulated in alginate and alginate-chitosan coated beads. The best survival rate 
was achieved when the encapsulation formulation included 10 % skim milk (15.79 %), but this 
was only marginally higher than non-encapsulated cells mixed with 10 % skim milk (11.02 %). 
Others studies had reported less than 1 % survival of bacterial probiotics (Pediococcus 
acidilactici) following freeze-drying when capsules were made with alginate alone or alginate-
chitosan with or without milk addition (Halim et al., 2017).  
The effect of encapsulation on probiotics viability during dehydration has largely been 
carried out using a number of different encapsulation formulations, using different probiotic 
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strains and with different control treatments. For this reason, it is difficult to draw firm 
conclusions regarding recommendation for encapsulation formulations to provide consistent 
protection during dehydration. This trend of variation in wall materials and concentration as well 
as strain use also applies with respect to studies examining the efficacy of protection against the 
challenges associated with temperature, storage and in vivo animal delivery. A systematic 
comparison of different formulations across a variety of probiotic strains should be conducted.  
2.2.3.2 Effects of encapsulation on probiotic sensitivity to heat challenge 
During feed/food processing, probiotic products are subject to several heat challenges as 
described above in section 2.1.1. Heat challenge is a major stress factor for probiotic organisms 
with viability markedly decreasing as the temperature and time of exposure increases. However, 
several studies have shown significant improvement in heat tolerance by encapsulation of 
probiotic organisms (Teoh et al., 2011; Abbaszadeh et al., 2014; Moumita et al., 2017). Two 
categories of the heat challenge test that are commonly performed include determination of 
viability after exposure to temperatures of less than 70 °C for extended periods of time (10 to 60 
min.) or after exposure to temperatures above 70 °C for short periods (less than 1 min.). Teoh et 
al. (2011) tested viability of L. acidophilus and B. pseudocatenulatum after encapsulation in 
chitosan coated alginate-starch at 55, 60 and 65 °C over 30 min without dehydration. The results 
showed that encapsulated cells had significantly improved survival when compared to the free 
cell at 55 and 60 °C. After challenge at 60 °C for 30 min, the reduction of viability for free cells 
was 5.00 log cfu/mL, whereas a reduction of 1.99 log cfu/mL for L. acidophilus and 0.85 log 
cfu/mL for B. pseudocatenulatum was observed after encapsulation. However, when heat 
challenge was conducted at 65 °C for 30 min, only encapsulated B. pseudocatenulatum was 
significantly protected by encapsulation (Teoh et al., 2011).  In a similar type of study, Sabikhi et 
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al. (2010) examined the protective effect of encapsulation on probiotic viability after high 
temperature short duration heat challenge. The authors encapsulated L. acidophilus in an alginate 
- starch matrix and examined viability after the heat challenge for 72, 85 and 90 °C for 30 s 
without prior dehydration. Encapsulated cells showed significantly improved survival when 
compared to non-encapsulated cells at all temperatures investigated. Loss of viability increased 
with increased temperature, however, even with the severest challenge (90 °C for 30 s), the 
reduction in viability for the encapsulated cells was 4.14 log cfu/mL compared to 9.13 log 
cfu/mL for non-encapsulated cells (Sabikhi et al., 2010). The effect of encapsulation heat 
protection is clearly strain dependent. Borges (2012) tested alginate based encapsulation of   L. 
casei, L. paracasei, L. acidophilus and B. animalis during heat challenge at 55 and 60 °C for 60 
min without prior dehydration. Only encapsulated L. acidophilus showed an improved protection 
at 55 °C when compared to free cells.  
Limited research had been done to examine the efficacy of dehydrated encapsulation 
products during heat challenge even though dried products are the preferred product form in the 
feed industry. Nevertheless, some studies have demonstrated protection against heat challenge of 
encapsulated and dehydrated products. For instance, spray dried Bifidobacterium BB-12 
encapsulated with skim milk and prebiotic oligosaccharides was challenged with heat at 55, 65 
and 75 °C for 1 and 10 min.  There was a significant protection from encapsulation at 55 °C for 
10 min although only by about 0.5 log cfu/g. Under challenge at 65 °C for 10 min, there was no 
detection of viable free cells whereas the viability of encapsulated cells remained high (9 log 
cfu/g). Encapsulation did not however, protect against challenge at 75 °C (Fritzen-Freire et al., 
2013). In another case, freeze-dried alginate-based capsules containing L. plantarum were 
challenged at 75 °C for 30 s and 90 °C for 5 s. The reduction in viability of free cells was about 
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3.22 log cfu/g whereas a reduction of 1.15 log cfu/g was observed for the encapsulated cells. 
Similar protection was also noticed at 90 °C for 5 s for encapsulated L. plantarum when 
compared to free cells (Fareez et al., 2017).  
Although the efficacy of encapsulation on the heat challenge depends on the 
encapsulation formula, strain characteristics, challenge temperature and duration, significant 
protection has been noticed for encapsulation during both low-temperature long duration and 
high-temperature short duration challenge conditions. However, the heat challenge data on 
dehydrated products are limited. In the aspect of feed processing, the efficacy of encapsulation 
during pelleting (temperature can be as high as 90 °C and less than 2 min) is unknown.  
2.2.3.3 Effects of encapsulation on probiotic viability during storage  
Viability of probiotic organisms during storage varies considerably due to a number of 
factors including strain differences, water residuals, encapsulation material and methods, storage 
temperature, control group selection and whether dehydration was employed. Temperature is a 
primary factor affecting viability during storage. A wide range of temperatures has been 
investigated reflecting storage conditions for relatively small volumes of product prior 
incorporation in feed and environmental temperatures commonly experienced during storage of 
prepared feeds.  
For sensitive bacterial strains storage viability represents a significant challenge. 
Unfortunately, research has shown that encapsulation is ineffective when storage occurs at 
ambient temperatures (19 to 24 °C) or higher. Weinbreck et al. (2010) tested the viability of L. 
rhamnosus coated with whey protein with or without an extra layer of palm oil during storage at 
37 °C for 2 weeks. The results indicated protection was not improved with encapsulation when 
compared to free cells (Weinbreck et al., 2010). Similarly, O'Riordan et al. (2001) tested 
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Bifidobacterium PL1 coated with starch by spray drying and stored at ambient temperature (19-
24 °C) for 20 d. The viability of the probiotic bacteria decreased markedly from 10 log cfu/g to 
less than 5 log cfu/g and was not improved by encapsulation (O'riordan et al., 2001). Similar 
studies have confirmed inefficient protection of encapsulated probiotics during storage at 
ambient temperature (O'riordan et al., 2001; Martin et al., 2013; Tomás et al., 2015; Xu et al., 
2016). However, some exceptional successful cases have been reported. For example, Sánchez et 
al. (2017) reported viability of a Lactobacillus bacteria (detailed information on species and 
strain was not reported) encapsulated in sodium alginate and calcium carbonate by an 
emulsification - internal gelation procedure, compared to non-encapsulated bacteria following 
storage at  - 20, 4, 25 °C. Authors reported 100 % of survival of encapsulated bacteria after 150 d 
of storage independent of storage temperature (Sánchez et al., 2017). Another study of 
encapsulated Shewanella putrefaciens observed a 40 % viability loss after 30 d storage at 22 °C 
after alginate coating (Rosas‐Ledesma et al., 2012).  
Several studies have shown a significant protection of encapsulated probiotic bacteria 
stored under refrigerated conditions. Varankovich et al. (2017) encapsulated L. rhamnosus and L. 
helveticus with pea protein-alginate with or without extra chitosan coating. After freeze-drying, 
capsules were either vacuum packaged or not and stored at 4 and 22 °C for 9 weeks. The overall 
viability of encapsulated probiotics stored at 4 °C was better than at 22 °C (Varankovich et al., 
2017). Rosas-Ledesma (2012) found that alginate coated S. putrefaciens maintained its viability 
over 90 % when stored for one mo at 4 °C. A similar trend was observed when L. acidophilus 
was encapsulated with mucilage and flaxseed protein by spray drying and followed by stored at 
4 °C for 45 d (Bustamante et al., 2015).  The maximum viability was found when stored at -
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20 °C of L. casei encapsulated by skim milk, trehalose and maltodextrin compared to other 
temperature tested (4, 25, 37 °C) (Liao et al., 2017).  
In summary, encapsulation can provide protection against loss of viability when storage 
temperature is below ambient temperature. Few studies have reported any advantage of 
encapsulation on the viability of probiotic during storage above ambient temperature.  
2.2.3.3 Effects of encapsulation on probiotic survival during gastrointestinal delivery in vitro 
and in vivo 
The delivery of viable encapsulated probiotic organisms to the distal digestive tract 
represents the final challenge in probiotic delivery. Research on the efficacy of encapsulation of 
probiotic organisms during gastrointestinal tract transit is mostly conducted using in vitro testing. 
Several studies have noted an improved protection during simulated gastric acid challenge (pH 
as low as 1.2) as well as simulated intestinal juice challenge (Zhang et al., 2013). These studies 
demonstrated that the addition of wall material and the matrix formed by cross-linking provided 
additional protection during in vitro gastrointestinal challenge. Alginate-based capsules such as 
alginate-starch (Sultana et al., 2000), alginate-chitosan (Vandenberg et al., 2001), pea protein 
isolate-alginate (Klemmer et al., 2011b), alginate-skim milk (Shi et al., 2013) and alginate-
prebiotics (Iyer and Kailasapathy, 2005) have all been demonstrated to protect viability in 
simulated upper digestive tract challenges when compared to free cells. Furthermore, in one 
study, the encapsulated core bacteria were released in the intestinal juice presumably in response 
to the action of digestive enzymes included in the simulation cocktail (Klemmer et al., 2011b). 
The study of encapsulated probiotic organisms during transit in the animal 
gastrointestinal tract is very limited. These limitations are mainly due to the complex 
gastrointestinal tract environment and lack of tracking methods for the target encapsulated 
bacteria. Traditional selective culture methods are typically not strain specific such that 
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differentiation of the encapsulated probiotic and commensal bacteria resident in the digestive 
tract is difficult. Whereas molecular methods mainly based on quantitative real-time PCR 
(Polymerase chain reaction) can improve selectivity, traditional DNA-based PCR techniques do 
not differentiate live and dead cells. New molecular methods to differentiate live and dead cells, 
for example, based on cell wall permeability to ethidium monoazide, are being developed, 
however, their accuracy of these methods are poor (Flekna et al., 2007).  
Nevertheless, Rodklongtan et al. (2014) used PCR and RAPD (Random Amplified 
Polymorphic DNA) to detect the appearance of encapsulated and non-encapsulated L. reuteri in 
excreta of 3 broiler birds. The authors used the appearance in excreta of an indigestible marker 
incorporated in feed with the probiotic to confirm feed passage. The probiotic was detected in 
excreta by PCR only when fed in encapsulated form indicating protection of at least probiotic 
DNA (Rodklongtan et al., 2014). Varankovich et al. (2015) encapsulated B. adolescentis in a pea 
protein isolate-alginate capsules and supplemented the diet to rats. By using qPCR, the authors 
detected specific B. adolescentis DNA in fecal material suggesting probiotic protection during 
intestinal tract transit. The authors could not establish whether the encapsulated bacterium was 
viable, and unfortunately, they did not include a non-encapsulated control group making 
interpretation regarding the efficacy of the encapsulation method impossible. Interestingly in 
another study, a fluorescence protein-labeling method was applied by Rosas-Ledesma et al. 
(2012) to test the efficacy of delivery of an alginate coated Shewanella putrefaciens on delivery 
to fish. The feeding trail results showed that encapsulated bacteria could be recovered in excreta 
of Senegalese sole whereas no recovery was evident in the non-encapsulated probiotic control 
group. 
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Two other studies have investigated in vivo host responses to encapsulated probiotic are 
very noteworthy. Pirarat et al. (2015) encapsulated L. rhamnosus GG (LGG) with skim milk and 
alginate by extrusion, followed by freeze-drying. The encapsulated probiotics were fed to Nile 
tilapia for 30 d with free cells and a non-probiotic group as controls. When encapsulated 
probiotic was added to feed, fish weight gain improved at 14 and 30 d when compared to both 
the control group and the non-encapsulated probiotic group. Similarly, encapsulated LGG 
significantly improved intraepithelial lymphocyte number and protected against challenge with S. 
agalactiae, whereas the non-encapsulated control was not effective (Pirarat et al., 2015). In 
contrast, Iyer et al. (2013) measured in vivo bacteria release pattern using qPCR as well as 
cytokine expression in mice fed chitosan-coated alginate-starch capsules containing L. casei. 
Encapsulated bacteria were not released in gastric and duodenal contents for 24 h. However, a 
cytokine expression response was observed in mice fed either the encapsulated or non-
encapsulated probiotic compared to the untreated control (Iyer et al., 2013). 
In summary, different encapsulation formula provided broad protection for core probiotic 
strains during in vitro gastric challenge when compared to non-encapsulated bacteria. Due to the 
lack of tracking method for in vivo delivery, studies examining efficacy of encapsulation in the 
animal gastrointestinal tract are limited. However, in the limited studies conducted, 
encapsulation showed a potential to improve probiotic delivery to the distal intestine. .  
2.3 Overall summary  
Several probiotic bacterial strains provided significant benefits to animal health and 
growth performance. However, there are limited strains that can be applied in the commercial 
feed market for direct application due to the lack of stability during probiotic manufacturing, 
feed processing and upper gastrointestinal tract challenges. The commercial strains are mainly 
  
 
56 
  
spore-forming bacillus, yeast and hardy lactic acid bacteria. In order to broaden the utilization of 
probiotic strains, additional protections are required. Encapsulation, using one of several 
available techniques, a variety of wall materials and a variety of formulations, is one solution 
that has been investigated. Encapsulation has been shown to protect a number of sensitive 
bacterial strains against dehydration, thermal and chemical stresses experienced during 
processing, storage and delivery to the intestinal tract. Therefore, this technology provides an 
approach to broaden the selection of commercial bacterial strains to include those with a health 
benefit but sensitivity to stressors associated with manufacture, storage and passage through the 
upper gastrointestinal tract.  Alternatively, the technology may simplify the commercial adoption 
of current Lactobacillus probiotic strains that cannot be directly incorporated in to feed. 
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2.4 Hypothesis and Objectives 
 
Hypothesis: 
The encapsulation of probiotic bacteria in a pea protein isolate-alginate matrix will improve the 
viability of the probiotic during freeze-drying, storage, feed processing and transit through the 
gastrointestinal tract of animals. 
Objectives: 
 Develop and scale pea protein-based encapsulation of probiotic bacteria to permit study 
of encapsulation efficacy on inclusion in feed.  
 Determine the efficacy of pea protein-based capsules to protect probiotic bacteria from 
loss of viability during freeze-drying and storage of dried products.  
 Determine the efficacy of pea protein-based capsules to protect probiotic bacteria from 
loss of viability during challenges associated with feed processing. 
 Determine the efficacy of pea protein capsules to enhance viability and colonization of 
probiotic bacteria in the distal gastrointestinal tract when supplemented in feed.  
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3 EFFICACY OF PEA PROTEIN ISOLATE-ALGINATE ENCAPSULATION ON 
VIABILITY OF PROBIOTIC BACTERIUM DURING FREEZE-DRYING AND 
STORAGE 
3.1 Abstract  
Several experiments were conducted to determine whether pea protein isolate (PPI) - 
alginate (AL) capsules (PPC) could improve probiotic viability during drying and storage. Early 
stationary phase Bifidobacterium adolescentis (BA) or Lactobacillus reuteri (LR) cultures were 
suspended in one volume of 10 % skim milk (BA-M and LR-M) or encapsulated in 4.0 % PPI 
and 0.5 % AL followed by extrusion and crosslinking (BA-PPC and LR-PPC). To examine the 
additive or synergistic effect of other preservatives, BA capsules were prepared without 
preservatives (BA-PPC), with 0.25 % skim milk and 0.075 % glucose (BA-PPC-M), 1.5 % 
glycerol (BA-PPC-G) or 0.02 % cysteine-HCl (BA-PPC-H). Loss of viability during freeze-
drying was significantly (P < 0.0001) reduced in BA-PPC (1.22 ± 0.02 log cfu/g) compared to 
non-encapsulated BA without preservatives (5.32 ± 0.13 log cfu/g). However, the addition of 
milk plus glucose or glycerol to non-encapsulated BA provided similar protection (BA-M: 0.75 ± 
0.12 log cfu/g; BA-G: 1.05 ± 0.06 log cfu/g) compared to BA-PPC. Moreover, encapsulation 
with milk and glucose (BA-PPC-M) further protected (P < 0.001) against loss of viability (0.62 ± 
0.33 log cfu/g) compared with BA-PPC. The addition of cysteine-HCl did not reduce the loss of 
viability in non-encapsulated bacteria (5.75 ± 0.09 log cfu/g) or encapsulated bacteria (1.32 ± 
0.13 log cfu/g). After storage at -80 °C for 335days, the reduction in viability of BA-M was 5.36 
log cfu/g and markedly greater (P < 0.01) than observed for BA-PPC (1.99 log cfu/g). The 
addition of preservatives to BA-PPC or vacuum packaging did not affect the loss of viability. 
After 14 d storage at room temperature, BA-PPC prepared with any of the added preservatives 
protected (P < 0.001) against loss of viability compared with BA-M. Vacuum packaging 
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marginally reduced (P < 0.05) loss of viability during storage at room temperature for 14 d (2.21 
± 0.15 vs. 2.02 ± 0.23 log cfu/g). L. reuteri was more resistant to loss of viability during storage 
compared to B. adolescentis. Loss of viability was less than 0.2 log cfu/g and not different 
between LR-M and LR-PPC after storage for 84 d at -80, -20 or 4 °C. When stored after 23 d at 
37 °C, the viability of both L. reuteri decreased rapidly without a difference between LR-M and 
LR-PPC. Following challenge in simulated gastric juice (SGJ), the loss of viability of B. 
adolescentis was greater (P < 0.01) for BA-M compared to BA-PPC. Milk plus glucose or 
glycerol as preservatives in addition to encapsulation further increased viability during SGJ 
challenge (P < 0.05) when compared to BA-PPC. Encapsulation showed strain and temperature 
dependency in protecting bacteria during storage. More protection was found when B. 
adolescentis was encapsulated and stored at -80 °C whereas encapsulation did not protect against 
loss of viability of a more resistant bacteria, L. reuteri, during storage at 37 °C. Milk plus 
glucose or glycerol provided some additional protection against loss of viability of B. 
adolescentis during freeze-drying and SGJ challenge when used in combination with 
encapsulation. 
3.2 Introduction  
The gastrointestinal (GI) tract of mammals harbours a variety of microbes whose 
numbers can reach up to 1012 cfu/mL in the colon (Castillo et al., 2006). The intestinal 
microbiota has been demonstrated to have significant effects on animal health including the 
development of immunity, exclusion of pathogens and contribution to numerous metabolic 
diseases (Duc et al., 2004; Cutting, 2011; Knap et al., 2011). Manipulating the gut microbiota by 
supplementing probiotics, has shown promising health benefits in humans (Rolfe, 2000; Sanders, 
2000). Similarly in the livestock industry, a number of researchers have reported benefits to 
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probiotic supplementation including increased growth performance (Estrada et al., 2001), 
improved efficiency of feed utilization (Altaher et al., 2015) and reduced occurrence of diarrhoea 
(Pieper et al. 2010; Scharek-Tedin et al., 2013) although benefits are not consistently observed 
(Szabo et al. 2009). 
Commercial probiotic products are largely limited to a few “hardy” strains that are 
naturally resistant to environmental challenges presented during processing and storage. To date, 
the commercial probiotic supplements used are mainly spore-forming Bacillus spp., yeast (S. 
cerevisiae) and E. faecium (Anadón et al., 2006). Other products containing Lactobacillus or 
Bifidobacterium spp. are primarily stored at 4 °C and, in the case of food animals, applied by 
mixing with feed, just prior to feeding, due to their short shelf-life (Kalavathy et al., 2003; 
Mountzouris et al., 2007; Jung et al., 2008). The removal of water (drying), exposure to oxygen, 
humidity and variations in temperature are all common environmental challenges during 
processing and storage that can be lethal to many sensitive bacteria limiting their probiotic 
application (Goderska, 2012). To improve the viability of sensitive bacteria during drying and 
storage, a number of methods have been investigated including gene mutation, encapsulation or 
adding preservative compounds with varying degrees of success (Lee et al., 2004; Corbo et al., 
2011; Sousa et al., 2012).           
Encapsulation entraps probiotics into a coating matrix to provide additional protection 
against environmental challenges. Encapsulation improved protection of probiotic viability in 
several studies conducted in liquid-based conditions such as gastric juice (Guérin et al., 2003; 
Klemmer et al., 2011a), fruit juice (Ding and Shah, 2008) and dairy products (Iyer and 
Kailasapathy, 2005) typical of human food applications. Encapsulation has also improved 
viability of bacteria during freeze-drying (Giulio et al., 2005; Tsen et al., 2007; Heidebach et al., 
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2010). However, a limited number of studies have investigated the impact of encapsulation on 
dry-based products and their conclusions are inconsistent. For example, improved protection was 
observed in protein-carbohydrate-oil matrix coated B. infantis when stored at 25 ºC for 5 weeks 
(Crittenden et al., 2006) as well as a coated L. acidophilus stored at 25 and 37 ºC for 20 d (Ann 
et al., 2007). In contrast, encapsulation did not improve the viability of L. rhamnosus when 
coated with a whey protein, with or without the extra layer of palm oil, and stored at 37 °C for 4 
weeks (Weinbreck et al., 2010). Bacteria viability was also not improved for a starch-
encapsulated Bifidobacterium spp. stored at 19-24 °C for 20 d (O'riordan et al., 2001).     
Although encapsulation materials used in the above studies are considered good barriers, 
a more adequate protection matrix may be needed to ensure consistent protection of probiotics 
stored as dry products. Alginate is one of the most commonly used probiotic encapsulation 
materials due to its low cost, non-toxic nature and ability to form a viscous gel after cross-linking 
(Su et al., 2011; Sathyabama et al., 2014). Numerous studies had shown promising effects of 
alginate encapsulation in protecting probiotics (Hansen et al., 2002; Annan et al., 2008; Chávarri 
et al., 2010). However, alginate alone did not show adequate protection (Lee and Heo, 2000). 
Adding other materials to the encapsulation matrix such as proteins or starch further protected 
bacteria from environmental challenges (Sultana et al., 2000; Gbassi et al., 2009; Heidebach et 
al., 2010).  
A number of preservatives have been examined to aid in maintaining probiotic viability 
during processing with and without encapsulation. For example, the addition of cryoprotectants 
to the encapsulation was shown to enhance protection of bacteria during freeze-drying (Shi et al., 
2013). Previous work has demonstrated that isolated pea protein, a non-gene modified plant-
based protein, is effective in preserving viability of bacteria on exposure to simulated gastric 
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juice (Klemmer et al., 2011a; Varankovich et al., 2015) and in improving delivery of viable 
probiotic bacteria to the distal digestive tract (Wang et al., 2016). The effects of alginate based 
encapsulation with the addition of pea protein isolate on bacteria viability during storage is 
largely unknown. Therefore, the objective of the present study was to determine the effect of a 
pea protein isolate-alginate encapsulation method, with or without added preservatives, on the 
viability of two model probiotic bacteria (B. adolescentis and L. reuteri) under different 
environmental conditions.   
3.3 Materials and Methods 
3.3.1 Bacterial culture  
A single colony of Bifidobacterium adolescentis ATCC 15703 (BA) and Lactobacillus 
reuteri ATCC 53608 (LR) [American Type Culture Collection (ATCC), Manassas, VA, USA] 
were inoculated into 100 mL reinforced clostridial media (RCM, Oxoid Ltd., Basingstroke, 
England) or de Man, Rogosa and Sharpe (MRS, Oxoid Ltd., Basingstroke, England) media, 
respectively. The bacteria cultures were incubated for 24 h under anaerobic (80 % N2, 10 % CO2 
and 10 % H2) conditions at 37 °C. This 24 h culture was then inoculated into fresh RCM broth 
media at a 1:1000 ratio and cultured for an additional 20 h (BA) or 14 h (LR) under anaerobic 
conditions at 37 °C to early stationary phase. B. adolescentis and L. reuteri were then centrifuged 
(4200 x g, 10 min, 4 °C) and the bacterial pellet was resuspended in peptone water. 
3.3.2 Preparation of pea protein-alginate capsules 
Pea protein-alginate capsules (PPC) were prepared using the adapted extrusion method 
described by Wood (2010). Briefly, pea protein isolate (PPI) (Nutri-Pea Limited, 80% protein, 
1.81% lipid, 10.78% cabohydrate, Portage-la-Prairie, MB, Canada) was dissolved into ddH2O 
(containing 4 % pea protein; pH adjusted to 8.0 with 1 M NaOH) and mechanically stirred for 30 
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min in a water bath at 80 ºC. The PPI solution was then cooled to room temperature and adjusted 
to pH 7.0 with 1 M HCl. Alginate (Sigma-Aldrich, Oakville, ON, CA) was added at 0.5 % (w/w) 
and the mixture heated to 80 ºC with mechanical stirring for another 45 min until the alginate 
was completely dissolved. The resulting pea protein and alginate solution (PAS) was cooled to 
room temperature before BA and LR were added at a ratio of 1 part washed bacteria to 18 parts 
(w/w) PAS with continuous stirring. The PAS was then extruded (Figure 3.1) through a 20 G 
needle under air pressure and dropped into a cross-linking solution (5 % CaCl2 and 1 % Tween 
20). After 30 min hardening time, the capsules were filtered over filter paper (Particle retention> 
20µm, Fisherbrand®, EU). Capsules were washed three times with one volume of peptone water 
(bacteria peptone 1.0 g, NaCl 5 g, dd H2O adjusted to 1 L) and collected onto aluminium trays 
prior to freeze-drying. 
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Figure 3.1. Schematic diagram of extrusion system for laboratory-scale production of capsules 
using a pea protein isolate-alginate solution (PAS) containing core bacteria. 
 
3.3.3 Evaluation of preservatives on viability of B. adolescentis 
Several preservatives were added to B. adolescentis cell preparations prior to freeze-
drying to assess their effect on bacteria viability. Non-encapsulated bacteria cells were 
resuspended in one volume (v/v) of peptone water with of one of four preservatives including, no 
preservative (BA); 10 % (w/w) skim milk powder and 0.5 volumes of a 10 % (w/w) glucose 
solution (BA-M); 0.5 % (w/w) cysteine-HCl (BA-H); and 0.3 volumes of glycerol (BA-G). Cell 
suspensions were freeze dried directly or used to prepare PPC containing no preservative (BA-
PPC), containing milk and glucose (BA-PPC-M), containing cysteine-HCl (BA-PPC-H) or 
containing glycerol (BA-PPC-G).   
3.3.4 Freeze-drying 
Non-encapsulated bacteria cell suspensions were transferred to Petri dishes to a fluid 
depth of approximately 5 mm and freeze dried for 48 h (vacuum collector -50 ºC, 0.140 mBar, 
shelf temperature -20 ºC). Encapsulated bacteria were distributed in Petri dishes to a depth of 8 
mm and freeze dried under the same conditions as non-encapsulated cell suspensions. Following 
freeze-drying, dry matter (DM) and moisture content were determined by oven drying at 55 ºC to 
a constant weight. Final moisture content was confirmed as below 7 % w/w. The diameter of 
freeze-dried PPC was (1823.12 ± 570.22 µm) as measured using a laser scattering particle size 
distribution analyzer (Horiban Instruments Inc., Irvine, CA) in triplicate. The mean diameter of 
PPC was not affected by the addition of preservatives.   
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3.3.5 Effect of encapsulation and preservatives on viability of B. adolescentis during freeze- 
drying  
To determine the effect of encapsulation and preservatives on bacteria viability during 
freeze-drying, samples of both non-encapsulated and encapsulated BA were collected before and 
after freeze-drying and cultured for enumeration. All suspended samples were homogenized 
three times for 10 s at speed 6 (Omni Macro Homogenizer, Omni International Inc., Marietta, 
GA) on ice to ensure disruption of capsules. The homogenized samples were further diluted in 
peptone water, plated on RCM and cultured at 37 °C under anaerobic conditions (BD, Gaspakim. 
Anaerobe container system, USA) for 48 h. Colonies were enumerated after culture, and viability 
reported as the difference (log reduction) in log cfu/g dry matter before and after freeze-drying. 
3.3.6 Effect of encapsulation, vacuum packaging and preservative addition on viability of 
B. adolescentis during storage 
Five formulations containing BA, evaluated for viability after freeze-drying, were also 
evaluated for viability during storage under different conditions. The five formulations included 
BA-M, BA-PPC, BA-PPC-M, BA-PPC-H and BA-PPC-G. After freeze-drying formulations 
were placed in plastic bags and sealed without vacuum or after vacuum removal of air to 
compare the effect of vacuum packaging versus no vacuum packaging (FoodSaver Vacuum 
Packing System, V2040, China). Formulations were stored at -80 °C and at room temperature 
(21 °C). For formulations stored at room temperature, B. adolescentis viability was determined 
in triplicate samples on storage days 1, 3, 5, 7, 9, 14 and 19. For formulations stored at -80 °C, 
bacteria viability was determined in triplicate samples on storage days 1, 14, 28, 44, 90 and 335. 
3.3.7 Effect of encapsulation on viability of L. reuteri during storage 
A similar comparison was conducted for non-encapsulated L. reuteri with milk 
preservatives (LR-M) and encapsulated but unpreserved L. reuteri (LR-PPC). Stored aliquots of 
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LR-M and LR-PPC were stored at a range of different temperatures. LR-M was diluted with corn 
starch to 109cfu/g. The viability of bacteria stored under different temperatures was determined 
as follows: on storage days 1, 2, 5, 6, 9, 12, 15 and 23 for formulations stored at 37 °C; on 
storage days 1, 2, 5, 9, 15, 23, 56 and 84 for formulations stored at 4 °C; and on storage days 6, 
56 and 84 for formulations stored at -20 °C and -80 °C.  
3.3.8 Effect of encapsulation on viability of B. adolescentis in simulated gastric juice 
The viability of non-encapsulated freeze-dried B. adolescentis with milk as preservative 
(BA-M) was compared to the viability of B. adolescentis in freeze-dried PPC prepared without 
preservatives (BA-PPC) or with one of the three preservatives described above (BA-PPC-M, 
BA-PPC-G and BA-PPC-H). The B. adolescentis formulations were incubated for 2 h at 37 °C in 
simulated gastric juice (SGJ: 0.08 M HCl and 0.2 % NaCl (w/v), pH 2.0). The log reduction in 
viable counts was determined after the 2 h incubation period. 
3.3.9 Statistical analysis 
A completely randomized design with factorial arrangement was used to assess bacteria 
viability. The effect of freeze-drying on viability was analyzed by two-way ANOVA using 
treatment (encapsulation vs. non-encapsulation), preservative (no preservative, milk plus 
glucose, cysteine-HCl, and glycerol) and their interaction as sources of variation. Bacterial 
viability during storage was also analyzed as to two-way ANOVA separately for each storage 
temperature and each experimental day. Treatments (BA-M, BA-PPC, BA-PPC-H, BA-PPC-M 
and BA-PPC-G) and packaging (vacuum vs. no vacuum) were used as the main effects. A one-
way ANOVA was used to analyze the effect of treatment on bacterial viability in SGJ challenge. 
For all experiments, the log reduction in viability was calculated as the dependent variable with 
separation of means using Tukey’s mean separation procedure. The analysis was conducted using 
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SAS version 9.4 (Statistical Analysis Software, SAS Institute Inc, 2013, Cary, NC, USA) 
software with Proc Mixed procedure and probabilities were considered significant at P < 0.05. 
3.4 Results  
3.4.1 Effect of freeze-drying on the viability of non-encapsulated and encapsulated B. 
adolescentis  
The log reduction in viability of non-encapsulated and encapsulated B. adolescentis, after 
freeze-drying with different preservatives, is shown in Table 3.1. Milk plus glucose and glycerol 
were equally effective in protecting against loss of viability of non-encapsulated B. adolescentis 
(BA-M and BA-G) limiting the reduction in viability to approximately 1 log cfu/g. In 
comparison, non-encapsulated B. adolescentis viability was reduced by greater than 5 log cfu/g 
during freeze-drying without added preservatives (BA) or with added cysteine-HCl (BA-H).  
 
Table 3.1. Mean reduction (log10 cfu/g) in the viability of non-encapsulated B. 
adolescentis (BA) and encapsulated B. adolescentis (BA-PPC) after freeze-drying without 
preservative or with milk plus glucose (M), cysteine-HCl (H) or glycerol (G) as 
preservatives.
 
 
 
Log reduction (log 10 cfu/g DM)
1 
  BA
2 
BA-PPC
3 
No preservatives   5.32 ± 0.13a 1.22 ± 0.02bc 
M 0.75 ± 0.12cd 0.62 ± 0.33d 
H 5.75 ± 0.09a 1.32 ± 0.13b 
G 1.05 ± 0.06bcd 0.77 ± 0.03cd 
     1 
Values are mean ± SEM (n = 3).  
     2 
Starting concentration range: 10.02±0.04  to 10.91±0.08 log cfu/g. 
    3 Starting concentration range:  8.25±0.04 to 8.57±0.2 log cfu/g. 
    a-d, An Encapsulation X Preservative interaction was observed; All means with a 
different letter are different at P < 0.001. 
 
 
Encapsulation alone markedly reduced the loss of viability of B. adolescentis (BA-PPC) 
compared to non-encapsulation without preservatives (BA; P < 0.001). Encapsulated B. 
  
 
68 
  
adolescentis preserved with milk plus glucose (BA-PPC-M) or glycerol (BA-PPC-G) protected 
bacteria viability to a similar degree as the same treatments applied to non-encapsulated bacteria. 
However, the addition of milk plus glucose during encapsulation (BA-PPC-M) significantly 
improved viability compared to encapsulation without any preservatives (BA-PPC; P < 0.001). 
The addition of cysteine-HCl and glycerol to encapsulated bacteria did not significantly alter 
viability relative to encapsulation without any preservatives. There was also no significant 
difference in viability between non-encapsulated and encapsulated B. adolescentis preserved 
with milk plus glucose (BA-M and BA-PPC-M, respectively). Glycerol performed similar to 
milk plus glucose in preserving viability, but the glycerol preservatives formed a viscous gel 
upon freeze-drying BA, which made sample handling difficult and unsuitable for mechanical 
processing.  Milk plus glucose (BA-M) was therefore selected as the preservative control group 
in the following storage test.  
3.4.2 Shelf-life of B. adolescentis storage at -80 °C 
There was no significant difference in the viability of B. adolescentis stored at -80 °C in vacuum 
(Figure 3.2A) versus non-vacuum packaging (Figure 3.2B) throughout the entire storage period. 
After 10 d of storage at -80 °C, the viability of B. adolescentis without encapsulation (BA-M) 
was reduced significantly (P < 0.05) compared to with encapsulation (BA-PPC). This initial 
rapid decline in viability of non-encapsulated B. adolescentis slowed after 10 d, such that the 
difference in viability between encapsulated and non-encapsulated bacteria remained relatively 
constant until 91 d. At 335 d of storage, the viability of BA-M was markedly reduced (P < 0.001) 
compared to encapsulated bacteria (BA-PPC, BA-PPC-M, BA-PPC-H and BA-PPC-G). There 
was no difference in the viability of encapsulated BA when encapsulated with the tested 
preservatives. 
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Figure 3.2. Mean (± SEM, n = 3) reduction (log cfu/g) in B. adolescentis viability during storage 
at -80 °C for 335 d. Prior to freeze-drying bacteria were either non-encapsulated with milk plus 
glucose (BA-M) or encapsulated without preservatives (BA-PPC), with milk plus glucose (BA-
PPC-M), with cysteine HCl (BA-PPC-H), or with glycerol (BA-PPC-G) as preservatives. A: 
Vacuum packaged B: Non-vacuum packaged. Significant differences are indicated with an 
asterisk (* P < 0.001 between BA-M and BA-PPCs). Starting concentration for BA-M is 
12.28±0.65 log cfu/g and for encapsulated PPC group ranged from 7.06±0.22 to 7.30±0.28 log 
cfu/g. 
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3.4.3 Shelf-life of B. adolescentis at room temperature 
Loss of viability of B. adolescentis occurred more rapidly at room temperature compared 
to -80 °C (Table 3.2.). B. adolescentis viability was reduced by 1.75 to 2.64 log cfu/g at room 
temperature after 14 d of storage for all groups. Frequent sampling between 3 to 14 d storage 
indicated that encapsulation with preservatives improved viability compared with non-
encapsulated bacteria. Encapsulation with cysteine-HCl, milk plus glucose or glycerol as a 
preservative significantly reduced the loss of viability at 14 d storage when compared to BA-M 
and BA-PPC. Vacuum packaging marginally, but significantly, reduced loss of viability at 7, 9 
and 14 d of storage. At the day 3, without vacuum packaging, encapsulation significantly 
protected bacteria viability during the challenge while the preservatives provided no additional 
advantages. Under vacuum packaging, PPC and PPC-M significantly protected bacteria when 
compared to non-encapsulation. For non-encapsulated bacteria, vacuum packaging protected 
against loss of viability. Encapsulation provided additional protection except in the case of 
capsules prepared with glycerol and cysteine-HCl.  
 
3.4.4 Shelf-life of L. reuteri stored at different temperatures        
At storage temperatures of 4, -20 and -80 °C, L. reuteri survived well, such that the 
reduction in viability was less than 0.2 log cfu/g after 84 d of storage (data not shown). The 
viability of L. reuteri was unaffected by encapsulation (data not shown).  Loss of viability of L.  
reuteri occurred rapidly when stored at 37 ºC, such that viable counts were below the detection 
limit for enumeration after 23 d. Encapsulation did not slow the rate of loss of viability for 
bacteria stored at 37 ºC (Figure 3.3).  
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Table 3.2.  Mean (n = 3) reduction (log10 cfu/g) in the viability of encapsulated (PPC) and non-encapsulated B. adolescentis (BA) 
after storage at room temperature for 14 d. Treatments included a non-encapsulated control with milk plus glucose preservative 
(BA-M), a pea-protein-alginate encapsulation without a preservative (BA-PPC) or encapsulation with milk plus glucose (BA-PPC-
M), cysteine-HCl (BA-PPC-H) or glycerol (BA-PPC-G) as preservatives. All treatments were tested with and without vacuum 
packaging. 
 Treatment    Packaging  Treatment 
X 
Packaging  
 BA-M BA-
PPC 
BA-
PPC-H 
BA-
PPC-
M 
BA-
PPC-G 
SEM P  Non 
Vacuum 
Vacuum SEM P  
Day 3 0.98a 0.05c 0.40bc 0.09c 0.48b 0.09 < 0.0001  0.30b 0.50a 0.58 0.0233  0.0117 
Day 5 0.97ab 0.92ab 1.36a 0.63b 0.75b 0.13     0.006  0.94 0.92 0.08 0.8599  0.4288 
Day 7  1.34ab 1.15b 1.75a 1.16b 1.23b 0.11    0.0046  1.48a 1.18b 0.07 0.0068  0.5968 
Day 9 2.26a 1.37c 1.87ab 1.34c 1.45bc 0.99 < 0.0001  1.81a 1.51b 0.06 0.0037  0.6031 
Day 14  2.64a 2.32ab 2.04bc 1.75c 1.83c 0.09 < 0.0001  2.21a 2.02b 0.05 0.0208  0.4044 
a-c: Means with a different letter are significant different at P < 0.05. 
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Figure 3.3. Mean (± SEM, n = 3) reduction (log cfu/g) in L. reuteri viability stored at 37 °C for 
23 d. Prior to freeze-drying bacteria were either non-encapsulated with milk as a preservative 
(LR-M) or encapsulated without preservative (LR-PPC). Starting concentration for LR-M is 
9.82±0.02 log cfu/g and for LR-PPC is 9.46±0.04 log cfu/g. 
 
 
3.4.5 Effect of encapsulation protection on challenge in simulated gastric juice of B. 
adolescentis 
After a challenge in SGJ for 2 h, B. adolescentis loss of viability was significantly lower 
in freeze-dried encapsulated bacteria group (1.43 ± 0.26 log cfu/g) compared to non-
encapsulated (BA-M; 4.78 ± 0.15 log cfu/g; Figure 3.4).  The addition of milk plus glucose (BA-
PPC-M; 1.21 ± 0.11 log cfu/g) and glycerol (BA-PPC-G; 1.18 ± 0.13 log cfu/g) further reduced 
(P < 0.05) loss of viability in SGJ compared to PPC without  preservatives (BA-PPC; 1.82 ± 0.11 
log cfu/g).   
  
 
73 
  
 
Figure 3.4. Mean (± SEM, n = 3) reduction (log cfu/g) in viable count of B. adolescentis after 2 
h in simulated gastric juice for non-encapsulated bacteria preserved with milk (BA-M) and 
bacteria encapsulated without preservatives (BA-PPC) or encapsulated with milk and glucose 
(BA-PPC-M), cysteine-HCl (BA-PPC-H), or glycerol (BA-PPC-G). Vertical bars represent SEM. 
Bars with different letters indicate treatments are different at P < 0.05. Starting concentration for 
BA-M is 7.08 ±0.08 log cfu/g and for PPC group is ranged from 6.89±0.08 to 7.18±0.19 log 
cfu/g.  
 
3.5 Discussion      
Probiotic bacteria can provide promising benefits to improve the health of humans 
(Sanders, 2000) and animals (Musa and Seri, 2016). However, a loss of viability in probiotics 
sensitive to processing and storage has limited the development and application of probiotic 
bacteria in the food and feed industries (Anal and Singh, 2007; Rokka and Rantamäki, 2010). 
This study investigated the potential of a pea-protein and alginate-based encapsulation method, 
with and without the addition of one of several preservatives, on the viability of model probiotic 
bacteria during freeze-drying and storage.      
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3.5.1 Viability after freeze-drying  
Although freeze-drying is considered a relatively gentle procedure, water removal and 
temperature change during drying increases stress on bacterial cells, which can damage the cell 
membrane (Castro et al., 1997).  In the present study, a substantial loss in viability (> 5 log cfu/g  
DM) was observed in B. adolescentis when freeze dried without preservatives. Encapsulation 
without preservatives protected against loss of viability during freeze-drying. There is limited 
research on the impact of encapsulation on bacterial viability during freeze-drying. Heidebach et 
al. (2010) tested the effect of a casein-based microencapsulation on the viability of two bacterial 
strains (Bifidobacterium lactis Bb12 and Lactobacillus paracasei subsp. paracasei F19) 
compared to free cells after freeze-drying. Although there is considerable variation in loss of 
viability of lactic acid bacteria during freeze-drying, the Bifidobacterium strain was more 
resistant to loss of viability during freeze-drying compared to the Lactobacillus strain. Heidebach 
et al. (2010) reported that encapsulation did not improve viability of the hardy Bifidobacterium 
strain, whereas encapsulation markedly improved viability of the more susceptible Lactobacillus 
strain. The studies above suggest encapsulation does offer protection against loss of viability 
during freeze-drying for sensitive bacteria. 
This study also evaluated the effect of different protective preservatives on B. 
adolescentis viability during freeze-drying, with or without encapsulation. The preservatives 
milk plus glucose and glycerol improved viability during freeze-drying of non-encapsulated 
bacteria whereas the addition of cysteine-HCL did not improve viability. Skim milk and sugars 
are commonly used as preservatives during freeze-drying of bacteria. For example, similar to this 
study, the addition of milk and trehalose improved viability of L. bulgaricus after freeze-drying 
(Castro et al., 1997) and the addition of sucrose improved viability of E. coli and B. thuringiensis 
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after freeze-drying (Leslie et al., 1995). Although B. adolescentis is an anaerobic bacterium, it 
was not surprising that cysteine-HCL, an oxygen reducing agent, was not effective in protecting 
against loss of viability because freeze-drying was carried out under vacuum conditions.  
Among the preservatives tested, only the addition of milk plus glucose during 
encapsulation significantly improved viability of B. adolescentis after freeze-drying compared to 
encapsulation without the preservatives. However, the preservatives milk plus glucose with 
encapsulation did not further improve viability after freeze-drying compared with milk plus 
glucose without encapsulation. Thus encapsulation can replace the use of certain preservatives to 
improve viability of B. adolescentis after freeze-drying, but there was limited advantage in 
combining the preservatives with encapsulation. Our results contrasted Kearney et al. (1990), 
who showed that Ca-alginate capsules prepared using either glycerol with skim milk or adonitol 
with skim milk improved viability of L. plantarum after freeze-drying compared to the 
cryoprotectants without encapsulation. Similarly, Martin-Dejardin et al. (2013) observed that 
sugars (maltose or trehalose) or glycerol improved viability of B. bifidum after freeze-drying 
when incorporated into alginate-pectin capsules. These differences may relate to the use of pea 
protein and alginate in the capsules prepared in the current study, compared with calcium cross-
linked alginate or alginate–pectin used in the other studies. Most of the cryoprotective effects of 
protein, sugar or glycerol preservatives is likely associated with displacement of water and/or a 
reduction in the formation of destructive ice crystals (Crowe et al., 1988). Pea proteins 
incorporated in the capsules in the current study may have provided the cryoprotective effect 
typically provided by milk proteins such that there was limited added protection with the 
preservatives milk protein and glucose or glycerol.  
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3.5.2 Viability during storage 
Probiotics with a long shelf-life, which are resistant to fluctuating temperatures, would be 
ideal for use in the commercial application of probiotic products. However, there is no consensus 
on the effects of preservatives and encapsulation on the viability of bacteria during storage due to 
differences in storage temperature, storage solution, dry or liquid products and control groups.                   
Several studies have observed improved bacteria viability with use of preservatives 
and/or encapsulation during storage below 0 °C. However, results have varied considerably 
depending on bacteria strain and storage temperature. Survival of freeze-dried Streptococcus 
phocae was improved when stored with trehalose, glucose, galactose, skim milk and glycerol at a 
range of temperatures from -20 to 35 °C for up to 6 mo (Kanmani et al., 2011b).  However, the 
author also demonstrated that microcapsules, prepared with alginate and the preservatives 
trehalose, inulin and Tween 80, were effective in preventing viability loss during storage 
(Kanmani et al., 2011b). Ying et al. (2012) showed that L. rhamnosus GG, encapsulated in whey 
protein isolate-maltodextrin and stored at 25 °C, was maximized when glucose was added but 
not inulin (Ying et al., 2012). Recently, improved survival was observed with alginate-
encapsulated Lactobacillus casei stored at -15 °C compared to free cells (Xu et al., 2016). Sousa 
et al. (2012) encapsulated several lactic acid bacteria strains in Ca-alginate, with or without 
cysteine-HCl, and examined the effect of storage (as wet cells) on viability compared with free 
cells. In their study, encapsulation improved storage viability only at temperatures below 0 °C 
and cysteine HCl provided an added protective effect. When L. bulgaricus was encapsulated in 
chitosan calcium alginate, viability improved when stored at 22 °C but not at 4 °C, compared to 
free cells (Lee et al., 2004). Finally, encapsulation improved B. infantis viability when stored at 
25 ºC when compared to non-encapsulated bacteria (both on dry basis) (Crittenden et al., 2006).   
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In the present study, encapsulation protected B. adolescentis against loss of viability 
when stored at -80 ºC compared with free cells prepared in milk plus glucose. The strain of L. 
reuteri used in the present study demonstrated no significant loss of viability during storage at 4 
ºC and -80 ºC, even when stored as free cells with milk. Storage of L. reuteri at 37 ºC resulted in 
a rapid loss of viability that was not reduced with encapsulation. Unfortunately, viability loss 
during storage at room temperature was not examined, although this temperature may have 
resulted in a more gradual loss of viability. However, others have reported that encapsulation is 
ineffective when bacteria are stored above 0 ºC (O'Riordan et al., 2001; Weinbreck et al., 2010).  
Vacuum packaging did not improve the viability of B. adolescentis during storage at         
-80 °C, although some limited protection was observed at room temperature. Vacuum packaging 
is recommended for storage of dry bacteria because it can control both water activity and oxygen 
level (Carvalho et al., 2004). Unfortunately, although vacuum packaging was applied in several 
probiotic encapsulation storage studies (Chen and Mustapha, 2012; Okuro et al., 2013b), none of 
these studies has compared vacuum versus non-vacuum packaging. However, several studies 
have observed a prolonged shelf-life with vacuum packaging of probiotic-coated food products 
(Yingyuad et al., 2006; Jaworska et al., 2011). In the present study, all the samples were stored in 
sealed bags, with and without vacuum removal of air. Packaging alone may have sufficiently 
limited oxygen and water activity while bacteria were stored a -80 °C with very low metabolic 
activity. However, oxygen and water remaining in the sealed bags may have affected viability 
under the conditions of higher metabolic activity expected at room temperature.   
Water percentage is a critical factor for shelf-life. It was reported that less than 4 % water 
should be present during long-term storage of dry products (Gardiner et al., 2000) whereas 
higher than 10 % water is not desired (Desmond et al., 2002). In the present study, percent water 
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for PPC groups averaged from 6.3 to 6.7 %, which was similar to values obtained in another 
study using whey protein-pullulan capsules (Çabuk and Harsa, 2015). A more extended freeze-
drying period did not decrease percent water (data not shown). The moisture content of 
encapsulated bacteria was typically 1 % higher than free cells, a factor that may have contributed 
to reduced effectiveness of encapsulation at temperatures above 0 °C. 
3.5.3 In vitro function 
In addition to improved viability during processing and storage, encapsulation of 
probiotic bacteria may provide protection against the harsh conditions present in the upper 
gastrointestinal tract of animals and improve probiotic delivery to distal gut regions. In this study, 
encapsulation of B. adolescentis improved the viability of bacteria in SGJ compared to free cells, 
which has been reported previously for B. adolescentis (Klemmer et al., 2011a) and other 
probiotic strains (Annan et al., 2008; Zhang et al., 2013). This study confirmed that the inclusion 
of milk plus glucose or glycerol during encapsulation provided added protection against viability 
loss in B. adolescentis in SGJ compared to encapsulation alone. These preservatives may occupy 
pores present in the pea-protein matrix (Klemmer et al., 2011a), thereby reducing the diffusion of 
gastric juice into the capsule and preventing it from contacting the bacteria. The inclusion of 
these preservatives during capsule preparation may improve the in vivo efficacy of pea protein 
capsules delivery of probiotic bacteria to the distal intestine. 
3.6 Conclusion  
In conclusion, pea protein isolate-alginate encapsulation significantly protected B. 
adolescentis during freeze-drying and gastric-juice challenge. The effects of encapsulation on 
bacteria storage varied with temperature and bacteria strain. Not surprisingly, the susceptible 
bacteria (B. adolensentis) benefited more from encapsulation relative to the hardy strain (L. 
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reuteri). The addition of protective preservatives, milk plus glucose, in capsules improved 
viability during freeze-drying and acid challenge. Vacuum packaging of the anaerobe B. 
adolescentis, did not improve viability when stored at -80 °C whereas limited protection was 
noted at room temperature.  Results suggest that encapsulation in a pea protein-alginate matrix 
can provide protection against loss of bacterial viability during freeze-drying and storage,  but 
the magnitude of the effect is strain dependent.  Further work is required to establish techniques 
to permit long-term viability of sensitive probiotics under ambient temperature conditions 
commonly found in livestock feeding systems.  
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4 EFFICACY OF PEA PROTEIN ISOLATE-ALGINATE ENCAPSULATION ON 
VIABILITY OF PROBIOTIC BACTERIUM DURING FEED PELLETING 
4.1 Abstract 
Three sets of experiments were designed and conducted to determine the effect of 
encapsulation using a pea protein isolate (PPI) - alginate (AL) matrix on probiotic bacterial 
viability in response to thermal and pressure challenges during steam pelleting. Early stationary 
phase Bifidobacterium adolescentis (BA) or Lactobacillus reuteri (LR) cultures were suspended 
in 1 volume of 10 % skim milk (BA-M and LR-M) or encapsulated in a 4.0 % PPI and 1.0 % AL 
followed by extrusion and crosslinking (BA-PPC and LR-PPC). Loss of viability of bacteria on 
exposure to 50, 70 and 90 °C for 30, 60 and 180 s was significantly reduced (P < 0.05) by 
encapsulation compared to non-encapsulated BA and LR. Under the most severest challenge 
(90 °C for 180 s), the reduction in viable counts for BA-PPC and LR-PPC was 1.43 ± 0.03 and 
2.43 ± 0.02 log cfu/g, respectively, compared with 3.20 ± 0.25 and 3.47 ± 0.20 log cfu/g, for non-
encapsulated bacteria. To examine the combined effect of heat and pressure challenges, freeze-
dried bacteria were mixed with complete animal feed and placed in the chamber of a single 
channel pelleting apparatus with temperature and pressure controls. In separate experiments, 95 
MPa pressure was applied for 30 s without additional heat, or at 50, 70 and 90 °C. When the 
pressure was applied without additional heat, there was no significant difference in loss of 
viability between LR-M (0.77 ± 0.24 log cfu/g) and LR-PPC (0.43 ± 0.20 log cfu/g). However, 
encapsulation significantly (P < 0.05) improved viability when pressure was applied at 50 °C 
(0.75 ± 0.17 vs. 1.69 ± 0.14 log reduction cfu/g), 70 °C (1.40 ± 0.08 vs. 2.33 ± 0.08 log reduction 
cfu/g) and 90 °C (2.09 ± 0.09 vs. 3.43 ± 0.24 log reduction cfu/g). The viability of both 
encapsulated and non-encapsulated LR was markedly reduced when mixed in completed feed 
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and pelleted, with or without steam. Encapsulation did not protected bacteria during commercial 
pelleting.  
Pea protein isolate-alginate-based encapsulation provided significant protection against 
loss of probiotic viability when compared to non-encapsulated bacteria following a heat and 
pressure challenge. However, encapsulation was not sufficient to provide adequate protection 
against loss of viability under commercial pelleting conditions.    
4.2 Introduction   
Following their introduction to the feed industry in 1974 (Fuller, 1992), probiotics have 
been used as feed additives and as an alternative to prophylactic antibiotics to improve animal 
health and growth performance in farm animals and pets (Verschuere et al., 2000; Benato et al., 
2014; Prieto et al., 2014). Probiotics are viable microorganisms that when supplied in sufficient 
numbers, could alter the microflora (by implantation or colonization) and exert beneficial health 
effects in host (Schrezenmeir and de Vrese, 2001). This definition underlines the requirement for 
delivery of viable microorganisms in order to be considered a probiotic product. A major 
challenge in the application of probiotics in the feed and livestock industry has been the harsh 
conditions that feeds are exposed to during processing, storage and delivery. These conditions 
limit probiotic viability and have to date restricted probiotic inclusion in feeds to only a few 
species of microorganisms (Anadón et al., 2006; Amerah et al., 2013). 
Feed pelleting is a common processing method that results in the agglomeration of small 
feed particles into pellets by applying moisture, heat and pressure  (Falk. 1985). Pelleted feed is 
widely employed in the food animal industry to improve palatability, average daily gain and feed 
conversion rate while reducing foodborne pathogens and decreasing feed wastage (Kjeldsen and 
Dahl, 1999; Medel et al., 2004; Doyle and Erickson, 2006). The pelleting process typically 
  
 
82 
  
includes a conditioning step where heat and optional steam are applied to mash feed (Abdollahi 
et al., 2013a). Steam conditioning increases feed binding characteristics and improves pellet 
formation rate as the mash is forced through a metal die (Skoch et al., 1981).  
The conditioner temperature, retention time and die size are commonly adjusted to 
control pellet quality and feed nutritional value (Briggs et al., 1999; Abdollahi et al., 2010; 
Abdollahi et al., 2013c). Generally, for monogastric feed production, conditioning times are less 
than 2 min with a temperature range of 70 to 90 °C (Thomas et al., 1997; Doyle and Erickson, 
2006). The size of die is also routinely changed, between 0.5 to 10 mm in diameter, to maximize 
pellet performance in a particular application (Bertipaglia et al., 2010; Gopal et al., 2010; 
Abdollahi et al., 2013b) with smaller dies requiring a higher pressure and longer time to force 
feed pass through die. Higher temperatures, steam application and smaller die size produce 
harsher conditions and are associated with improved control of feed-borne pathogens but may 
also reduce the activity of sensitive feed additives such as enzymes (Spring et al., 1996; Jones 
and Richardson, 2004; Doyle and Erickson, 2006).  Due to the harsh conditions employed during 
pelleting, only a few probiotic organisms, including spore-forming bacteria Bacillus spp. 
(Amerah et al., 2013); yeast S. cerevisiae (Mathew et al., 1998); and E. faecium (Simon et al., 
2005), have been demonstrated to retain viability after pelleting. 
Encapsulation of probiotic bacteria is an emerging method to protect against loss of 
viability during harsh environmental conditions including feed processing. Encapsulation 
immobilizes probiotic bacteria inside coated material and can protect bacteria from storage losses 
(Corbo et al., 2011; Klemmer et al., 2011b). Encapsulation can also protect against the harsh 
conditions of the upper gastrointestinal tract (e.g. gastric acid and bile acids) improving distal gut 
delivery. Alginate encapsulation has been shown to be effective as a thermal protectant reducing 
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loss of viability for 8 strains of Lactobacillus and Bifidobacterium compared to non-encapsulated 
bacteria when challenged at 65 ºC for 1 h (Ding and Shah, 2007). Similarly, a study with alginate 
coated Lactobacillus casei showed heat protection after challenge at 55, 60 and 65 °C for 20 min 
(Mandal et al., 2006). This suggests encapsulation could provide protection against loss of 
viability during pelleting. 
However, industrial pelleting processes generally exceed these temperatures and include 
the addition of moisture and pressure that can lead to further loss of viability for probiotics. 
Pressure over 90 MPa resulted in a linear reduction in L. acidophilus viability (Chan and Zhang, 
2002). An extensive search of the literature showed that there have been no peer-reviewed 
reports examining the effect of encapsulation on probiotic viability during feed pelleting. 
Therefore, the objective of this study was to investigate the efficacy of pea protein encapsulation 
in protecting the viability of model probiotic bacteria against exposure to conditions observed 
during commercial pelleting.   
4.3 Material and Methods 
4.3.1Preparation of pea protein-alginate encapsulated and non-encapsulated bacteria 
Single colonies of B. adolensentis (BA, ATCC 15703) and L. reuteri (LR, ATCC 53608) 
were inoculated in 10 mL broth of Reinforced Clostridial Agar (RCM, Oxoid Ltd., Basingstroke, 
England) or de Man Rogosa and Sharpe (MRS, Oxoid Ltd., Basingstroke, England), respectively. 
The bacteria cultures were incubated for 24 h under anaerobic (GasPak™ Anaerobic container 
system, Becton, Dickson and Company, Sparks, MD, USA) conditions at 37 °C. This 24 h 
culture was then inoculated into fresh RCM or MRS broth at a 1:1000 ratio and cultured for an 
additional 20 h (BA) or 14 h (LR) under anaerobic conditions at 37 °C until early stationary 
phase. Cultures were then centrifuged (4000 x g, 10 min at 4°C) and washed with peptone water 
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[Bacto
TM 
peptones 1.0 g/L (Becton, Dickson and Company, Sparks, MD, USA)]. Non-
encapsulated bacteria were suspended in 1 volume of 10 % skim milk (LR-M). Pea protein-
alginate capsules (PPC) were prepared for each bacterium (BA-PPC, LR-PPC) by the adapted 
extrusion method as described before (Wood, 2010). Briefly, a Pea Protein-Alginate Solution 
(PAS) was prepared using 4 % (w/w) pea protein isolate (Nutri-Pea Limited, 80% protein, 1.81% 
lipid, 10.78% cabohydrate, Portage-la-Prairie, MB, Canada) and 1 % (w/w) alginate (Acros 
organics, CAS: 9005383, New Jersey,US) in dd H2O. BA or LR was added into the PAS with 
mixing at a ratio of 1:18 (w/w) prior to extrusion and crosslinking in a solution containing 5 % 
CaCl2 and 1 % Tween 20 for 30 min. Both encapsulated bacteria and non-encapsulated bacteria 
were vacuum freeze-dried for 7 d with a shelf temperature at -20 °C, a collector temperature at -
50 °C and a pressure of 11 Pa (Freezone 6L benchtop freeze dry systems, Labconco®, USA). 
4.3.2 Thermal challenge  
Early stationary phase BA and LR cultures were centrifuged (Beckman J6-MC, Palo alto, 
CA USA; 4000 x g, 10 min at 4 °C), washed and resuspended in peptone water, separately. 
Resuspended BA or LR and freshly prepared PPC containing BA or LR, were diluted 1:10 in 
peptone water in triplicate and 10 mL was placed in a water bath at 50, 70 and 90 ºC. After 0, 30, 
60 and 180 s, tubes were removed from the water bath and cooled to room temperature. The 
contents of all tubes were homogenized on ice (Fisher Scientific™ PowerGen™ Model 125 
Homogenizer, USA) at speed 6 (30,000 rpm) for 3 x 10 s to disrupt the PPC, serially diluted and 
plated on Reinforced Clostridial Media (RCM, Oxoid, Basingstroke, England) for BA and de 
Man Rogosa and Sharpe agar (MRS, Becton, Dickson and Company, Sparks, MD, USA) for LR. 
Colonies were enumerated and log reduction in viable count compared to time zero determined 
after anaerobic culture for 24 h (LR) and 48 h (BA), at 37 ºC.  
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4.3.3 Single channel pelleting apparatus challenge 
Freeze-dried non-encapsulated and encapsulated LR were added to a complete mashed 
feed (containing, wheat, barley, soybean meal, corn distiller’s grains with solubles, and micro 
ingredients) to a concentration of 10
7 
cfu/g diet. Approximately 1 g of mixed mash feed was 
placed into a tabletop pelleting apparatus (Instron 3366R4848, MA, USA) permitting production 
of single pellets under controlled temperature and pressure conditions. Pellets were produced at 
50, 70 or 90 ºC for 30 s at a pressure of 95 MPa with die size of 6.35 mm. The resulting feed 
pellets, generated in triplicate sets, were cooled to room temperature and ground by mortar and 
pestle. A 1:10 (w/w) dilution was prepared in peptone water, followed by homogenization on ice 
as described above to disrupt PPC. The homogenized solutions were again serially diluted with 
peptone water and plated on MRS agar. Colonies were enumerated after anaerobic culture for 24 
h at 37 ºC and the log reduction in the viable count was compared to the non-pelleted control. 
4.3.4 Steam pelleting  
Mashed feed (2.5 kg) was mixed with LR-PPC or LR-M to approximately 107 cfu/g diet 
and pelleted using a laboratory scale feed pelleting machine (CPM P/N 3-3093-15, 
Crawfordsville, IN, USA) operated at 90 ºC with a die size of 4.7 mm. Pellets were produced in 
triplicate experiments with addition of steam (1.4 kg/h at 241 kPa) or without steam. 
Approximately 200 g of pelleted samples were removed from the last 1 kg of feed produced. 
Conditioner temperature was measured by five probes located along the conditioner during 
pelleting; die temperature was measured by a digital infrared thermometer and pellet temperature 
was measured by both digital infrared thermometer and probes placed at exit points on pelleting 
machine. Pelleted feeds were cooled to room temperature and then 5 g of feed was mixed with 
25 mL peptone water and homogenized on ice as described above. The homogenized solutions 
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were serially diluted with peptone water and plated on MRS agar for culture at 37 ºC for 24 h 
under anaerobic conditions. Colonies were enumerated and log reduction in viable counts versus 
pre-pelleted control were reported. 
4.3.5 Statistical analysis  
The effects of the encapsulation on the viability of model bacteria during thermal 
challenge, single channel pelleting and commercial pelleting were analyzed by one way ANOVA 
using Proc Mixed procedure in SAS version 9.4 (Statistical Analysis Software, SAS Institute Inc, 
2013, Cary, NC, USA) with Tukey’s mean separation procedure. Microbial counts were log10 
transformed prior to analysis.  
4.4 Results    
4.4.1 Thermal challenge  
Encapsulation significantly and consistently reduced (P < 0.05) the loss of viability after 
heat treatment for both L. reuteri (Figure 4.1) and B. adolescentis (Figure 4.2) compared to non-
encapsulated bacteria at all tested temperature and exposure times. As expected, without 
encapsulation, both bacterial species lost viability during heat challenge demonstrating increased 
loss of viability with increased temperature and time of exposure. Encapsulation protected both 
bacteria strains from loss of viability such that, with the exception of the severest challenge (90 
ºC for 180 s), loss of viability was less than 0.5 log cfu/g for encapsulated bacteria. At the 
severest challenge, the reduction in viable counts for encapsulated B. adolescentis and L. reuteri 
was 1.43 ± 0.03 and 2.43 ± 0.02 (log cfu/g), respectively, compared with 3.20 ± 0.25 and 3.47 ± 
0.20 log cfu/g, respectively, for non-encapsulated bacteria.  
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Figure 4.1. Mean (± SEM, n = 3) reduction (log cfu/g) in the viable count after heat treatment of 
non-encapsulated L. reuteri (LR) and pea protein encapsulated L. reuteri (LR-PPC) at 50, 70 and 
90 ºC for 30, 60 and 180 s. Time points denoted with asterisks are significantly different (P < 
0.05). Starting concentration for LR is 8.15±0.08 log cfu/g and LR-PPC is 7.37±0.09 log cfu/g.   
 
 
 
Figure 4.2. Mean (± SEM, n = 3) reduction (log cfu/g) in the viable count after heat treatment of 
non-encapsulated B. adolensentis (BA) and pea protein encapsulated B. adolensentis (BA-PPC) 
at 50, 70 and 90 ºC for 30, 90 and 180 s. Time points denoted with asterisks are significantly 
different (P < 0.05). Starting concentration for BA is 7.84±0.02 log cfu/g and BA-PPC is 
6.94±0.03 log cfu/g.  
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4.4.2 Single channel pelleting apparatus challenge 
Encapsulation protected against loss of viability of L. reuteri during pelleting in a single 
channel apparatus at 50, 70 and 90 ºC (P < 0.05) using a constant pressure of 95 MPa for 30 s 
(Figure 4.3).  The reduction in viable counts at 50, 70 and 90 ºC was 1.69 ± 0.14, 2.33 ± 0.08 
and 3.43 ± 0.09 log cfu/g, respectively for non-encapsulated bacteria whereas the reduction in 
viable counts after encapsulation was 0.75 ± 0.17, 1.40 ± 0.08, 2.09 ± 0.09 cfu/g, respectively. 
When a pellet was produced at 95 MPa for 30 s without supplemental heat no significant 
difference in bacterial loss. Viability was observed between encapsulated (0.43 ± 0.20 log cfu/g) 
and non-encapsulated L. reuteri (0.77 ± 0.24 log cfu/g).   
 
Figure 4.3. Mean (± SEM, n = 3) reduction (log cfu/g) in viable count using a single channel 
apparatus to pellet a mash feed mixed with non-encapsulated L. reuteri (LR-M) and pea protein 
encapsulated L. reuteri (LR-PPC) without supplemental heat or at 50, 70 and 90 ºC for 30 s. 
Time points denoted with asterisks are significantly different (P < 0.05).Vertical bars represent 
standard error of mean. Starting concentration for LR-M is 7.78±0.08 log cfu/g and LR-PPC 
7.02±0.14 log cfu/g. 
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4.4.3 Steam pelleting   
Steam pelleting using a small scale pelleting machine resulted in a marked loss of 
viability of L. reuteri (Figure 4.4).  Bacterial counts in steam pelleted samples were below the 
detection limit for 3 of 9 samples containing LR-PPC and 5 of 9 samples containing LR-M. 
Detection limit 2.08 log cfu/g was applied to these samples. When pelleting was performed 
without steam addition, approximately half of the feed did not form into pellets such that this 
material was separated into pelleted feed and non-pelleted mash components for analysis of 
viable counts of L. reuteri. For the mashed feed, the loss of encapsulation of L. reuteri was 
smaller than non-encapsulated form (LR-PPC: 0.52 ±0.46 and LR-M 1.40±0.34 cfu/g, P=0.08)   
(Figure 4.4).   There was no significant difference between the viability in pelleted feed for both 
groups.  
The temperature of the die, pellets and conditioner observed during pelleting, with and 
without the addition of steam, are given in Table 4.1. The temperature in each location did not 
differ between pelleting runs conducted using feed containing encapsulated or non-encapsulated 
bacteria. There was no significant difference between each run of LR-PPC and LR-M. Without 
steam, the temperature of the conditioner, die and pellets was approximately 64, 61 and 70 ºC, 
respectively. With the addition of steam, the temperature in the conditioner increased by 
approximately 20 ºC and in the die by approximately 5 ºC, resulting in newly-formed pellets 
approximately 15 °C warmer.  
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Figure 4.4. Mean (± SEM, n = 3) reduction (log cfu/g) in the viable count after pelleting with or 
without steam treatment, of feed mixed with non-encapsulated resistant L. reuteri (LR-M) and 
pea protein encapsulated L. reuteri (LR-PPC) at a conditioner temperature 90 ºC. Time points 
denoted with an asterisk are significantly different (P < 0.05). Vertical bars represent standard 
error of mean. Starting concentraion for LR-M is 7.11±0.10 log cfu/g and for LR-PPC is 
6.93±0.09 log cfu/g. 
 
 
Table 4.1. Temperature of conditioner, die and pellets during pelleting ± SEM 
  Conditioner (°C) Die (°C) Pellets (°C) 
No Steam LR-PPC 63.6 ± 2.8 70.0 ± 0.0 60.3 ± 2.1 
 LR-M 64.4 ± 2.4 70.0 ± 0.0 61.3 ± 1.2 
Steam LR-PPC 84.7 ± 0.4 77.0 ± 1.6 76.0 ± 1.4 
 LR-M 83.1 ± 2.6 73.0 ± 3.7 75.0 ± 1.6 
 
4.5 Discussion 
Pelleting is commonly used in the feed industry to improve the efficiency of conversion 
of feed to animal products and reduce waste (Gramkow et al., 2016). However, pelleting poses a 
challenge to using probiotics in animal feed processing as the high temperature, steam and 
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pressure generated during the pelleting process are lethal to most bacteria. As a result, bacterial 
probiotics suitable for in-feed application in pelleted diets have been largely limited to highly 
thermostable species such as spore-forming Bacillus spp. and yeast (Mathew et al., 1998; 
Amerah et al., 2013). This study examined the effect of a range of temperature, steam and 
pressure conditions typically produced during the commercial feed pelleting process on the 
viability of lactic acid bacteria following encapsulation in a pea protein alginate matrix.  
4.5.1 Thermal challenge  
In the first set of experiments, two lactic acid bacterial species commonly used as 
probiotics (Cole et al., 1989; Lan et al., 2003) were exposed to heat under the temperature range 
and exposure duration that occurs during pelleting. Pea protein-alginate encapsulation was highly 
effective in protecting both species under heat challenge. Indeed, loss of viability of encapsulated 
bacteria was maintained at less than 0.5 log cfu/g at all temperatures and times tested with the 
exception of the most severe heat change (90 °C for 180 s). Several other studies similarly 
observed improved thermal protection with alginate-based encapsulation. For example, alginate 
capsules protected bacteria at temperatures below 70 °C and for duration of 10 min to 1 h 
(Mandal et al., 2006; Azim et al., 2012; Borges et al., 2012), although these conditions do not 
reflect conditions found during feed pelleting. The effects of encapsulation on probiotic viability 
at higher temperatures were studied by Sabikhi et al. (2010). The authors reported a protective 
effect of alginate and cornstarch capsules on L. acidophilus viability on exposure to challenge 
temperatures at 72, 85 and 90 °C for durations of 30 s. Loss of viability for non-encapsulated 
cells was (8.29, 8.51, 9.13 log cfu/mL) compared with coated cell was only (1.19, 2.18, 4.14 log 
cfu/mL) (Sabikhi et al., 2010), a much greater protective response to encapsulation than observed 
in the present study.  
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Several factors may affect the degree of thermal protection provided to probiotic bacteria 
by encapsulation. For example, increasing alginate concentration reduces the number and length 
of capsule pores (Hannoun and Stephanopoulos, 1986) and was reported to increase thermal 
protection (Mandal et al., 2006). Chen (2007) also proposed that alginate alone provided 
minimum protection against thermal challenge, possibly associated with heat-induced structural 
changes causing loss of strength in the alginate-calcium. Increasing the protein concentration in 
the encapsulation formulation increased bacteria survival after heat challenge (Chen et al., 2007). 
Adding starch (Sabikhi et al., 2010; Teoh et al., 2011) or other polysaccharides including gellan 
(Chen et al., 2007), bagasse (Shaharuddin and Muhamad, 2015), carrageenan (Cheow and 
Hadinoto, 2013), or chitosan (Abbaszadeh et al., 2014) to an encapsulation matrix was also 
reported to improve heat tolerance of bacteria during challenge. Martin et al. (2013) proposed 
that starch may improve the protection provided by alginate coating by stabilizing alginate 
particles; starch is synergistic in gelling with alginate and provides nutrients to coated cells 
(Martin et al., 2013). 
In the current study, the capsules were produced with a relatively low concentration of 
alginate (1 %) compared to previous reports but with the inclusion of pea protein. The addition of 
4 % of pea protein in this study may have enhanced thermal protection in the current 
formulation. Although the interaction of pea protein with alginate requires further investigation, 
pea protein was proposed stabilize alginate crosslinks and provide nutrients for bacteria. Wood 
(2010) showed that the addition of pea protein isolates resulted in a denser alginate capsules 
structure and less porous and smoother capsule surface. These physical changes may have 
contributed to an improvement in B. adolesentis survival after challenge under acid conditions 
when pea protein was formulated in the capsules compared to capsules that only contained 
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alginate (Wood, 2010). 
In the present study, non-encapsulated B. adolesentis was generally more sensitive to heat 
challenge (with the exception of 180 s exposure at 90 °C) compared to L. reuteri. This 
observation is consistent with previous reports, establishing species and strain variation in heat 
tolerance (Borges et al., 2012). The degree of thermal protection provided by encapsulation was 
also greater for B. adolescentis, where complete protection against loss of viability for exposures 
at 50 and 70 °C was observed. In contrast, encapsulation did not provide complete protection for 
L. reuteri even though this bacterium was less sensitive to thermal stress when not encapsulated. 
Borges et al. (2012) also found strain variation in protection against loss of viability due to 
thermal stress. A comparison of viability of L. casei, L. paracasei, L. acidophilus and B. animalis 
during exposure to heat (55 or 60 °C) for up to 1 h, demonstrated that encapsulation in a 2 % 
alginate matrix provided thermal protect only for L. acidophilus and only at 55 °C (Borges et al., 
2012). Because of its greater resistance to thermal stress, L. reuteri was selected for use in the 
remaining experiments. 
4.5.2 Single channel pelleting apparatus challenge 
Using a single channel pelleting apparatus, encapsulated and non-encapsulated L. reuteri 
cells were exposed to a pressure of 95 MPa to mimic the die pressure produced in a commercial 
feed pelleting equipment (Thomas et al., 1997). Pressure alone has been shown to inhibit 
bacterial enzyme activity, affect cell structure, gene transcription and translation (Patterson, 
2000; Murchie et al., 2005; Vogel et al., 2005; Abe, 2007). Indeed, pressure can also reduce 
bacteria viability as observed by Sheehan (2007), who noted a reduction in bacterial viability 
ranging from 5.9 to 7.9 log cfu/g for six strains of Lactobacillus and Bifidobacterium, after a 
high pressure challenge at 400 MPa for 5 min. In another study, Chan and Zhang, (2002) 
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observed a linear decrease in cell survival rate of freeze-dried L. acidophilus when exposed to 
compression ranging from 90 to 180 MPa with only a 33 % survival after exposure to 180 MPa.  
Increasing temperature, in combination with pressure, increased the loss of bacterial 
viability consistent with the results of the thermal challenge. Interestingly, the loss of viability of 
L. reuteri was greater in the single pellet apparatus compared to the same temperature challenge 
applied without pressure. The results suggest the pressure has an additive negative effect on 
viability when combined with the heat challenge. Similarly, previous studies have shown that the 
combination of high pressure treatment and heat can dramatically improve microbial inactivation 
in food products (Patterson and Kilpatrick, 1998; Considine et al., 2008).   
4.5.3 Commercial pelleting  
Due to limits in lab-scale production of pea-protein encapsulated bacteria, limited 
quantities of supplemented mash feed could be generated requiring a prioritization of the 
pelleting parameters that could be examined in the present study. Two temperature settings were 
examined: operating without the addition of steam (conditioner at 64 °C) and the addition of 
steam (conditioner at 84 °C). Use of steam added moisture, a variable not examined in the 
previous small-scale experiments. Unfortunately, consistent pellets were not observed when the 
pelleting machine was operated without steam resulting in half the material exiting the machine 
in mash form. Encapsulation protected L. reuteri in the mash fraction of feed exiting the die. 
Interestingly, the loss of viability for both encapsulated and non-encapsulated L. reuteri was 
similar in magnitude to that observed in the dry heat experiments at similar temperatures (70 °C 
for 180 s) as observed here in the pelleting die. The L. reuteri in the pelleted feed fraction exiting 
the pellet machine showed markedly reduced viability (more than 4 log cfu/g reduction in both 
treatments) compared to the mashed feed fraction. It is likely that the pressure force exerted on 
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the pelleted fraction while passing through the die, and the duration of heat exposure, was 
increased for the pelleted fraction relative to the mash fraction resulting in a reduced level of 
protection by encapsulation.   
The addition of steam to the conditioner increased the conditioner temperature by 
approximately 20 °C to 84 °C and the temperature of the die to approximately 75 °C. Loss of 
viability of L. reuteri exceeded 4 log cfu/g and the viability of some replicates in both treatments 
was below the detection limit. Encapsulation did not protect against loss of viability. The 
magnitude of viability loss, in comparison to previous experiments exposing L. reuteri to similar 
levels of heat, or heat and pressure via single channel pelleting, was unexpected. The addition of 
steam and moisture at the conditioner may have increased the rate of heating and penetration of 
heat into the pellet. Moisture contact and rehydration of the bacteria may have reduced heat 
tolerance as reported elsewhere (Zayed and Roos, 2004).  
There are limited publications examining the survival of probiotic bacteria during feed 
pelleting. Resistance to loss of viability during pelleting has only been observed with specific 
spore-forming or heat-tolerant strains. For example, more than 90 % of Bacillus subtilis spores 
survived after pelleting at a temperature of 90 °C (Amerah et al., 2013), Similarly, Bacillus 
cereus toyoi spores have a survival rate of 95 % at a pelleting temperature of 87 °C.  In contrast, 
E. faecium is a non-spore forming bacterium with a reported recovery rate of 35 % at a pelleting 
temperature of 80 °C (Simon et al., 2005). Finally, probiotic yeast strains demonstrate heat 
tolerance such that S. cerevisiae can be pelleted with only 0.3 log cfu/g loss with the conditioner 
at 60 °C (Mathew et al., 1998). There are limited reports examining tolerance of lactic acid 
bacteria during pelleting. The findings of this study confirm the susceptibility of lactic acid 
bacteria to the conditions found during pelleting. Encapsulation in a pea protein isolate–alginate 
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matrix was not able to impart significant survival of lactic acid bacteria during pelleting.  
4.6 Conclusion  
In conclusion, pea protein isolate-alginate encapsulation protected B. adolescentis and L. 
reuteri during the thermal challenge. Pea protein isolate-alginate encapsulation also significantly 
protected bacteria viability during a combined thermal and pressure challenge, designed to 
mimic conditions found during commercial pelleting. However, lab scale feed pelleting, with and 
without steam addition, resulted in significant loss of bacterial viability. Encapsulation did not 
protect bacteria during commercial pelleting. Even low temperature commercial feed pelleting 
imposes harsh environmental conditions such that marked improvement in encapsulation 
methodology will be required to permit inclusion of heat sensitive probiotics in pelleted feeds.  
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5 EFFICACY OF PEA PROTEIN ISOLATE-ALGINATE ENCAPSULATION ON 
VIABILITY OF A PROBIOTIC BACTERIUM IN THE PORCINE DIGESTIVE TRACT1 
5.1 Abstract 
The aim of this study was to investigate the efficacy of pea protein isolate-alginate 
capsules (PPCs) on probiotic viability during transit of the porcine gastrointestinal tract. A 
Lactobacillus reuteri ATCC 53608 isolate selected for rifampin plus streptomycin resistance 
(LRR) was encapsulated in a pea protein isolate and alginate (LRR-PPC) using an extrusion and 
cross-linking method prior to freeze-drying. An in vitro study in simulated gastric juice showed 
that encapsulation increased (P < 0.001) survival in strong acid. After incorporation into the diet 
of weaned pigs, LRR were recovered from feces and digesta by selective culture. Fecal shedding 
of LRR from pigs fed LRR-PPC was higher (P < 0.001) than from pigs fed non-encapsulated 
LRR. Viable LRR counts were not different in homogenized stomach contents, however, higher 
(P < 0.001) counts were observed in distal intestinal contents for pigs fed LRR-PPC. Probiotic 
encapsulation using pea protein-alginate matrix can protect bacteria during upper intestinal 
transit improving viability in the distal gut and permitting a broader range of sensitive bacterial 
species candidates for probiotic application.   
5.2 Introduction 
Probiotic bacteria supplementation holds promise to improve animal and human health as 
an alternative strategy to in-feed/food prophylactic antibiotic use. A prerequisite for such 
application of probiotics is to maintain the viability of the probiotic organism at a sufficiently 
                                                          
1
 A version of this chapter has been published: Wang, J., Nickerson, M. T., Low, N. H., & Van Kessel, A. G. (2016). 
Efficacy of pea protein isolate–alginate encapsulation on viability of a probiotic bacterium in the porcine digestive 
tract. Canadian Journal of Animal Science, 97(2), 214-222. 
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high level to be able to colonize the distal gut adequately to affect the host beneficially 
(Rambaud et al., 1993). Bacteria with probiotic properties may be sensitive to the digestive 
enzymes, gastric acid, bile salts and other antimicrobial compounds present in the upper 
gastrointestinal tract (Klemmer et al., 2011b; Zhang et al., 2013; Tee et al., 2014) limiting their 
viability and thus application as oral supplements. Providing additional mechanisms to protect 
sensitive bacteria against environmental challenges in the gastrointestinal tract could improve the 
efficacy of existing probiotics and/or permit application of novel probiotic species. 
Encapsulation, which is an approach to immobilize and trap probiotic bacteria in a 
coating matrix, has been shown to improve the viability of probiotic strains during in vitro 
challenge (Lee and Heo, 2000; Klemmer et al., 2011b; Sathyabama et al., 2014). Several coating 
polymer materials have been used for encapsulation such as alginate, chitosan, carrageenan 
(Annan et al., 2008; Tee et al., 2014). Alginate is an inexpensive, non-toxic, gel-forming material 
broadly used in encapsulation in the presence of calcium ion (Su et al., 2011; Sathyabama et al., 
2014).  However, alginate alone did not show sufficient protection of probiotic viability in vitro 
(Lee and Heo, 2000). Milk proteins have been widely used in combination with alginate to 
improve probiotic protection (Picot and Lacroix, 2004; Heidebach et al., 2010). Pea protein 
isolates are an abundant and low-cost alternative plant protein source which have shown similar 
protective properties as milk proteins in combination with alginate (Klemmer et al., 2011b).  
Although, numerous studies have shown improved bacterial in vitro viability following 
encapsulation, there has been limited investigations on the effect of encapsulation on probiotic 
viability in vivo. Rosas-Ledesma (2012) showed that red fluorescence protein-labelled 
Shewanella putrefaciens coated with alginate could be recovered from the ileum of Senegalese 
sole whereas non-encapsulated S. putrefaciens could not. Similarly, chitosan-coated alginate 
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capsules increased Lactobacillus spp. abundance in mouse (Iyer et al., 2013) and chicken 
intestine (Rodklongtan et al., 2014). We hypothesized that pea-protein alginate encapsulation of 
a probiotic would increase the viability of the organism in the digestive tract. Therefore, in the 
present study, we selected an antibiotic-resistant strain of L. reuteri as a model probiotic species, 
to investigate the efficacy of a pea protein isolate-alginate encapsulation method on probiotic 
viability in the porcine digestive tract.   
5.3 Materials and Methods 
All experimental protocols involving animals were approved by the Animal Care 
Committee of the University of Saskatchewan (Animal protocol #20110065) and the 
experiments were performed in accordance with recommendations of the Canadian Council on 
Animal Care (1993). 
5.3.1 Selection and stability of antibiotic-resistant L. reuteri 
To confirm the concentration and class of antibiotic necessary to inhibit growth of 
resident lactobacilli in pigs, fresh porcine fecal samples (1 g) from weaned piglets (n = 10) were 
diluted with 9 g of peptone water [Bacto
TM 
peptones 1.0 g/L (Becton, Dickson and Company, 
Sparks, MD, USA), NaCl 8.5 mM (Fisher Scientific, Ottawa, ON, CA)]. The diluted feces were 
plated on de Man Rogosa and Sharpe agar (MRS, Becton, Dickson and Company, Sparks, MD, 
USA) containing rifampin (Sigma-Aldrich, St. Louis, MO, USA) at concentrations of 20, 100 or 
200 µg/mL or containing a combination of rifampin and streptomycin (Sigma-Aldrich, St. Louis, 
MO, USA) where streptomycin was added at ten times the concentration of rifampin (Pedersen 
and Tannock, 1989; Simpson et al., 2000). Plates were cultured for 48 h at 37 °C under anaerobic 
conditions (GasPak™ Anaerobic container system, Becton, Dickson and Company, Sparks, MD, 
USA) for enumeration of live bacteria. 
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To establish a resistant bacterium, a single colony of L. reuteri ATCC 53608 (Manassas, 
VA, USA) was inoculated into 10 mL MRS broth and cultured for 24 h at 37 ºC anaerobically.  
An aliquot of 10 µL of starter culture was amplified into 10 mL fresh MRS broth containing 
rifampin plus streptomycin at 1 µg/mL broth and 10 µg/mL broth, respectively.  This subculture 
procedure was repeated daily with increased concentration of both antibiotics until a 
concentration of 400 µg/mL rifampin and 4000 µg/mL streptomycin was achieved. An aliquot 
was then plated on MRS agar containing both antibiotics (400 µg/mL rifampin and 4000 µg/mL 
streptomycin) to isolate a single resistant colony for overnight culture and storage in 30 % 
glycerol (w/w) at -80 ºC.    
Single colonies of wild-type L. reuteri (LRW) and resistance L. reuteri (LRR) were 
inoculated in 10 mL MRS broth with antibiotic (200 µg/mL rifampin + 2000 µg/mL 
streptomycin, AB+) or without antibiotic (AB-) to establish growth kinetics. Optical density (600 
nm) and viable counts were measured every 2 and 4 h, respectively in an anaerobic chamber (80 % 
N2, 10 % CO2, and 10 % H2) for 32 h at 37 ºC. 
The stability of antibiotic resistance was measured by subculturing of LRR in the absence 
of antibiotic. The frozen stock was cultured on MRS agar (AB-) and a single colony 
subsequently inoculated into 10 mL MRS (AB-) broth followed by anaerobic culture for 24 h at 
37ºC. After 24 h, a 100 µL aliquot was plated on MRS (AB+) containing 200 µg/mL rifampin + 
2000 µg/mL streptomycin to enumerate viable antibiotic-resistant LRR. A 10 µL aliquot of the 
24 h culture was inoculated into fresh 10 mL MRS (AB-) for another 24 h. This process was 
repeated every 24 h for 14 d. Colonies formed on MRS (AB+) were enumerated each day to 
establish retention of antibiotic-resistant LRR.    
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5.3.2 Preparation of encapsulated and non-encapsulated bacteria 
Early stationary phase (12 to 14 h) LRR cultures were centrifuged, washed with peptone 
water and either resuspended in 1 volume of 10 % skim milk (LRR-M) or encapsulated in a pea 
protein isolate (PropulseTM Pea protein isolate, 80 % protein, Nutri-Pea Limited, Portage-la-
Prairie, MB, Canada)-alginate (Sigma-Aldrich, Oakville, ON, CA) matrix (LRR-PPC). Pea 
protein-alginate capsules were prepared by an adapted extrusion method as described by 
Klemmer (Klemmer et al., 2011b). Briefly, pea protein isolate (PPI) was dissolved into ddH2O 
(5 % w/w containing 4 % pea protein) at pH 8.0 (adjusted with 1 M NaOH) with mechanical 
stirring for 30 min in a water bath at 80 ºC. The PPI solution was then cooled to room 
temperature and adjusted to pH 7.0 with 1 M HCl. Alginate was added at 0.6 % (w/w) and the 
mixture heated to 80 ºC with mechanical stirring for another 45 min until the alginate was 
completely dissolved. The pea protein and alginate solution (PAS) was then cooled to room 
temperature before washed LRR were added at a ratio of 1 part washed bacteria to 18 parts (w/w) 
PAS with continuous stirring. The PAS was then extruded through a 20 G needle under air 
pressure and dropped into a cross-link solution [5 % CaCl2 and 1 % Tween 20 (Fisher, New 
Jersey, USA)]. After a 30 min hardening time, the capsules were filtered by filter paper (Particle 
retention> 20µm  Fisherbrand®, EU) and collected in aluminium trays. All LRR-PPCs and LRR-
M were vacuum freeze-dried for 5 d at -20 °C shelf temperature and -50 °C collector temperature 
with a pressure of 0.11 mBar (Freezone 6 L benchtop freeze dry systems, Labconco®, USA) and 
stored at -80 ºC until use (Figure 5.1). 
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                                                A                                                        B 
Figure 5.1. Pea protein isolate-alginate capsules. A) Wet capsules after cross-linking and 
filtering; B) Freeze-dried capsules. 
5.3.3 In vitro challenge in simulated gastric juice and simulated intestinal juice  
Early stationary phase (12 to 14 h) LRW and LRR cultures were harvested and triplicate 
samples of freshly prepared LRW, LRR and LRR-PPC were suspended to a concentration of 
approximately 8 log cfu/mL in simulated gastric juice [SGJ: 0.08 M HCl and 0.2 % NaCl (w/v), 
pH 1.5 or pH 2.0 ] at 37 ºC for 2 h or simulated intestinal juice [SIJ: 1.25 % NaHCO3 (Fisher, 
New Jersey, USA), 0.6 % (w/v) Difco
TM 
Oxgall (Becton, Dickson and Company, Sparks, MD), 
0.09 % Pancreatin (Sigma, Oakville, ON) ] for 3 h (Klemmer, 2011a). After incubation, SGJ 
treated samples were neutralized to pH 7.0 using 0.1 M NaOH. In order to physically disrupt the 
capsules and accurately enumerate viable bacteria, samples were homogenized on ice using a 
homogenizer (Fisher Scientific™ PowerGen™ Model 125 Homogenizer, USA) at speed 6 
(30,000 rpm) for 3 x 5s.  The samples were then plated on MRS agar and incubated at 37 ºC 
anaerobically for 48 h to enumerate the viable L. reuteri.  
5.3.4 In vivo probiotic delivery in pigs 
A total of 24 weaned pigs (8.81 ± 0.13 kg body weight, PIC commercial breed) were 
divided into three treatments (4 pigs/pen) and balanced by weight and gender. All the treatment 
groups received a non-medicated mash feed based on wheat, barley, soybean meal, and corn 
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distillers grains with solubles and meeting the nutrient requirements for the weanling pig (NRC 
1998). To control cross contamination, pens assigned to the control treatment group were housed 
on the opposite end of the room from pens assigned to pigs supplemented with bacteria. Boots 
were cleared of organic matters and sprayed with ethanol (75 %) after each visit of individual 
pens. Beginning of 6 d post-weaning (experimental d 0), pigs were supplemented with LRR-PPC 
or LRR-M at a level of 10
6 
cfu/g diet. Pigs in the third treatment group (Control) did not receive 
probiotic bacterial supplementation. Diets containing probiotic bacteria were prepared fresh each 
morning for three consecutive days using bacterial aliquots stored at -80 ºC. Water and diets 
were offered ad libitum throughout the experiment and feed intake recorded daily. Body weight 
was recorded at the beginning and end of the supplementation period. To confirm probiotic 
viability, subsamples (5 g) of feed were collected daily at 09:00 from both orts and freshly mixed 
feed, diluted in 10 mL peptone water and homogenized on ice. Samples were plated on MRS 
agar (200 µg/mL rifampin + 2000 µg/mL streptomycin) and cultured anaerobically for 48 h at 37 
ºC to permit enumeration of LRR.  
5.3.5 Enumeration of LRR in feces and digesta  
Fecal samples were collected on days 0, 1, 2 and 3 from the anus of individual pigs by 
digital manipulation. Fecal subsamples (0.2 g) were collected into pre-weighted 15 mL conical 
tubes containing 1 mL peptone water to permit enumeration of viable L. reuteri on selective 
MRS agar (200 µg/mL rifampin + 2000 µg/mL streptomycin). 
 All piglets were killed by captive bolt stunning and pithing at experimental day 4. Total 
contents (without mucosal scrapings) was collected from the stomach, duodenum (the proximal 
10% of small intestinal length), jejunum (1 m before and after intestinal midpoint), ileum (distal 
1 m of the small intestine exclusive of 10 cm proximal to the ileo-cecal junction), cecum, 
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proximal colon (ileocecal junction to apex of colonic spiral) and distal colon (apex to base of 
colonic spiral). All contents were collected into separate sterile plastic weight boats, mixed and 
subsampled. Subsamples (200 mg) from each location except for stomach were collected into 
pre-weighed 15-mL conical tubes containing 1 mL peptone water to permit enumeration of 
viable antibiotic-resistant L. reuteri using MRS agar containing antibiotic. In the case of stomach 
contents, a subsample (2 g) was collected into pre-weighed 50-mL conical tubes containing 5 mL 
peptone water. Stomach samples were either plated directly or after homogenization on ice 
(Fisher Scientific™ PowerGen™ Model 125 Homogenizer) at speed 6 (30,000 rpm) for 3 x 10 s 
in order to physically disrupt capsules.  
5.3.6 Statistical analysis  
The data analysis was processed by SAS version 9.4 (Statistical Analysis Software, SAS 
Institute Inc, 2013, Cary, NC, USA) using the mixed procedure. One-way analysis of variance 
(ANOVA) was used to assess treatment differences for in vitro experiments. A completely 
randomized design with factorial arrangement was used to assess lactobacillus counts in feed 
using treatment (LRR-PPC vs. LRR-M) and Time (0 vs. 24 h) as main effects. A repeated 
measures analysis was used to compare resistant lactobacilli counts in feces and intestinal 
contents using treatment as a main effect and day post inoculation or gastrointestinal location as 
repeated sources of variance, respectively. When a significant interaction with the repeated 
variable was observed, means within the repeated variable were separated by one-way ANOVA. 
Where treatment effects with more than two levels were significant (P < 0.05), means were 
separated using Tukey’s multiple comparisons. For in vivo experiments, pig was considered the 
experimental unit. 
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5.4 Results 
5.4.1 Characteristics of antibiotic-resistant L. reuteri 
One strain of L. reuteri was isolated that was capable of growth in 400 µg/mL rifampin + 
4000 µg/mL streptomycin following culture in the presence of gradually increasing antibiotic 
concentrations. This level of resistance exceeded the level of resistance observed in swine fecal 
microbiota. No growth of bacteria was observed in the culture of swine feces on selective MRS 
agar containing at least 200 µg/mL rifampin + 2000 µg/mL streptomycin (data not shown).  The 
growth of wild-type LRW and LRR in MRS broth with antibiotic (200 µg/mL rifampin + 2000 
µg/mL streptomycin, AB+) or without antibiotic (AB-) was followed over 32 h. Stationary phase 
for all the groups was observed from 10 to 18 h followed by exponential growth to about 32 h. 
The growth pattern of wild-type L. reuteri in AB- was similar to resistant L. reuteri in AB+. 
Wild-type L. reuteri did not grow in AB+. After daily subculture of LRR for 14 d in AB- MRS 
broth, the number of viable LRR recovered on the AB+ MRS agar remained consistent for each 
day at 9 log cfu/mL broth indicating no loss of resistance. 
5.4.2 In vitro challenge in simulated gastric juice and simulated intestinal juice  
After 2 h incubation in SGJ (pH 2.0) and 3 h in SIJ (pH=7.3), there was no difference in 
the reduction of viability of LRW, LRR or LRR-PPC (Table 5.1). However, after samples were 
challenged in SGJ (pH 1.5) for 2 h, a significant reduction in viability occurred for non-
encapsulated LRW and LRR (3.54 ± 0.06 and 3.51 ± 0.09 log cfu/g, respectively) compared to 
LRR-PPC group (1.13 ± 0.06 log cfu/g).  
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Table 5.1. Reduction in viable counts (log cfu/g) of freshly prepared wild-type (LRW), 
antibiotic-resistant (LRR) and encapsulated resistant L. reuteri (LRR-PPC) before or 
after challenge in simulated gastric juice (SGJ, pH 2.0 and pH 1.5) for 2 h and 
simulated intestinal juice (SIJ, pH = 7.3) for 3 h
a
.   
  pH  LRR-PPC     LRR     LRW P 
SGJ 2 1.02 ± 0.01 1.04 ± 0.23 1.06 ± 0.08 0.9721 
 1.5 1.13 ± 0.06a 3.51 ± 0.09b 3.54 ± 0.06c <0.001 
SIJ 7.3 0.04 ± 0.09 0.06 ± 0.45 0.10 ± 0.23 0.9805 
Note: Means with a different letter in the same row were significantly different at 
P<0.001 level. 
a 
Results are Mean ± SEM for triplicate determinations. 
5.4.3 Probiotic viability in feed 
Viable count of L. reuteri in freshly prepared feed and in feed recovered from feeding 
troughs after 24 h on each of the three experimental supplementation days is shown in Table 5.2.  
The viable count was not different for feed supplemented with LRR-M or LRR-PPC. However, 
there was a significant reduction (P < 0.001) of viable bacteria after 24 h for both LRR-PPC and 
LRR-M group. No antibiotic-resistant bacteria were recovered from the control diet.  
 
 
 
Table 5.2. Number (log cfu/g feed) of antibiotic-resistant bacteria enumerated on AB+ MRS
a
 agar 
for freshly prepared feed and feed recovered after 24 h for freeze-dried antibiotic-resistant L. reuteri 
with milk (LRR-M) and antibiotic-resistant L. reuteri coated with pea protein isolate-alginate 
capsules (LRR-PPC) supplemented diets for consecutively 3 d
b
. 
 Treatment Time (h) P value 
 LRR-PPC LRR-M 0 24 TRT T INT 
Enumeration 5.88 ± 0.2 5.89 ± 0.15 6.29±0.08 5.48 ± 0.06 0.9428 <0.001 0.3414 
a
AB+MRS: de Man, Rogosa and Sharpe media containing rifampin (200 µg/mL) and streptomycin 
(2000 µg/mL). 
b
Results are mean ± SEM for triplicate determinations. 
TRT = treatment, T = time, INT = interaction. 
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5.4.4 Probiotic shedding in feces 
Feed intake per pig was 245 ± 14 g/d, and not different among the three treatment groups 
for each day of supplementation. The number of antibiotic-resistant lactobacilli recovered in 
feces on each day of the study is shown in Table 5.3.  There was no recovery of antibiotic-
resistant lactobacilli on day 0 for all groups. Statistical comparison of antibiotic-resistant 
lactobacilli counts in feces from days 1 to 3 in LRR-M and LRR-PPC groups (excluding control 
group) using a repeated measures approach, indicated a significant (P < 0.01) effect of treatment 
and experimental day and a trend (P < 0.1) towards a treatment by day interaction. Fecal resistant 
lactobacilli count from the LRR-M group was significantly (P < 0.001) lower compared with the 
count in feces from LRR-PPC pigs during each of the 3 d in the feeding period. The shedding of 
antibiotic resistant lactobacilli increased (P < 0.05) on day 2 and day 3 compared with day 1 
independent of how LRR were administered (LRR-M or LRR-PPC). A trend towards a 
significant treatment by day interaction suggested that the increase in fecal shedding of resistant 
lactobacilli was greater in LRR-PPC as compared to LRR-M. No fecal shedding of resistant 
lactobacilli was observed on experimental day 1 in the control group. However, two control pigs 
shed antibiotic-resistant lactobacilli at 4.60 log cfu/g on day 2 and two pigs shed resistant 
lactobacilli at 4.62 and 4.60 log cfu/g on day 3. Only one pig shed resistant lactobacilli on both 
days.  
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5.4.5 Enumeration of viable LRR in digesta  
Counts of viable antibiotic-resistant lactobacilli in intestinal contents recovered along the 
gastrointestinal tract are showed in Figure 5.2. As expected, counts in control pigs were below 2 
log cfu/g in all locations.  Interestingly, in contents from stomach and duodenum, viable 
antibiotic- resistant lactobacilli counts were higher (P < 0.001) in LRR-M compared to LRR-
PCC pigs. In contrast, antibiotic-resistant lactobacilli counts in the distal small intestine, cecum 
and colon were higher (P < 0.001) in LRR-PPC compared to LRR-M pigs. Homogenization of 
the contents from stomach increased lactobacilli counts in stomach contents from LRR-PPC pigs 
without affecting the counts for LRR-M pigs such that homogenized counts were not different 
between the two treatment groups.   
Table 5.3. Antibiotic-resistant lactobacilli (log cfu/g feces) in fecal samples from pigs fed diets 
supplemented with freeze-dried antibiotic-resistant L. reuteri with milk (LRR-M) or antibiotic-
resistant L. reuteri coated with pea protein isolate-alginate capsules (LRR-PPC)
a
. 
Day post 
inoculation 
                           Treatment 
     LRR-M LRR-PPC   Overall   Control
b
 
Day 0        n.d.
c
       n.d.       n.d.  n.d. 
Day 1 4.96 ± 0.13 5.42 ± 0.02 5.19±0.35a  n.d. 
Day 2 5.29 ± 0.22 6.02 ± 0.11 5.65±0.61b  1.00 ± 0.61
 
Day 3 5.13 ± 0.16 6.32 ± 0.19 5.72±0.77b  0.53 ± 0.50
 
Overall  5.13 ± 0.10a 5.92 ± 0.11b   0.51 ± 0.28 
Note:  Means with a different letter in the same row were significantly different at P < 0.001 
level. 
a 
Results are Mean ± SEM (n = 8). Data were analyzed using Proc Mixed procedure using 
treatment as a main effect and day post inoculation as a repeated source of variation. Treatment 
P < 0.001, Day P = 0.0035, Treatment X Day P = 0.0857. 
b 
Data from the control group was not included in the statistical analysis. On day 2, two pigs out 
of eight both shed antibiotic resistant lactobacilli at 4.60 log cfu/g. On day 3, two pigs out of 
eight pigs shed antibiotic resistant lactobacilli with a mean of 4.60 and 4.62 log cfu/g, 
respectively. Only one pig shed resistant lactobacilli on both days. 
c 
n.d. Means no detectable value.  
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Figure 5.2. Antibiotic-resistant lactobacilli (mean log cfu/g digesta) enumerated in digesta (n = 8) 
from pigs fed the control diet or diets supplemented with freeze-dried antibiotic-resistant L. 
reuteri with milk (LRR-M) and antibiotic-resistant L. reuteri coated with pea protein isolate-
alginate capsules (LRR-PPC). Comparison of LRR-M and LRR-PPC treatment groups by 
repeated measures indicated Treatment by Location Interaction P < 0.01. (*within location P < 
0.05 between LRR-M and LRR-PPC). Vertical bars represent SEM. 
 
5.5 Discussion 
Encapsulation has been shown to provide protection to a variety of probiotic bacteria 
during in vitro challenge with simulated gastric juice and bile salts compared to non-
encapsulated bacteria (Guérin et al., 2003; Lotfipour et al., 2012; Piątek et al., 2012; Zhang et al., 
2013; Cook et al., 2014). Work has also shown improved bacteria viability in acid food products 
following encapsulation (Martoni et al., 2007; Ortakci and Sert, 2012). However, there are very 
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few studies establishing the efficacy of encapsulation technologies on the viability of probiotic 
bacteria in the intestinal tract. One limitation of investigating the viability of encapsulated 
probiotics is the difficulty in the selective enumeration of the encapsulated probiotic strain. 
Traditional selective culture methods are generally unable to differentiate probiotic bacterial 
strains from bacteria commonly found in the digestive tract. Furthermore, while molecular 
methods such as qPCR demonstrate improved selectivity, differentiation of live and dead 
bacteria remains difficult with this approach. In the current study, L. reuteri was selected as a 
model probiotic bacterium which has been reported as possessing probiotic properties including 
secretion of the antimicrobial protein reuterin (Muthukumarasamy et al., 2006) and improving 
animal growth performance (Agustina et al., 2013). By using natural selection, a strain of L. 
reuteri with stable resistance to antibiotics at concentrations exceeding resistance in lactobacilli 
colonizing the pig digestive tract was identified. This strain of L. reuteri allowed specific 
enumeration of viable probiotic in porcine feces and gastrointestinal tract after supplementation 
in feed following encapsulation in a pea protein isolate–alginate matrix or not.  
5.5.1 In vitro challenge 
Generally, lactic acid bacteria show good acid tolerance (van de Guchte et al., 2002). In 
this study, both wild-type L. reuteri ATCC 53608 and the antibiotic-resistant strain, were tolerant 
to challenge with simulated gastric juice at pH 2.0. However, both strains became susceptible 
when challenged under SGJ at pH 1.5. The significant protection observed when the pH of SGJ 
was lowered to 1.5 is consistent with the other studies investigating encapsulation of 
Lactobacillus spp. (Muthukumarasamy et al., 2006; Hassan and Rasco, 2014). Further, PPCs 
have provided acid protection in other probiotic strains. Klemmer et al. (2011) demonstrated the 
PPC significantly improved acid tolerance of Bifidobacterium adolescentis that was otherwise 
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highly susceptible to challenge in SGJ (pH 2.0). In the case of simulated intestinal juice (SIJ) 
challenge, bile salts and pancreatin did not affect the viability of L. reuteri used in this study. 
Instead, SIJ lead to enlarged capsules and may have facilitated the release of encapsulated 
bacteria (Klemmer et al, 2011a). Given the resistance to SIJ observed for the non-encapsulated L. 
reuteri strain used in this study, it is not surprising that no further enhancement in resistance was 
observed after encapsulation.   
5.5.2 In vivo probiotic delivery using pea protein isolate-alginate capsules 
In order to confirm that pigs received the same dose of viable probiotic, viability was 
determined both immediately after mixing with feed and after 24 h in the feed troughs. L. reuteri 
demonstrated significant loss of viability of approximately 1 log cfu /g feed during 24 h in feed 
at room temperature independent of whether the probiotic was encapsulated or not. Thus, 
although this observation confirmed that pigs received the same dose of viable probiotic, lack of 
protection from loss of viability during storage in feed is a significant obstacle to the commercial 
application of some probiotic strains including lactobacilli, which was not improved by pea 
protein-alginate encapsulation (Weinbreck et al., 2010). Encapsulation has been previously 
shown to improve the viable shelf-life of probiotic bacteria when stored frozen but not on storage 
at room temperature (Heidebach et al., 2010). Given the typical storage times for prepared feeds, 
loss of 1 log cfu per gram feed per day would not be commercially acceptable, limiting 
application to mixing with probiotic immediately prior to feeding.  
Fecal shedding of antibiotic-resistant L. reuteri was observed within 24 h of 
supplementation consistent with expected. Transit time in the pig digestive tract could be vary by 
the diet composition and individual pigs and could take from 20 to 102 h to reach to the rectum 
in pig (Kim et al., 2007). Encapsulation appeared to increase the number of viable L. reuteri shed 
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in feces within 24 h compared to non-encapsulated and supported a further increase in shedding 
of approximately 0.5 log cfu/g feces over the 3 d feeding period. The observation suggested that 
encapsulation improved viable probiotic delivery to the distal gastrointestinal tract as previously 
observed in mice (Iyer et al., 2013).  It is unclear why shedding may have increased over time to 
a greater extent in the encapsulated group. It is unlikely that the efficacy of the capsules 
improved but perhaps, the delivery of viable bacteria in higher number affected the dynamics of 
microbial colonization in this complex community permitting L. reuteri to occupy a larger niche. 
Finally, although efforts were made to minimize cross contamination of the probiotic between 
control and supplemented pigs, low counts of viable antibiotic-resistant lactobacilli were 
observed in feces of some control pigs 48 h after initiation of the experiment. Similar low levels 
were found in digesta collected after 3 d of feeding. Those contaminations in the control group 
may result from transport on air particles within the room or inadvertent contamination carried 
between pens by staff. Clearly, the design of studies comparing probiotic supplemented groups 
and control groups should be carefully considered to minimize transfer of the viable organism to 
control pigs. 
Enumeration of antibiotic-resistant L. reuteri in digesta collected along the length of the 
pig gastrointestinal tract indicated an interesting pattern. Whereas as viable antibiotic-resistant 
lactobacilli counts were relatively static in all locations in LRR-M pigs, counts in LRR-PPC pigs 
were below LRR-M in proximal regions and above LRR-M in distal regions. Although increased 
probiotic counts in distal locations for pigs fed LRR-PPC was consistent with higher levels of 
fecal shedding, low counts in proximal regions were unexpected. However, visual observation 
indicated the presence of intact capsules in the stomach that were present in declining abundance 
from proximal to distal regions of the small intestine. The few capsules observed in the ileum 
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appeared swollen and soft relative to the capsules observed in the stomach. Although there is 
limited research on the in vivo delivery of encapsulated probiotic, in vitro results have shown the 
release of Bifidobacterium adolescentis from pea protein-alginate capsules, formulated similarly 
to the current study, slowly in simulated intestinal juice (SIJ) over a 3-h period (Klemmer et al., 
2011b). The release mechanism of PPC was proposed to be mediated by the osmotic change, 
cleavage of amide bonds by pepsin and trypsin, and physical pressure. When stomach chyme 
from LRR-PPC pigs was homogenized to disrupt the capsules, similar bacteria counts were 
observed compared to the LRR-M group without pH adjusted to neutral for the stomach fluids.  
This increase in counts is consistent with our in vitro experience regarding enumeration of 
encapsulated bacteria where homogenization of capsules increased the recovery of viable counts 
enumerated on agar by 1 to 2 log cfu/g likely via physical disruption permitting bacteria 
dispersion on the plate. Given the observation of capsules along the length of the small intestine, 
it is likely that antibiotic resistant L. reuteri enumerated in these locations without 
homogenization underestimated total counts in LRR-PPC pigs.   
Although disruption of capsules increased counts in the stomach to the same level of non-
encapsulated bacteria, no increase in viability of antibiotic-resistant lactobacilli was evident in 
either stomach or upper small intestine. Because the pH of stomach contents from this study was 
above pH 3.0 at the time of euthanasia (data not shown), these observations are consistent with 
the tolerance of our L. reuteri strain to SGJ (pH 2.0). However, the results do not establish a 
mechanism by which the capsules improved L. reuteri colonization in distal gut locations.  
Interestingly, acid tolerance in lactic acid bacteria is related to H+-ATPase activity (H+ pump) 
(Matsumoto et al., 2004) while the survival mechanism from bile is unclear but may be related to 
triggering removal by an efflux pump (Gunn, 2000). Thus, both acid and bile tolerance 
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mechanisms require metabolic adaptations and ATP consumption. It is possible that while 
capsules may not improve viability, they could minimize the energy expenditure and metabolic 
adaptations required to survive in the upper gastrointestinal tract environment, improving their 
ability to compete for space and nutrients in the distal gut. Partial support for this could be 
extrapolated from the observation that loss of viable L. reuteri occurred when the pH of SGJ was 
lowered to 1.5.  
5.6 Conclusion 
An antibiotic-resistant L. reuteri was selected to establish the efficacy of pea protein - 
alginate capsules for in vivo delivery of a probiotic to the gastrointestinal tract of pigs. Although 
L. reuteri are resistant to acid conditions and bile found in the stomach and duodenum, 
respectively, encapsulation improved probiotic counts in the distal gastrointestinal tract and shed 
in feces. Encapsulation may be a viable approach to expanding the taxonomic repertoire of 
bacteria suitable for commercial probiotic application to include strains sensitive to 
environmental conditions in the upper gastrointestinal tract. Loss of probiotic viability in the feed 
bunk, however, was not improved by encapsulation. Whether encapsulation could also improve 
probiotic shelf-life under controlled conditions and or improve resistance to feed processing will 
require further investigation.    
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6 GENERAL DISCUSSION AND CONCLUSION  
A major obstacle for application of probiotic microorganisms in the animal feed industry 
is the maintenance of microbe viability during several challenges such as storage, processing and 
gastrointestinal passage. During probiotic product production and delivery to the animal, 
dehydration, oxidation, enzymatic, acidic, thermal and mechanical pressure are commonly 
encountered stressors that may all constitute lethal challenges. Exploring the efficacy of a 
protective matrix to protect against these challenges was the primary objective of this project. 
Specifically, we investigated the use of an extrusion method and a pea protein isolate–alginate 
matrix to microencapsulate bacteria and examined the efficacy of microencapsulation to protect 
the viability of model probiotic bacteria during challenges associated with probiotic production, 
storage, incorporation into feed and gastrointestinal delivery.  
6.1 Scale-up of encapsulation in a lab setup 
The current project required a large quantity of capsules (over 500 g) to permit 
examination of shelf-life over a 1 year period, to account for loss during the impact of 
commercial pelleting and to allow for inclusion of coated bacteria in the feed of a large animal. 
Compared to previous work, a relatively small amount of encapsulated probiotic was required to 
facilitate in vitro testing and small animal trials. Thus, the first objective of our project was to 
develop and scale up the production of a pea protein based encapsulation method (including 
freeze-drying) as previous work was mostly conducted using wet, freshly prepared capsules.  
A device that could produce capsules of consistent size and shape containing viable 
bacteria in sufficient quantity for an in vivo animal trial in a reasonable time frame was desired.  
Initial experiments involved extrusion using hand pressure with a large volume syringe (50 mL) 
as well as attempts to extrude using a peristaltic pump to apply extrusion pressure to the PAS 
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solution. However, these two methods were slow and too laborious to apply as an approach to 
produce the large quantities of capsules required. After several modifications, an appliance in 
which pressurized air could be controlled was set up to force the PAS liquid solution through an 
extrusion needle. Fine control of air pressure was critical in order to manage extrusion rate, 
capsule size and uniformity.  Nitrogen gas was initially used as the pressurizing gas rather than 
air when encapsulating anaerobic bacteria to reduce the potential stress from oxygen. However, 
in subsequent work, no difference was found between nitrogen gas and compressed air on the 
viability of anaerobic bacteria following extrusion (data not shown).   
Using the final design with pressurized air (see Figure 3.1), the maximum production of 
one device was approximately 250 g of dried capsules per day. Using two devices production of 
roughly 500 g of dried capsules per day was possible. A typical production run required about 12 
to 17 working days including, culture media preparation, culture of probiotic, glassware and tube 
sterilization (4 d), extrusion of wet capsules (1 to 3 d depending on the total quantity required) 
and freeze-drying (7 to 10 d). The average feed intake for a pig (6 to 8 wk olds) ranges from 0.75 
kg to 1 kg per day. When capsules are incorporated at 1 % (w/w) of the feed generating a 
relatively standard supplementation level of 10
5
 to 10
6 
cfu/g feed, a 3 d extrusion run was 
sufficient to supplement 50 kg feed. This amount of feed is sufficient to feed 2 weanling pigs for 
28 d. 
 Options to improve production capacity at the laboratory scale include doubling or 
tripling the number of appliances or to replace the single extrusion needle with multiple 
extrusion points (e.g. similar to a showerhead). Adaptations to extrusion methods applied in the 
literature include scaling up production through jet cutting and electrostatic droplet generation 
(Petrovic et al., 2007; Burgain et al., 2011). Jet cutting techniques use a cutter under the needle 
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that consists of a motor and cutting wire to continuously cut the fluids coming out from the 
needle at a high production rate (Pruβe et al., 1998). Electrostatic droplet generation applies 
electrostatic forces to disrupt the liquid surface at the needle tip producing small and uniform 
capsules (Poncelet et al., 1999). These methods could be applied in the future to increase the 
production and uniformity of capsules during extrusion.  
A loss of wall material occurred (approximately 5 % of dry matter) during extrusion and 
cross-linking as assessed by comparing the dry matter content of PAS and the dry matter 
recovered in freeze-dried capsules. Presumably, some PAS components (pea protein or alginate) 
leached into the cross-linking solution and could potentially be recovered, although this was not 
assessed. Similarly, a loss of bacteria (approximately 0.2 %) into the cross-link solution during 
production was also noticed because bacteria could be cultured from the cross-link solution. 
6.2 Efficacy of pea protein isolate-alginate encapsulation on the viability of probiotic 
bacterium during freeze-drying and storage 
There is limited research investigating the efficacy of encapsulation against loss of 
viability during freeze-drying (Heidebach et al., 2010) and during storage as dried capsules 
(Weinbreck et al., 2010). The loss of viability during freeze-drying was significantly improved 
by encapsulation compared to non-encapsulated bacteria in the B. adolescentis group. 
Encapsulation protected B. adolescentis during freeze-drying similar to the addition of milk plus 
glucose and glycerol, a common commercial practice. However, incorporating milk ingredients 
in the final products may lead to the allergy or religious concerns for human application. 
Although B. adolescentis is anaerobic, the addition of cysteine-HCl as a reducing agent did not 
improve viability during freeze-drying or storage as observed by others (Pan et al., 2013).  
Interestingly, glycerol was an effective additive in protecting against loss of viability. However, 
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the physical characteristics of glycerol after freeze-drying (sticky or gummy) made this additive 
undesirable given the impact of these characteristics on product “flow ability”. We did not 
examine a range of concentrations in testing additives, but instead the additive concentration 
applied in this project were based on industry and literature norms. An examination of a range of 
concentrations of the additives may be warranted in the context of application in combination 
with encapsulation.  
Limited advantages of PPC were observed in protecting against loss of probiotic viability 
during storage at different temperatures. The most protective effect from PPC was noted when 
the core bacteria was B. adolescentis and stored at -80 °C regardless of the additive used. It is 
unlikely that the level of protection observed during -80 °C would be of commercial value given 
that a simpler approach would be to recommend probiotic feed supplementation at a marginally 
higher rate accounting for storage losses. The rate of loss of bacterial viability increases as 
storage temperature increases and the protective effect of encapsulation on storage viability also 
became less as storage temperature increased. Indeed, no protective effect was observed at 
storage temperatures above 0 °C for neither B. adolescentis nor L. reuteri.  
Storage of probiotic at sub-zero temperatures to maintain probiotic shelf-life is costly and 
viable in the animal feed industry only for storage of concentrated product prior to addition to 
feed. Following incorporation into feed, the volume of product precludes sub-zero storage.  Thus, 
the most immediate challenge for the industry is to protect against the loss of probiotic viability 
during storage at uncontrolled temperatures experienced after incorporation in to feed and which 
range from sub-zero to over 40 °C. In our study, a significant loss of viability (about 0.8 log 
cfu/g) was observed during 24 h of storage at room temperature of encapsulated LR after 
incorporation in feed during the pig feeding period. Such a rate of loss of bacteria viability would 
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be unacceptable under commercial conditions where feed might be stored at room temperature 
for months rather than days.   
6.3 Efficacy of pea protein isolate-alginate encapsulation on viability of probiotic bacterium 
during feed pelleting 
Feed pelleting involves heat, steam and physical pressure challenges that are detrimental 
to bacteria viability. Indeed, pelleting is considered a processing method that could be used to 
control feed contamination by bacterial pathogens (Jones, 2011).  There are few studies reporting 
the viability of probiotic products after pelleting probably because of the harsh condition 
employed. Indeed, pelleting conditions offer a hurdle to the maintenance of bioactivity of some 
feed additives, notably feed enzymes included phytases and carbohydrases (Spring et al., 1996; 
Ribeiro et al., 2003). In the case of probiotic bacteria, published studies are largely limited to 
spores from Bacillus spp. known to be extremely resistant to harsh environmental conditions. 
Even so, only two studies have critically assessed the effect of pelleting on the viability of 
Bacillus spores (Jadamus et al., 2001; Amerah et al., 2013) and one other study examined the 
effect of different pelleting conditions on the survival of encapsulated E. faecium (Simon et al., 
2005). 
In the present study, encapsulation of using PPC provided significant protection during 
heat challenge (50, 70 and 90 °C) for B. adolescentis and L. reuteri as well as heat plus pressure 
(50, 70, 90 °C at 95 MPa) challenge for LR. However, there was lack of sufficient protection 
from encapsulation for core bacteria during the small commercial pelleting process. The 
significant reduction in viability during pelleting, compared to heat and pressure challenges, may 
be due to the second heat challenge at the die (70 to 77 °C) and the addition of steam. In this 
study, although the conditioner temperature was set at 90 °C, the actual temperature of the 
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conditioner was lower (64 °C without steam and 84 °C with steam) due to machine limitations. 
Even at a lower temperature of 64 °C, there was an approximately 4 log cfu/g reduction in 
viability for encapsulated and non-encapsulated bacteria groups. Therefore, PPC did not provide 
protection against loss of viability during steam pelleting. It will be difficult to develop an 
encapsulation protocol for vegetative bacteria that is able to protect against harsh pelleting 
conditions under steam, while also being capable of disintegrating in the gastrointestinal tract to 
release the organism into distal locations.  
For probiotic bacteria, post-pelleting application methods should be investigated as an 
alternative to inclusion prior to the pelleting step.  Examples including reconstituting dehydrated 
probiotics in water and spraying on feed after pelleting or even just before feeding may be 
commercially viable (Owunmi et al., 2016). Also, vacuum coating has been applied in the pet 
food industry to add probiotics after extrusion, an approach that could also be applied post 
pelleting (Kirejevas, 2007; Pascher et al., 2008). However, in addition to evaluating the impact 
of post pellet sprays or vacuum coating processes on probiotic viability, attention should be 
given to the potential for product separation from feed particles and sedimentation. Zhang, et al., 
(2016) indicated that a particle size larger than 1.5 mm is not recommended for incorporation 
with the feed due to sedimentation. This may be particularly problematic in the case of capsules 
of the size employed here, where sedimentation through feed, even in the case of mash is a likely 
possibility.  
6.4 Efficacy of pea protein isolate-alginate encapsulation on viability of a probiotic 
bacterium in the porcine digestive tract 
The final target of delivery of a probiotic product is the animal digestive tract. 
Encapsulation of PPC significantly protects B. adolescentis and L. reuteri during in vitro 
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gastrointestinal tract challenge as observed here and by others (Wood, 2010). Moreover, PPC 
showed significant protection of L. reuteri in pig digestive tract. The in vivo trial reported here 
showed that PPC carried and protected L. reuteri in the upper gastrointestinal tract and released it 
in the distal ileum. Compared to the non-encapsulated bacteria group, the PPC group 
successfully delivered more bacteria into the distal gastrointestinal tract resulting in increased 
shedding of the antibiotic resistant bacterium in feces. In the current study, the animal trial was a 
short feeding trial (3 d on the experimental diet) focussed on evaluating the delivery system and 
the specific recovery of viable probiotic in feces and along the gastrointestinal tract. We did not 
perform a long-term trial comparing the efficacy of probiotics on performance or health 
outcomes largely due to the variability of conditions under which probiotic supplementation 
results in positive responses. We, therefore, focussed on selecting a bacterium we could 
specifically track through antibiotic resistance. The species of bacterium was selected is 
commonly used as a probiotic organism. However, there was no consideration whether this strain 
would provide a health benefit.   
The development of an effective and specific recovery method for the animal trial was a 
challenge in the current study. As noted above, whereas molecular detection methods can be 
specific they lack the ability to assess viability and whereas culture-based methods permit 
assessment of viability, they lack specificity. The approach to select a stable, antibiotic-resistant 
bacterium to permit specific recovery of the encapsulated bacterium followed our experience 
with a separate study not reported here in which we attempted to assess recovery of encapsulated 
B. adolescentis. Both molecular (specific primer by qPCR) and selective culture (Beerens' agar) 
based methods were used to recover B. adolescentis from pigs that were fed diets containing 
encapsulated B. adolescentis or non-encapsulated B. adolescentis, with or without the addition of 
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FOS. The qPCR method could specifically detect the probiotic at the species level, but it could 
not differentiate between a probiotic that remained in capsules versus a probiotic that was viable 
and released. In the case of Beeren’s agar, the media was not selective for the probiotic species, 
which allowed for growth of bacteria species that normally reside in the pig intestine. 
Accordingly, these analyses did not permit clear interpretation of the efficacy of PPC in delivery 
and release of viable probiotics.  
 We investigated the potential to encapsulate other compounds using PPC with the 
intention of examining the efficacy of PPC to deliver bioactive payloads to the distal intestine 
(not reported here). We also encapsulated several different molecules including lysozyme, a 
fluorescein dye and butyrate selected to reflect a range of molecule sizes and chemistry, potential 
to serve as a capsule tracking system or potential as a beneficial gastrointestinal bioactive.  
However, the incorporation rate of these molecules (lysozyme 7.9 %, fluorescein isothiocyanate  
4 %, butyrate 13-17 %) with capsules was very low and would likely preclude any commercial 
application.     
We were able to produce small amounts of PPC containing food blue dye #1 sufficient to 
conduct a small in vivo trial in poultry with the intent of visually assessing capsule disintegration 
along the track. As shown in Figure 6.1A, intact capsules could be easily identified in the 
contents collected from the crop.  Interestingly, we were able to confirm the effective physical 
grinding capacity of the avian gizzard as shown in Figure 6.1B. The photograph shows the food 
dye-stained interior lining of the gizzard of chickens fed capsules containing dye and an absence 
of intact capsules in contents recovered from the gizzard or from distal locations. Although this 
study did not evaluate of the efficacy of capsules for in vivo payload delivery, we did identify 
poultry as an unsuitable model for this type of capsule. 
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Figure 6.1. Pea protein isolation-alginate capsules containing food dye in chicken digestive tract. 
A) Digesta in crop; B) Digesta in gizzard. 
 
6.5 Overall summary and conclusions   
An extrusion appliance and methodology were devised to scale-up production of pea 
protein isolate-alginate based capsules in quantities adequate to conduct efficacy testing in near 
commercial scale feed processing and in a large animal. This process enabled encapsulation of 
live probiotic bacteria efficiently. However, encapsulation of bioactive proteins or small 
molecules occurred with very low incorporation rates. The capsules were effective in protecting 
bacteria against loss of viability during freeze-drying. However, the efficacy of this capsule to 
protect probiotic bacteria from loss of viability during storage, especially above 0 °C, was 
limited. Although encapsulation protected probiotic bacteria during heat and pressure challenge, 
the capsules were not able to protect the viability of probiotics during pelleting, even at relatively 
low pelleting temperatures, compared to the industry norm. Lastly, this work was the first to 
demonstrate that pea-protein-based encapsulation enhanced the viability and colonization of 
probiotic bacteria delivered to the distal digestive tract when supplemented in the feed of 
A B 
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growing pigs. Therefore, whereas pea-protein based capsule may be useful in delivering sensitive 
bacteria to the distal gastrointestinal tract of target animals, viability during processing and 
storage remain a major challenge to commercial application.  
6.6 Future studies    
An improvement of encapsulation structures, encapsulation methods was recommended 
by Chen et al., (2017) for future probiotics encapsulation. In this project, although pea protein 
isolate-alginate encapsulation showed potential to enhance probiotic viability during some of the 
challenges probiotics experience during animal feed production, this technology alone will not 
address all challenges without further development and additional innovation. Other 
encapsulation methods that should also be investigated include emulsion-based methods that 
produce smaller-sized capsules. However, decreased capsule size could compromise the 
protection of core bacteria (Burgain et al., 2011). Capsule sizes (diameter) smaller than 100 µm 
are ideal for the incorporation of encapsulation in food products in order to prevent their effect 
on food texture (Talwalkar and Kailasapathy, 2004). The balance between effective protection 
and capsule size requires further investigation.  
A systematic evaluation of capsule formulation to maximize efficacy in protection of 
viability during storage and passage through the digestive tract is required. Due to time and cost, 
we were unable to evaluate variations in capsule composition including protein content and 
source, oligosaccharide content and source, and combinations of preservatives. A variety of 
formulations have been examined in the literature but there has not been a systematic comparison 
of preservative concentration, source of wall materials and additive combinations. Furthermore, 
studies have examined different bacterium or groups of bacteria and applied different controls, 
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preventing conclusions on whether specific formulations should be employed with specific 
species or strains.  
During initial studies, FOS was included in the matrix formulation as a prebiotic so that 
capsules protected probiotic viability against challenge and supported probiotic colonization in 
the gastrointestinal tract by serving as a preferred fermentation substrate. Products formulated to 
contain both prebiotic and probiotic have been termed “synbiotics” reflecting an expected 
synergy versus providing either prebiotic or probiotic benefits alone (Bielecka et al., 2002).  As 
noted above, we abandoned use of B. adolescentis as a model probiotic in favour of developing 
an antibiotic-resistant Lactobacillus to permit specific tracking of live bacteria during 
gastrointestinal tract passage. Because FOS is a preferred substrate for Bifdiobacterium species, 
its evaluation as a prebiotic in the case of a Lactobacillus payload was not warranted. 
Nevertheless, the efficacy of incorporating prebiotic compounds specific to the capsule payload 
requires further investigation.   
This work identified that a lack of protection during storage is the primary barrier to 
future probiotic development in animals. Investigation of a second layer of other wall 
components could be considered as a means of adding additional protection. Examples include 
an additional coating, such as chitosan or wax. This idea is based on the physical structure of 
PPC, which has several pores on the surface. An extra coating could block the pores reducing the 
contact of core bacteria with the outside environment and strengthen the wall matrix. Chitosan 
(as polycations) could further stabilize alginate-Ca
++
structure (Krasaekoopt et al., 2006).
 
Chitosan-coated alginate bead reportedly improves bacteria survival during acidic challenges and 
storage (Chávarri et al., 2010; Varankovich et al., 2017). Wax on the other hand, has been 
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reported as a good oxygen and moisture barrier (Weinbreck et al., 2010), and warrants further 
investigation.  
The steam pelleting process generates harsh environment conditions posing a substantial 
challenge to the protection of sensitive bacteria by encapsulation. Thus, research efforts should 
be directed towards the post-pellet application of probiotics. Options including post pelleting 
spray application as well as vacuum coating for heat-sensitive feed additives (Cao et al., 2007; 
Lamichhane, 2015). Post extrusion vacuum coating of probiotics has been reported in extruded 
pet food but detailed information is patented (Cavadini et al., 1999; verfügbar, 2007). Vacuum 
coating of encapsulated probiotics may have potential but there is currently no research on 
vacuum coating for probiotics after pelleting. Post-pellet vacuum coating may reduce the heat 
stress on probiotic products. However, additional protection is still needed, such as the 
encapsulation of probiotics during feed storage and delivery in the animal gastrointestinal tract. 
Furthermore, the encapsulation method applied in the current study may have limited application 
because the average size of capsules was 2 to 3 mm, which is unlikely to penetrate into a pelleted 
feed matrix.  A smaller sized capsule for probiotics will be needed for the vacuum coating study.  
 Animal species tested in this thesis was limited to swine and poultry. As noted above, the 
gizzard in poultry represents a separate challenge for the application of probiotics in this food 
animal species because the gizzard may not be well suited for the relatively large capsules 
generated by extrusion. Given that the gizzard lumen is an acidic environment (2.7 to 4.1), 
physical capsule disruption and release of the payload is likely. An examination of the fate of 
other types of capsules in the gizzard environment would be interesting given that poultry are a 
major target for probiotic intervention. Interestingly, given that the current extruded capsule 
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formulations tended to float in aqueous phase, their use to deliver probiotic bacteria as a pond 
surface feed for aquatic fish species (e.g. trout) may be of interest. 
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